Studies on Bioactive Heterocycles and other Moieties by Thakkar, Shailesh A.
          Saurashtra University 
     Re – Accredited Grade ‘B’ by NAAC 
     (CGPA 2.93) 
 
 
 
 
Thakkar, Shailesh A., 2010, “Studies on Bioactive Heterocycles and other 
Moieties”,  thesis PhD, Saurashtra University 
  
http://etheses.saurashtrauniversity.edu/id/eprint/468 
  
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge. 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author. 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given.  
 
 
 
 
 
 
 
 
 
Saurashtra University Theses Service 
http://etheses.saurashtrauniversity.edu 
repository@sauuni.ernet.in 
 
© The Author 
 
“STUDIES ON BIOACTIVE HETEROCYCLES  
AND OTHER MOIETIES” 
 
A THESIS SUBMITTED TO  
THE SAURASHTRA UNIVERSITY 
 
IN THE FACULTY OF SCIENCE  
FOR THE DEGREE OF 
 
DOCTOR OF PHILOSOPHY 
IN 
CHEMISTRY 
 
BY 
SHAILESH A. THAKRAR 
 
Supervisor : 
 
Prof. Anamik Shah 
DEPARTMENT OF CHEMISTRY 
(DST-FIST FUNDED AND UGC-SAP SPONSORED) 
SAURASHTRA UNIVERSITY 
RAJKOT – 360 005 GUJARAT (INDIA) 
 
OCTOBER – 2010 
 
 
 
 
 
 
Statement under O. Ph. D. 7 of Saurashtra University 
 
 
 
The work included in the thesis is done by me under the supervision of 
Prof. Anamik K. Shah and the contribution made thereof is my own 
work. 
 
 
Date: 
Place:                     Shailesh A. Thakrar 
  
 
 
 
 
CERTIFICATE 
This is to certify that the present work submitted for the Ph.D. degree of Saurashtra 
University by Mr. Shailesh A. Thakrar has been the result of work carried out under 
my supervision and is a good contribution in the field of organic, heterocyclic and 
synthetic medicinal chemistry. 
 
 
 
Date: 
Place:           Prof. Anamik K. Shah 
 DEDICATED 
TO 
MY FAMILY 
 ACKNOWLEDGEMENT 
It is moment of gratification and pride to look back with a sense of 
contentment at the long traveled path, to be able to recapture some of the 
fine moments, to be think of the infinite number of people, some who 
were with me from the beginning, some who joined me at different stages 
during this journey, whose kindness, love and blessings has brought me 
to this day. I wish to thank each of them from the bottom of my heart. 
Therefore first and foremost I bow my head humbly before 
ALMIGHTY GOD for making me much capable that I could adopt and 
finish this huge task. 
I bow my head with absolute respect and pleasantly convey my 
heartily thankfulness to my research guide and thesis supervisor, most 
respectable Prof. Anamik Shah, who has helped me at each and every 
stage of my research work with patience and enthusiasm. I am much 
indebted to him for his inspiring guidance, affection, generosity and 
everlasting supportive nature throughout the tenure of my research work.  
I would like to bow my head with utter respect and convey my 
pleasant regards to my most adorable mummy-papa, Mr. Arvindbhai K. 
Thakrar and Mrs. Jyotsnaben A. Thakrar for giving me permission 
and chance to undertake this project and also for their blessing, constant 
support, courage and enthusiasm, they have shown throughout my work 
without which the thesis would not have appeared in the present form. I 
am equally thankful to my dearest younger Brother Kalpesh and my 
sisters Nishadidi and Pritididi for their moral support and courage in 
each moment.  
My Special thanks to my jiju Dr. Jignesh Gadesha who gave me 
constant support during my all research work. I would like to give lots of 
love to our “LITTLE ANGEL” Vaidehi. 
I would like to express my feelings of gratitude to Prof. P.H. 
Parsania, Professor and Head, Department of Chemistry, Saurashtra 
University, Rajkot for providing adequate infrastructure facilities. 
I am also thankful to Dr. G.C.Bhimani who gave me constant 
support during my all research work. 
Words are inadequate to thanks my most beloved friends Abhay, 
Shrey, Vipul, Ashish, Hardevsinh and Dhairya who were always with 
me and helping me in all situation. 
Many many special thanks and lots of love to my dearest 
colleagues Rakshit, Dr. Dhawal, Nilay, Hitesh, Harshad, Manisha, 
Jignesh, Mrunal, Vaibhav, Ketki, Bharat, Bunty, Ravi, Sachin, Dipak, 
Punit, Paresh, Bharat, Vishwa, Pratik and Dilip.  
I would like to thank Dr. Preeti, Dr. Jyoti, Dr. Fatema, Dr. Atul, 
Dr. Vaibhav for all their help and support. 
I would also like to express my deep sense of gratitude to Dr. 
Ranjanben A. Shah and Mr. Aditya A. Shah for their kind concern and 
moral support that made my second home in Rajkot. 
I am also thankful to my Collegues Bhavesh, Dr. Ram, Govind, 
Minaxi, Chintan, Haresh, Kapil, Kaushik, Piyush, Renish, Naimish, Dipti, 
Amit, Mahesh, Piyush, Anil, Suresh, Jignesh, Lina, Pooja, Sandip, Ritesh, 
Ashish, Rahul, Bhatt and  Kataria. 
I am also thankful to Dr. Yogesh Naliapara, Dr. V.H. Shah, Dr. H. 
S. Joshi, Dr. Shipra Baluja, Dr. Manish Shah and Dr. Bhoya for their 
constant support. 
I would like to thank teaching and non-teaching staff members of 
Department of Chemistry, Saurashtra University, Rajkot. 
I am also grateful to Sophisticated Analytical Instrumentation 
Facility (SAIF), RSIC, Punjab University Chandigardh and Central Drug 
Research Institute (CDRI) Lucknow for 1
I am thankful to “National Facility For drug discovery through 
new chemical entities development and instrumentation support to 
small manufacturing pharma enterprises” for instrument support and 
limited financial assistance. 
H NMR and Department of 
Chemistry Saurashtra University, Rajkot for IR, Mass and Elemental 
Analysis. 
Lastly I would like to thank each and every one of them who 
helped me directly or indirectly during this wonderful and lots of 
experience gaining journey. 
I once again bow my head before almighty to facilitate me at every 
stage of my dream to accomplish this task. 
 
            Shailesh A. Thakrar 
Content 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
CONTENT 
 
General Remarks              
Abbreviations             
 
 
CHAPTER – 1 RAPID SYNTHESIS AND X-RAY CRYSTALLOGRAPHIC 
STUDY OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(1,3-
SUBSTITUTED DIPHENYL-1H-PYRAZOL-4-
YL)PYRIDINE-3,5-DI CAROBONITRILES. 
 
1.1 Introduction         1 
1.2 Literature Review        1 
1.3 Biological profile        18 
1.4 Pyrazoles : A versatile Synthon      20 
1.5 Aim of current work        21 
1.6 Reaction schemes        22 
1.7 Plausible reaction mechanism      23 
1.8 Experimental          24 
1.9 Physical data         27 
1.10 Spectral Discussion        28 
1.10.1 IR spectra                   28 
1.10.2 Mass spectra                   28 
1.10.3 1
1.10.4 Elemental analysis                  31 
H NMR spectral study                 28 
1.11 Analytical data        31 
1.12 Representative Spectras       34 
1.13 X-ray crystallographic study       38 
1.14 Result and discussion        51 
1.15 Conclusion         51 
1.15  References         52 
 
 
Content 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
CHAPTER – 2 SYNTHESIS OF NEW DIHYDRO PYRIDINES 
STRUCTURALLY RELATED TO MDR REVERTING 
AGENTS. 
2.1 Introduction                    61 
2.2 Literature Review        64 
2.3 1,4-dihydropyridine in MDR reversal                70 
2.4 Aim of current work        71 
2.5 Reaction schemes        72 
2.6 Plausible reaction mechanism      73 
2.7 Experimental          74 
2.8 Physical data         76 
2.9 Spectral Discussion        77 
2.9.1 IR spectra                  77 
2.9.2 Mass spectra                   77 
2.9.3 1
2.9.4 Elemental analysis                  80 
H NMR spectral study                  77 
2.10 Analytical data        80 
2.11 Result and discussion                                                                                     85 
2.12 Conclusion                                                                                                      85     
2.13 Representative Spectras                                                                                  86 
2.14  References                                                                                                       90 
 
CHAPTER – 3 SYNTHESIS OF ETHYL 5-CYANO-1,4-DIHYDRO-2,6-
DIMETHYL-4-(1,3-(SUBSTITUTED)-DIPHENYL-1H-
PYRAZOL-4-YL)PYRIDINE-3-CARBOXYLATES. 
 
3.1 Introduction                    94 
3.2 Literature Review        94 
3.3 Aim of current work        105 
3.4 Reaction schemes        106 
3.5 Plausible reaction mechanism      107 
3.6 Experimental          108 
3.7 Physical data         109 
3.8 Spectral Discussion        110 
Content 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
3.8.1 IR spectra                   110 
3.8.2 Mass spectras                   110 
3.8.3 1
3.8.4 Elemental analysis                  113 
H NMR spectral study                  110 
3.9 Analytical data        113 
3.10 Result and discussion                                                                                     118 
3.11 Conclusion                                                                                                      118 
3.12 Representative Spectra                                                                                   119       
3.13  References                                                                                                      123 
 
CHAPTER – 4 A RAPID MICROWAVE ASSISTED SYNTHESIS OF NEW 
COUMARINYL CHALCONES. 
 
4.1 Introduction                 126 
4.1.1 Synthesis of 4-hydroxycoumarins            127 
4.3.2 Biological activities                                     128 
4.3.3 Coumarinyl Chalcones            129      
4.2 Preparation methods of Chalcones                                       134 
4.3 Test for Chalcones                                                                                          141 
4.4 Aim of current work               141 
4.5 Reaction schemes               142 
4.6 Plausible reaction mechanism             143 
4.7 Experimental                144 
4.8 Physical data                146 
4.9 Spectral Discussion              147 
4.9.1 IR spectral study             147 
4.9.2 Mass spectral study             147 
4.9.3 1
4.9.4 Elemental analysis             150 
H NMR spectral study            147 
4.10 Analytical data              150 
4.11 Results and discussion             157 
4.12 Conclusion               157 
4.13 Representative Spectras            158 
4.14 References               162 
Content 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
 
CHAPTER – 5 CONVENTIONAL AND MICROWAVE ASSISTED 
SYNTHESIS OF NOVEL CYANO PYRIDINES. 
 
5.1 Introduction                  172 
5.2 Literature Review                 173 
5.3 Biological profile                                                  180 
5.4 Aim of current work                 181 
5.5 Reaction schemes                 182 
5.6 Plausible reaction mechanism               183 
5.7 Experimental                   184 
5.8 Physical data                  187 
5.9 Spectral Discussion                 188 
5.9.1 IR spectral study                188 
5.9.2 Mass spectral study                188 
5.9.3 1
5.9.4 Elemental analysis                191 
H NMR spectral study               188 
5.10 Analytical data                 191    
5.11 Results and discussion                199 
5.12 Conclusion                  199 
5.13 Representative Spectras                200 
5.14 References                  204 
 
CHAPTER – 6 SYNTHESIS OF BENZOPYRAN CLUBBED 1,5-
BENZODIAZAPINES APPENDED TO PYRAZOLES. 
 
6.1 Introduction                  210 
6.2 Synthetic Methods                 212 
6.3 Biological profile                                        218 
6.4 Aim of current work                 219 
6.5 Reaction schemes                 220 
6.6 Plausible reaction  mechanism               221 
6.7 Experimental                   222 
6.8 Physical data                  224 
6.9 Spectral Discussion                 225 
Content 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
6.9.1 IR spectral study                225 
6.9.2 Mass spectral study                225 
6.9.3 1
6.9.4 Elemental analysis                228 
H NMR spectral study               225 
6.10 Analytical data                 229 
6.11 Results and discussion                236 
6.12 Conclusion                  236 
6.13 Representative Spectras                237 
6.14 References                                                                                                    241 
 
CHAPTER – 7 BIOLOGICAL ACTIVITY OF SYNTHESIZED 
COMPOUNDS 
 
7.1 Introduction                  246 
7.2 Minimum inhibition concentration(MIC)              250 
7.3 Result and discussion                                                                                   257 
7.4 Conclusion                             258 
 
SUMMARY 
 
CONGERENCES/SEMINARS/WORKSHOPS ATTENDED 
 
 
 
 
 
 
 
 
 
 
 
  
General Remarks 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
 GNERAL REMARKS 
 
1. Melting points were recorded by open capillary method and are uncorrected. 
2. Infrared spectra were recorded on Shimadzu FT IR-8400 (Diffuse reflectance 
attachment) using KBr. Spectra were calibrated against the polystyrene 
absorption at ‘1610 cm-1
3. 
. 
1H Spectra were recorded on Bruker Avance II 400 spectrometer. Making a 
solution of samples in DMSO d6 and CDCl3
4. Mass spectra were recorded on Shimadzu GC MS-QP 2010 spectrometer 
operating at 70 eV using direct injection probe technique. 
 solvents using tetramethylsilane 
(TMS) as the internal standard unless otherwise mentioned, and are given in 
the δ scale. The standard abbreviations s, d, t, q, m, dd, dt, brs refer to singlet 
doublet, triplet, quartet, multiplet, doublet of a doublet, doublet of a triplet, ab 
quartet and broad singlet respectively. 
5. Analytical thin layer chromatography (TLC) was performed on Merck 
precoated silica gel-G F254
6. The chemicals used for the synthesis of intermediates and end products were 
purchased fro Spectrochem, Sisco Research Laboratories (SRL), Thomas 
baker, Sd fine chemicals, Loba chemie and SU-Lab.  
 aluminium plates. Visulization of the spots on TLC 
plates was achieved either by exposure to iodine vapor or UV light.     
7. All the reactions were carried out in Samsung MW83Y Microwave Oven 
which was locally modified for carrying out chemical reactions. 
8. All evaporation of solvents was carried out under reduced pressure on 
Heidolph LABOROTA-400-efficient. 
9. % Yield reported are isolated yields of material judged homogeneous by TLC 
and before recrystallization. 
10. The structures and names of all compounds given in the experimental section 
and in physical data table were generated ChemBio Draw Ultra 10.0. 
11. Elemental analysis was carried out on Vario EL Carlo Erba 1108.  
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ABBREVIATIONS 
 
CH3
Ar   Aromatic 
COOH  Acetic acid 
Av.   Average 
NH4
AOA   Antioxidant activity 
OAC  Ammonium acetate 
BP   Boiling point 
BF4  
BF
 Boron tetra fluoride 
3   
CAN   Ceric ammonium nitrate 
Boron triflouride 
CS2CO3 
CNS   Central Nervous System 
 Cesium carbonate 
Conc.   Concentrated 
DMF   Dimethyl Formamide 
DHP   Dihydropyridine 
DMSO   Dimethyl Sulfoxide 
Me2
NH(CH
CO  Dimethyl Carbonate 
3)2  
D.M.   Demineralized Water 
Dimethyl amine 
EtOH   Ethanol 
Equiv.   Equivalent 
EAA   Ethylacetoacetate 
FT-IR   Fourier Transform Infrared 
GC-MS  Gas Chromatography Mass spectra 
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HSC   Human squamous cell carcinoma 
HCl   Hydrochloric acid 
Hr.   Hour 
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Hz   Hertz 
I2   
ILC   Isoliquiritigenin chaldone 
Iodine 
MCRs    Multicomponent reactions 
CH3
MDR   Multidrug resistance 
MgI  Methyl magnesium Iodide 
MF   Molecular Formula 
MW   Molecular Weight 
MP   Melting point 
MeOH   Methanol 
MAA   Methylacetoacetate 
Mw   Microwave 
MIC   Minimum inhibition concentration 
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CH
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3
NCEs   New Chemical Entities 
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KBr   Potassium Bromide 
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R.T.   Room temperature 
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Rf   Retention Factor 
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NaHCO3  
NaBH
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NaH   Sodium hydride 
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Chapter-1 
Rapid synthesis and X-ray crystallographic 
study of 1,4-dihydro-2,6-dimethyl-4-(1,3-
substituted diphenyl-1H-pyrazol-4-
yl)pyridine-3,5-dicarbonitriles. 
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1.1 INTRODUCTION 
 
1,4-dihydropyridines contribute as an important class of compounds in 
medicinal chemistry, leading to several new drugs currently widely used especially as 
calcium channel  blockers and in other cardiovascular disease also. 
Dihydropyridine chemistry began in 1882 when Hantzsch1 published the 
synthesis, which now bears his name Hantzsch reaction and the work was limited to 
symmetric diesters at C3 & C5 
Some recent work is summarized as under. 
position. Then the synthesis was modified for 
Unsymmetric 1, 4-dihydropyridines also and last few years more than 10,000 papers, 
reviews and patents were published on these molecules. 
 
1.2 LITERATURE REVIEW 
 
  Josef et al.2
 Acetophenone when reacted
 prepared 3, 5-dicyano-2, 6-methyl-1,4-dihydopyridine by the 
condensation of acetone/cyclopentanone/cyclohexanone with benzoyl acetonitile. In 
this reaction 2,4,6-triphenyl-2-cyanomethyl-2H-pyran was also obtained in lower 
yields.   
3
 
 with 3-amino crotononitrile gave symmetric 3,5-
dicyano-2,4,6-trimethyl-4-phenyl-1,4-dihydropyridine. 
COCH3
H3C NH2
CN
N
H
CH3NC
H3C CH3
CN
 
 
 While symmetric 3,5-dicyano-1,4-dihydropyridine was prepared by the 
condensation of aldehyde with 3-amino crotononitrile in suitable acidic medium like 
acetic acid4-6 or hydrochloric acid.
 
7 
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CHO
H3C NH2
CN
N
H
H
NC
H3C CH3
CN
 
 
 A number of dihydropyridine derivatives have been prepared by reduction8,9
    
of 
the corresponding pyridines or pyridinium salts with complex metal hydrides. 
N
CN
NaBH4
N
H
CN
N
NC CN
NaBH4
N
H
NC CN
N
H
NC CN
 
     
 3,5-Dicyano-4-methyl pyridine9 and 3,5-dicyano-2,6-dimethyl pyridines9,10
 
 
afforded to give the dihydropyridine. 
N
H
NC CN
CH3
N
H
NC CN
H3C CH3
 
 
 The conversion of pyridine to dihydropyridine was carried out by employing 
Grignard reagent such as methyl magnesium iodide.11,12
     
  
N
NC CN
H3C
CH3MgI
N
H
NC
H3C CH3
CN
N
H
NC
H3C CH3
CN
CH3
H
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The preparation of Hantzch type 3,5-dicyano-1,4-dihydropyridine is 
sometimes reported via formation of tetrahyropyridine, which are isolated at room 
temperature in the presence of ammonium acetate.
 
13 
N
H
CH3
CNNC
H3C CH3
H
N
H
R
H
NC
H3C CH3
N R
 
 
A novel synthesis of polyfunctionally-substituted pyridine was reported by 
Famhy et al.14
 
 During this reaction, sometimes the formation of tautomer was also 
reported. 
NC
H2N COOCH2CH3
CN CN
CN
N
H
NC
H3C
CN
COOC2H5
CN
H
N
H
NC CN
H3C
H
CN
COOC2H5
 
 
 Shah et al.15
 
 prepared many cyano-1,4-dihydropyridines. Out of many 
compounds 3,5-dicyano-2,6-diethoxy-4-(2-hydroxy phenyl)-N-(2-pyridyl)-1,4-
dihydropyridine showed good anti-inflammatory activity and also showed moderated 
increase in blood pressure at 1mg/kg and 5 mg/kg. 
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N
NC
H3CH2COC COCH2CH3
CN
H
HO
 
 
Another compounds showed moderate hypotensive activity. 
 
N
NC
H3CH2COC COCH2CH3
CN
OCH3
H
 
 
 Mustafa et al.16
 
 developed an efficient synthesis method for 1,4-
dihydropyridines. It has been developing using 3 or 4 component condensation 
reactions of aldehydes, 1,3-dicarbonyl compounds, and ammonium acetate in the 
presence of aluminium sulfuric acid catalyst in minimum methanol at reflux 
temperature. This procedure offers several advantages including high yields, an 
environment friendly procedures, short reaction times, and a simple work-up 
procedure.   
1,4-Dihydropyridines (DHPs) are class of nitrogen containing heterocycles 
having a 6-membered ring. 1,4-DHPs, which are the most potent calcium antagonists  
or  calcium channel blockers, have received much attention due to their wide range of 
pharmaceutical and biological properties such as inhibition of human cytochrome 
P450 enzyme,17 angiotensine-converting  enzyme inhibition, and blood pressure 
control on chronic, nondiabetic nephropathies.18 1,4-DHP compounds play important 
roles in medicinal chemistry, for example nifedipine, amlodipine, felodipine, and 
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nicardipine, which are the best selling drugs used in the treatment of cardiovascular 
diseases.19
  
        
Matloubi et al.20
 
 has synthesized one-pot four-component reaction of 
aldehydes, ethyl acetoacetate/5,5-dimethyl-1,3-cyclohexanedione, ethyl acetoacetate 
and ammonium acetate in the presence of 10 mol% of ZnO as a heterogeneous 
catalyst for the synthesis of corresponding 1,4- dihydropyridine and 
polyhydroquinoline derivatives via the Hantzsch condensation is described. The 
present methodology offers several advantages such as simple procedure, excellent 
yields, and short reaction time. 
CHO
R
O
OC2H5
O
CH3COONH4
N
H
O
C2H5O
O
OC2H5
R
ZnO
10 mol %
 
 
Multi-component reactions (MCRs) have emerged as an efficient and 
powerful tool in modern synthetic organic chemistry allowing the facile creation of 
several new bonds in a one-pot reaction. Clearly, for multi-step synthetic procedures, 
the number of reactions and purification steps are among the most important criteria 
for the efficiency and practicability of the process and should be as low as possible. 
Therefore, in the last decade, research in academia and industry has increasingly 
emphasized the use of MCRs as well as domino reaction sequences for a broad range 
of products.
 
21 
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Catalysts such as Sc(OTf)3,22 Silica gel/NaHSO4,23 heteropolyacid,24 I2,25 
CAN,26 Yb(OTf)327 and Baker’s yeast 28 
  
have also been used in this reaction. 
Domestic microwave ovens as well as laboratory reactors have been 
successfully employed to prepare dialkyl 1,4-dihydropyridine-3,5-dicarboxylates and 
to induce the synthesis of the corresponding aromatic derivatives. In that latter 
particular case, unexpected results have been reported.  
 
Described more than one century ago by Hantzsch,29  dialkyl 1,4-dihydro-2,6-
dimethylpyridine-3,5-dicarboxylates (1,4-DHP) have now been recognized as vital 
drugs in the treatment of angina and hypertension. Some of them (Amlodipine, 
Felodipine, Isradipine, Lacidipine, Nicardipine, Nifedipine, Nimodipine, 
Nitrendipine) have been commercialized and it has been proven that their therapeutic 
success is related to their efficacy to bind to calcium channels and consequently to 
decrease the passage of the transmembrane calcium current, associated in smooth 
muscle with a long lasting relaxation and in cardiac muscle with a reduction of 
contractility throughout the heart.
 
30-32 
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The usefulness of those calcium antagonists has led to the development of 
novel synthetic strategies to improve classical methods of preparation33-35
 
 and 
microwave activation stands among the alternative routes proposed the past decade.  
Aromatization of 1,4-DHP has also attracted considerable attention in recent 
years as Böcker36 has demonstrated that metabolism of those drugs involves a 
cytochrome P-450 catalyzed oxidation in the liver. The so-obtained pyridines are 
devoid of the pharmacological activity of the parent heterocycles and are further 
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transformed by additional chemical modifications. Due to the biological importance 
of the oxidation step of 1, 4-DHP, that reaction has been the subject of a large number 
of studies and a plethora of reagents has been utilized to mimic the in vivo 
transformation. In that field, surprising results have been collected when the reactions 
are performed under microwave irradiation.  
 
The pioneering report on the use of microwave activation to obtain Hantzsch 
1,4-DHP was published by Alajarin et al. in 1992.37This group prepared a series of 4-
aryl derivatives in a domestic oven by the classical multicomponent method 
(aldehyde: 15 mmol; alkyl acetoacetate: 43 mmol; ammonia: 30 mmol; ethanol: 3 
mL). Yields ranged from 15 to 52 % for a reaction time of 4 minutes. The authors 
claim that classical protocols for the formation of the same compounds require a 
reflux period of 12 hours but they did not notice any yield improvement when 
microwave irradiation was applied. Three years later the same group extended its 
work38 to the preparation of 3,5-unsymmetrically substituted 1,4-DHP starting from 
arylmethyleneacetoacetate (8 mmol) and 3-aminocrotonate (4 mmol) in ethanol (4.5 
mL). This report again emphasizes that the rapidity of the microwave-assisted 
syntheses does not affect the isolated yields. The same year Zhang39 obtained four 4-
aryl 1,4-DHP from 3-aminocrotonate (20 mmol), methyl acetoacetate (20 mmol) and 
arylaldehydes (20 mmol) in a domestic oven. For the first time, the preparations were 
conducted in the absence of solvent. Yields ranging from 59 to 77 % are reported and 
optimized heating periods do not exceed 10 minutes. To avoid any loss of volatile 
material, the reaction flasks were fitted with a condenser containing xylene. Also in 
1995, Khadilkar40
 
 used the same building blocks as Zhang but in the presence of a 
solvent (ethanol, volume not reported; 3-aminocrotonate: 10 mmol; methyl 
acetoacetate: 14 mmol; arylaldehyde: 10 mmol). The heterocycles were prepared in a 
domestic oven within 3 to 5 minutes in 32 to 80 % yield.  
Interestingly, Khadilkar41 also described the formation, in a domestic oven, of 
1,4-DHP in an aqueous hydrotrope solution (50% butylmonoglycolsulphate : 5 ml). 
The experiments were performed with 3-aminocrotonate (10 mmol), methyl 
acetoacetate (14 mmol) and aliphatic or aromatic aldehydes (10 mmol). The final 
products were obtained within 3 to 6 minutes in 35 to 97 % yield. All reactions 
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described by Khadilkar 40,41 were carried out by exposing the reactants to microwaves 
in containers equipped with a condenser charged with precooled carbon tetrachloride. 
The coupling of microwave heating (in a domestic oven) with the use of a mineral 
solid support (alumina: 2 g) has later been exploited by Suarez 42
 
 to synthesize, within 
6 minutes and with a yield higher than 85 %, an unsymmetrical 1,4-DHP from methyl 
3-aminocrotonate (3 mmol), ethyl acetoacetate (3 mmol) and benzaldehyde (3 mmol).  
A catalytic amount of DMF (0.5 ml), as an energy transfer medium to attain 
higher temperatures, was added to the reaction mixture.  
 
In 2001, a single-mode microwave reactor (SmithSyntheziser from Personal 
Chemistry, Uppsala, Sweden) was used for the first time to accelerate the preparation 
of series of 1,4-DHP from various alkyl acetoacetates (12.5 mmol), aldehydes (2.5 
mmol) and 25 % aqueous ammonium hydroxide (10.0 mmol).43 
 
In comparison with 
experiments performed in domestic ovens, use of a laboratory synthesizer does not 
appear to provide improved results.  
Oxidation of 1,4-DHP under microwave irradiation was reported for the first 
time in 1991 by Alvarez et al. 44,45 They oxidized a series of 1,4-DHP (0.5 g) in a 
domestic oven by treatment on a mixture of manganese dioxide and Mexican 
bentonite clay (5.0 g, prepared from 1:2 or 1:4 mixtures of potassium permanganate 
and clay) in the absence of solvent. The procedure is characterized by short reaction 
times (10 minutes) and fair to quantitative yields (47-100 %). The most noticeable 
results were observed when starting from 1,4-DHP bearing a methyl, ethyl, or propyl 
group in position 4. Indeed those reactions afforded, unexpectedly, mixtures of 4-
alkylpyridines and 4-unsubstituted pyridine. In contrast, the same group related,46 two 
years later, that those 4-alkyl 1,4-DHP (0.25 g) do not undergo the dealkylation 
process when they are treated for 1 minute in a domestic microwave oven in the 
presence of a HNO3/Mexican bentonite clay system (2.5 g; prepared from a 1:1 
mixture of the components). Aromatization of 1,4-DHP has also been studied by 
Varma.47 He observed that solid state oxidation of 1, 4-DHP (1mmol) using elemental 
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sulfur (1.3 mmol) and microwave activation in a domestic oven affords the dehydro 
derivatives, whichever the 4-substituent is. 
  
 
Glycinium chlorochromate48
 
 (GCC) supported onto silica gel was used as an 
effective oxidizing agent for the aromatization of 1,4-dihydropyridine. 
Many of the reported reagents involve the use of strong oxidants such as 
KMno4,49 CrO3,50 HNO3,51 Pyridinium chlorochromate (PCC),52 Ceric ammonium 
nitrate (CAN),53 bentonite clay-supported manganese dioxide,54 Sulphar,55 
Palladium/Charcoal dehydrogenations56 and bismuth nitrate.57
 
 How ever this 
aromatization reaction with most of these reagents leads to dealkylation at the 4-
position or formation of side products. 
N
H
R
H
O
O
O
O
GCC
N
R
O
O
O
O
 
 
Lakshmi kantam et al.58
consistent activity. 
 has reported the one pot, three component synthesis 
of 2-amino-4-aryl-3,5-dicyano-6-sulfanylpyridines and the corresponding 1,4-
dihydropyridines are from readily accessible starting materials. Heating of an 
ethanolic solution of structurally diverse aldehydes with various thiols and 
malononitrile in the presence of nanocrystalline magnesium oxide provides the highly 
substituted pyridine derivatives in moderate to high yields, each representing a 
privileged medicinal scaffold with their structural motif. After completion of the 
reaction, the catalyst can be recovered efficiently and reused with 
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HAr
O
CN
CN
2 R SH
NAP-MgO
EtOH, reflux N
NC
H2N SR
CN
Ar
 
 
Gunaras et al.59 investigated 1,4-dihydropyridine structure as a less harmful 
alternative to synthetic phenolic antioxidants in liposomes under conditions 
simulating food storage. The antioxidant activities (AOA) of 2,6-dimethyl-3,5-
dialkoxycarbonyl- 1,4-dihydropyridines possessing various side chain length alkyls 
(CH3 - C16H33
 
) in ester moiety were tested in transition metalion catalyzed liposome 
peroxidation and compared with AOA of Trolox™ and Probucol™. The compounds 
with ethyl - butyl residues in the 3,5-position ester moieties exert the most 
pronounced AOA. The AOA of tested compounds is associated with their ability to 
incorporate into liposomes. 
Quaternary ammonium bromate have been prepared from the corresponding 
bromide  and use as a mild and efficient oxidizing agent for the aromatization of  
Hantzsch esters and related compounds to pyridine derivatives.
 
60 
N
H
R1 H
EtOOC
H3C CH3
COOEt
Solvent/reflux
R4NBrO3
NH3C CH3
COOEtEtOOC
R1
R4NBr
HBrO3
R4NBrO3
 
 
Cozzi et al.61
 
 prepared unsymmetric 4-[3-(1H-imidazol-1-yl-) Phenyl]-1,4-
dihydropyridines and studied their antitumor activity. They correlated activity with 
Letrozole, Anastrozole and other aromatase inhibitors. 
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N
H
H3C CH3
COCH3H3COOC
N
N
H
 
 
Mohammad et al.62
 
 had prepared 1,4-dihydropyridine under solvent free 
condition. Ethyl acetoacetate and a range of aldehydes in the presence of ammonium 
acetate were converted into 1,4-dihydropyridines under mild and solvent free 
conditions with good to excellent yields. 
O
OEt
O
R CHO CH3COONH4
N
H
H3C CH3
COOEtEtOOC
R
 
 
Bossert et al.63-66
 
 prepared many N-substituted 1,4-dihydropyridine derivative 
by Hantzsch reaction of an amine, acetoacetic ester and an aldehyde, where the 
condensation also proceeded in ethyl alcohol instead of pyridine.  
N
R2OOC COOR2
H3C CH3
R1
R
H
 
 
Duburs et al.67
 
 prepared N-benzyl-2,6-dimethyl-4-(3-nitro phenyl)- 3,5-
dicarbethyoxy-1,4-dihydropyridine by the condensation of m-nitro benzaldehyde with 
ethyl acetoacetate and benzyl amine using pyridine as a solvent. 
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N
H3CH2COOC
H3C
COOCH2CH3
CH3
H
NO2
 
 
Michael et al.68
 
 prepared antihypertensive and coronary vasodilator N-
substituted -1,4-dihydropyridine. 
N
CH2
H3CH2COOC
H3C
COOCH2CH3
CH3
H
CHOH
NH
CH3H3C
H3C
 
 
Minoru et al.69 prepared N-phenoxy-1,4-dihydropyridine by the reaction of m-
nitro benzaldehyde and methyl acetoacetate in presence of zinc chloride in ethyl 
acetate at room temperature for 65 min, then at 60-65O
  
C for 6 hrs to give heptadione, 
which was cyclized with hydroxylamine in methanol at room temperature. 
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CHO
NO2
O O
OCH3
Zinc chloride
COCH3
COOCH3
H3COC
H3COOC
N
OH
CH3
COOCH3H3COOC
H3C
NO2
NH2OH
 
 
Hung et al.70
 
 were successful in synthesizing antihypertensive model of 
Flordipine, contrary to the belief proposed by Triggle that N-substituted 1,4-
dihydropyridine will not give good antihypertensive activity, probably the concept of 
prodrug would not have been predicted at that time and –NH was believed to be 
essential for calcium channel antagonism. 
CF3
NH3C CH3
COOCH2CH3H3CH2COOC
H2C
H
CH2
N
O
 
 
Shah et al.71
 
 also prepared some Mannich Compounds and studied their 
antimicrobial profile. 
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R1
N CH3H3C
H3COOC COOCH3
N
S
R2
 
 
1,4-dihydropyridines were subjected to Mannich reaction to get new 2-alkyl-1-
(1’-dihydropyridinyl methyl) benzimidazole as hybrid molecule and was expected to 
give promising biological active molecules. They were reported to have good 
antimicrobial activity72
 
 instead of usual cardiovascular profile. 
R2
N CH3H3C
R1OC COR1
N
N
H
 
 
Pitzenberger et al.73
 
 investigated similar analogs in which benzyl amine 
reacted with acetoacetic ester and via formation as titan amine complex, leading to 
usual Hantzsch synthesis. 
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N CH3H3C
H3COOC COOCH3
H
CH3
 
 
Alkaer et al.74
 
 converted Amlodipine into a derivative as potent vasodilator. 
N
H
COOEtEtOOC
H3C O
Cl
N N
CH3
CH3CH3
 
 
Tsuchida et al.75
 
 has shown that CD-349 can be appeared to be a potent 
cerebrovasodilator in dogs and could be useful in the treatment of cerebrovascular 
disorders in human. 
N
H
H3C CH3
O O
O OO2NO
ONO2
CH3
 
 
Another class of 1,4-DHPs having a cyano group at 3 and 5 position was 
prepared by Court et al.76
 
  in 1952. They have prepared 3,5-dicyano-2,6-diphenyl-4-
(2-nitrophenyl)-1,4-dihydropyridine as well as 3,5-dicyano-2,6-dimethyl-4-(2-
nitrophenyl) 1,4-dihydropyridine and other similar compounds.   
Chapter – 1                                              Rapid synthesis and X-ray crystallography..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              17 
 
 
 
At this laboratory, the researchers of our group have reported the Tumor-
specific Cytotoxicity and MDR-reversal activity of dihydropyridines.77
  
  
 
Gaveriya et al.78 
 
have reported the synthesis and MDR reversal activity in 
Tumor cells. 
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1.3   BIOLOGICAL PROFILE   
 
Dihydropyridine (DHP) chemistry began in 1882 when Hantzch published the 
synthesis. The DHP nucleus is common to numerous bioactive compounds which 
include various vasodilaor, antihypertensive, bronchodilator, antiatherosclerotic, 
hepatoprotective, antitumor, antimutagenic, eroprotective and antidiabetic agents.
 
77-82 
DHP have found commercial utility as calcium channel blockers, as 
exemplified by therapeutic agents such as Nifedipine,83 Nitrendipine84 and 
Nimodipine.85 Second generation calcium antagonists include DHP derivatives with 
improved bioavailability, tissue selectivity, and/or stability such as the 
antihypertensive, antianginal drugs like Elgodipine,86 Furnidipine,87-88 Darodipine,89 
Pranidipine,90 Lemildipine,91 Dexniguldipine,92 Lacidipine93 and Benidipine.94 
Number of DHP calcium agonists has been introduced as potential drug candidates for 
treatment of congestive heart failure.95-96
 
   
The key characteristic of calcium channel blockers is their inhibition of entry 
of calcium ions via a subset of channels, thereby leading to imairment of contractin. 
There are three main groups of calcium channel blockers, i.e. dihydropyridines, 
phenylalkylamines and benzothiazepines, typical examples of which are nifedipine, 
verapamil and diltiazem respectively.97-100
 
 Each has a specific receptor on the calcium 
channel and a different profile of pharmacological activity. Dihydropyridines have a 
less negative inotropic effect than phenylalkylamines and benzothiazepines but can 
sometimes cause reflex tachycardia.Dihydropyridines are able to reduce peripheral 
resistance, generally without clinically significant cardiodepression.  
 Among DHPs with other types of bioactivity, Cerebrocrast101 has been 
recently introduced as a neuroprotectant and cognition enhancer lacking neuronal-
specific calcium antagonist properties. In addition, a number of DHPs with platelet 
antiaggregatory activity have also been discovered.102 These recent examples 
highlights the level of ongoing interest  toword new DHP derivatives  and have 
prompted us to explore this pharmacophoric scaffold to develop a fertile source of 
bioactive molecules. 
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1,4-DHPs posses different pharmacological activities such as antitumor,103 
vasodilator,104 coronary vasodilator and cardiopathic,105 antimayocardiac ischemic, 
antiulcer,106 antiallergic,107 antiinflammatory108 and antiarrhythmic,109 PAF 
antagonist,110  Adenosine A3 receptor antagonist111 and MDR reversal activity.
 
112-113 
In particular, DHP-CA (calcium channel antagonist DHP) are extensively used 
for the treatment of hypertension,114 subarachnoid hemorrhage,115-116 myocardial 
infarction117-120 and stable121-122 and unstable angina123-124 even though recently their 
therapeutic efficacy in myocardial infarction and angina has been questioned.125 This 
class of compounds is also under clinical evaluation for the treatment of heart 
failure,126 ischemic brain damage127 nephropathies and atherosclerosis.
 
128 
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1.4  PYRAZOLS : A VERSATILE SYNTHON 
 
Pyrazole refers both to the class of simple aromatic ring organic compounds of 
the heterocyclic series characterized by a five-membered ring structure composed of 
three carbon atoms and two nitrogen atoms in adjacent positions and to the 
unsubstituted parent compound. Being so composed and having pharmacological 
effects on humans, they are classified as alkaloids, although they are rare in nature. 
 
N
N
H
pyrazole
 
 
The synthesis of pyrazoles remains of great interest owing to the wide 
applications in pharmaceutical and agrochemical industry due to their herbicidal, 
fungicidal, insecticidal, analgesic, antipyretic and anti-inflammatory properties129-130. 
Some methods have been developed in recent years, though the most important 
method is the reaction between hydrazones and β-dicarbonyl compounds131 This 
reaction involves the double condensation of 1, 3-diketones or α, β-unsaturated 
ketones with hydrazine or its derivatives.132-133 However, the appealing generality of 
this method is somewhat vitiated by the severe reaction conditions or the multistep 
sequences usually required to access the starting materials.134 Thus, continuous efforts 
have been devoted to the development of more general and versatile synthetic 
methodologies for this class of compound. 
 
135 
N N
O
1,3-diphenyl-1H-pyrazole-4-carbaldehyde
 
 
The application of Vilsmeier–Haack (VH) reagent (POCl3 / DMF) for 
formylation of a variety of both aromatic and heteroaromatic substrates is well 
Chapter – 1                                              Rapid synthesis and X-ray crystallography..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              21 
 
documented.136  Besides this, the reagent has also been extensively used for effecting 
various chemical transformations from other classes of compounds. Many of these 
reactions have led to novel and convenient routes for the synthesis of various 
heterocyclic compounds.137  A notable example that finds significant application in 
heterocyclic chemistry is the synthesis of 4-formylpyrazoles from the double 
formylation of hydrazones with Vilsmeier-Haack (VH) reagent.138-139 These 
observations, coupled with the recent developments on the simple synthesis of 
pyrazole derivatives, 140 especially 4-functionalized 1, 3-diphenylpyrazoles as 
antibacterial, anti-inflammatory,141-142 antiparasitic143 and antidiabetic144  drugs, 
prompted chemistry research to undertake the synthesis of pyrazole-4-carboxldehyde 
derivatives using Vilsmeier-Haack (VH).145-146
 
 The study is particularly aimed at 
developing a one-pot synthesis of pyrazole-4-carboxaldehyde oximes starting from 
acetophenone phenylhydrazones. 
 
1.5 AIM OF CURRENT WORK 
 
The aim of current work was to prepare a small series of 1,4-dihydropyridine 
bearing the cyano group having a pyrazole heterocyclic ring in place of the 
conventional phenyl ring. 
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1.6   REACTION SCHEMES 
 
1.6.1 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
STEP – 1 
 
HN
NH2 CH3O
H
N
N
CH3
R R
a
 
 
Reagents / Reaction Condition (a): Glacial acetic acid, Ethanol / Reflux, 5-6 hours. 
Where, R = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO
 
2 
STEP – 2 
 
H
N
N
CH3
R
b N N
CHO
R
 
 
Reagents / Reaction Condition (b): DMF – POCl3
Where, R = 4-H, 4-Cl, 4-F, 4-NO
 / 70-80°C, 5-6 hours. 
2, 3-NO
 
2 
1.6.2 PREPARATION OF 4-(1,3-(SUBSTITUTED) DIPHENYL-1H-
PYRAZOL-4-YL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3,5-
DICARBONITRILE  
 
N N
OHC
R
H3C
NH2
CN
N
H
NC
CH3H3C
N N
+
CN
a
R
 
 
Reagents / Reaction Condition (a): Glacial Acetic acid / 60-70°C, 1 hours. 
Where, R = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 
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1.7   PLAUSIBLE REACTION MECHANISM 
 
 
H3C NH2
CN
Acid
H+
H
NH3C
H
H
H
NC
H
O
R
NC
H
R
O
H3C N
H
H
H
H
-H2O/ -H+
NC
H3C NH
H
R
CN
NH2H3C
H+
NC
H3C N
H
R
CN
NH2H3C
H
H+
R
NC CN
H3C CH3
N
H
H
N
H
H
N
R
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H3C CH3
H
H
NH2
-NH3
N
H
R
NC CN
H3C CH3
 
 
 
 
 
 
Chapter – 1                                              Rapid synthesis and X-ray crystallography..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              24 
 
1.8   EXPERIMENTAL 
 
1.8.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1
 
H NMR was determined in CDCl3/DMSO solution on a Bruker Ac 400 
MHz spectrometer. Elemental analysis of the all the synthesized compounds was 
carried out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
1.8.2 PREPARATION OF PYRAZOLE ALDEHYDE: GENERAL 
METHOD 
 
STEP – 1 PREPARATON OF ACETOPHENONE PHENYL 
HYDRAZONES. 
 
Appropriately substituted Acetophenone (0.1 mole) was dissolved in 50 ml of 
ethanol into 250 ml beaker. Phenyl hydrazine (0.1 mole) was added to above flask 
along with 3-4 drops of glacial acetic acid. The reaction mixture was stirred for 1 
hours at room temperature. The progress and the completion of reaction were 
checked by silica gel-G F254 thin layer chromatography using ethyl acetate : hexane  
(6 :4 ) as a mobile phase. After the completion of the reaction, the reaction mixture 
was kept to room temperature for 1 hours and the crystalline product was separated 
by filtration. The product was washed with ethanol and dried to give substituted 
acetone phenyl hydrazone in good yield which was pure enough to use as such for 
the next step. 
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TABLE – 1.1 
 
Code No. Substitution MF MW (g/m) MP (°C) % Yield 
PA-01 H C14H14N2 210 126-128 78 
PA-02 4-CH3 C15H16N2 224 134-136 80 
PA-03 4-NO2 C14H13N3O2 255 136-138 76 
PA-04 2-OH C14H14N2O 226 142-144 79 
PA-05 2-OCH3 C15H16N2O 240 158-160 76 
PA-06 4-Cl C14H13ClN2 244 144-146 82 
PA-07 3-NO2 C14H13N3O2 255 136-138 78 
PA-08 4-F C14H13FN2 228 148-150 84 
 
 
STEP – 2 PREPARATION OF PYRAZOLE ALDEHYDES 
 
Dimethylformamide (0.32 mole) was transferred into 25 ml flat bottom flak. 
Phosphorous oxychloride (0.032 mole) was added drop wise to above flask under 
stirring at 0-5OC. After completion of the addition, the mixture was stirred at this 
temperature for 10-15 min. freshly prepared acetophenone hydrazone 0.03 mole was 
added to above mixture and the content was heated on water bath for 5-6 hours. The 
progress and the completion of reaction were checked by silica gel-G F254 thin layer 
chromatography using toluene: ethyl acetate (6: 4) as a mobile phase. After the 
reaction to be completed, the reaction mixture was cooled to room temperature and 
the content of the flask was poured on crushed ice to isolate the product. The 
separated product was filtered off and it was washed with cold water to remove 
acidity. It was dried at 65O
 
C and recrystallized from the mixture of DMF-Methanol to 
give crystalline pyrazole aldehyde in good yield.  
Similarly other compounds are also prepared 
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TABLE – 1.2 
 
Code No. Substitution MF MW (g/m) MP (°C) % Yield 
PY-01 H C16H12N2O 248 162-164 75 
PY-02 4-CH3 C17H14N2O 262 176-178 70 
PY-03 4-NO2 C16H11N3O3 293 144-146 82 
PY-04 2-OH C16H12N2O2 264 142-144 78 
PY-05 2-OCH3 C17H14N2O2 278 148-150 72 
PY-06 4-Cl C16H11ClN2O 282 164-166 70 
PY-07 4-NO2 C16H11N3O3 293 154-156 82 
PY-08 4-F C16H11FN2O 266 148-150 68 
 
 
1.8.3 PREPARATION OF 4-(1,3-(SUBSTITUTED) DIPHENYL-1H-
PYRAZOL-4-YL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3,5-
DICARBONITRILE.  
GENERAL METHOD 
 
A mixture of pyrazole aldehyde (0.01 mol), 3-amino crotononitrile (0.02 mol) 
in glacial CH3COOH was stirred for 1 hrs at 60-70O
Similarly other compounds are also prepared. 
C in a stoppered flask. The 
reaction mixture was kept at room temperature for half an hour. During the reaction 
the progress and the completion of reaction were checked by silica gel-G F254 thin 
layer chromatography using ethyl acetate: hexane (3: 2) as a mobile phase. After the 
reaction to be completed, the reaction mixture was kept to room temperature for 1 
hours and the crystalline product was separated by filtration. The solid product was 
obtained after cooling and then filtered and washed with first acetic acid and then with 
hexane.  
The physical constant of newly synthesized compounds are given in Table No.1.3  
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1.9   PHYSICAL DATA 
 
Physical data of 4-(1,3-(Substituted) diphenyl-1H-pyrazol-4-yl)-2,6-
dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile.  
 
 
 
TABLE – 1.3 
Code Substitution 
R 
MF MW MP 
O
Rf Value 
C 
STAB-01 H C24H19N5 377 208-210 0.40 
STAB-02 4-CH3 C25H21N5 391 198-200 0.43 
STAB-03 4-Cl C24H18ClN5 411 178-180 0.43 
STAB-04 4-NO2 C24H18N6O2 422 228-230 0.42 
STAB-05 2-OH C24H19N5O 393 212-214 0.44 
STAB-06 2-OCH3 C25H21N5O 407 238-240 0.43 
STAB-07 3-NO2 C24H18N6O2 422 196-198 0.47 
STAB-08 4-F C24H18FN5 395 218-220 0.42 
 
 
 
Rf value was determined using solvent system = Ethyl Acetate : Hexane (3 : 2) 
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1.10   SPECTRAL DISCUSSION 
 
1.10.1   IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 model using KBr pallet method. Various functional groups present were 
identified by characteristic frequency obtained for them.  
The characteristic bands of Hydroxyl groups were obtained for streching at 
3400-3650 cm-1 and those for bending were obtained at 1050-1250 cm-1.The 
stretching vibrations N-H group showed in the region of 3200 to 3500 cm-1 with a 
deformation due to in plane bending at 1650-1580 cm-1. It gives aromatic C-H 
stretching frequencies between 3000-3200 cm-1 and bending vibration near 1300-1500 
cm-1 respectively. C-H stretching frequencies for methyl and methylene group were 
obtained near 2950 cm-1 to 2850 cm-1.  Characteristic frequency of C-N stretching 
showed near 2100-2200 cm-1 and bending vibration near 1300-1400 cm-1
 
.  
1.10.2  MASS SPECTRA  
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 
 
ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom.  
1.10.3   1H NMR SPECTRA  
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer by making a solution of samples in CDCl3 solvent using 
tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons and carbons identified from 1H NMR spectrum and their 
chemical shift (δ ppm) were in the agreement of the structure of the molecule. J 
values were calculated to identify o, m and p coupling. In some cases, aromatic 
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protons were obtained as multiplet. Interpretation of representative spectra is 
discussed as under. 
 
1
 
H NMR of 1,4-Dihydro-2,6-dimethyl-4-(1-phenyl-3-p-  tolyl-1H-pyrazol-4-yl)-
pyridine-3,5-dicarbonitrile.  (STAB-02) 
N
H
H3C CH3
NC CN
NN CH3
1 3
4
2
5
8
9
10
6
7
11
1213
14
15
 
 
1. Proton no. 1 and 3 of total 6H gave a singlet at 1.95 δ ppm. 
2. Proton no. 8 of total 3H gave a singlet at 2.39 δ ppm. 
3. Proton no. 4 became deshielded and gave a characteristic singlet at 4.57 δ 
ppm. 
4. Proton no. 7 and 9 of 2H gave a Doublet at 7.22 δ ppm 
5. Proton no. 13 of 1H gave a triplet at 7.26 δppm- 7.29 δppm.  
-7.24 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
6. Proton no. 11, 12, 14 and 15 of 4H gave a multiplet at 7.43 δppm – 7.50 δppm. 
7. Proton no. 6 and 10 of 2H gave a dublet at 7.76 δ ppm -7.80 δ ppm and J value 
of this proton is 8.0 Hz. It suggest ortho coupling. 
8. Proton no. 5 of pyrazol ring gave a singlet at 8.09 δ ppm. 
9. Proton no. 2 of pyridine ring gave a singlet at 9.05 δ ppm.
   
  
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
structure for compound no. STAB-02 has been confirmed. The spectrum is given on 
page no. 35. 
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1
 
H NMR of  4-(3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydro-2,6-
dimethylpyridine-3,5-dicarbonitrile. (STAB-03) 
N
H
H3C CH3
NC CN
NN Cl
1 3
4
2
5
8
6
7
10
1112
13
14 9
 
 
1. Proton no. 1 and 3 of total 6H gave a singlet at 1.86 δ ppm. 
2. Proton no. 4 become deshielded and gave a characteristic signal at 4.48 δ ppm. 
3. Proton no. 12 of 1H gave a triplet at 7.18-7.22 δ ppm.    
4. Proton no. 6 and 9 of 2H gave a Doublet at 7.31 δ ppm 
5. Proton no. 11 and 13
-7.33 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
 
6. Proton no. 7 and 8 of 2H gave a Doublet at 7.48 δ ppm – 7.51 δ ppm and J 
value of this proton is 8.0Hz. It suggest ortho coupling. 
of 2H gave a triplet at 7.34 δ ppm – 7.38 δ ppm. 
7. Proton no. 10 and 14 of 2H gave a double dublet at 7.66 δ ppm -7.68 δ ppm. 
8. Proton no. 5 of 1H gave a singlet at 7.95 δ ppm. 
9. Proton no. 2 of 1H gave a singlet at 8.90 δ ppm.  
 
  
  
 
Thus, by observing and assigning the signals in the NMR spectrum and 
by the calculation of the J values for above proton, we can clearly suggest that the 
proposed structure for compound no. STAB-03 has been confirmed. The spectrum is 
given on page no. 37. 
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1.10.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds.  
The spectral and elemental analysis data are for individual compounds 
synthesized in this chapter is mentioned below. 
 
1.11 ANALYTICAL DATA  
 
1,4-Dihydro-2,6-dimethyl-4-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)pyridine-3,5-
dicarbonitrile. (STAB-02)  
Yield: 82%   IR (cm-1): 3296 (N-H stretching), 3126 (Aromatic C-H stretching), 2993 
(Aliphatic -CH3 stretching), 2839 (Aliphatic -CH2 stretching), 2198(C-N stretching), 
1662-1595 (N-H bending), 1508, 1448, 1354 (C-H bending), 1292 (C-N bending) 756 
(disubstituted), 686 (monosubstituted)   1H NMR (DMSO-d6) δ ppm: 1.95 (s, 6H), 
2.39 (s, 3H), 4.57 (s, 1H), 7.22-7.24 (d, 2H, J=8.0 Hz), 7.26-7.29 (t, 1H), 7.43-7.50 
(m, 4H),7.76-7.80 (d,2H, J=8.0Hz) 8.09 (s, 1H), 9.05 (s, 1H), MS: m/z = 391 (M+
 
) ; 
Anal. Calcd. for C25H21N5:  C, 76.70; H, 5.41; N,17.89; Found: C, 76.66; H, 5.36; N, 
17.81. 
4-(3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydro-2,6-dimethyl 
pyridine-3,5-dicarbonitile. (STAB-03)  
Yield: 85%IR (cm-1): 3290 (N-H stretching), 3126, 3016 (Aromatic C-H stretching), 
2993 (Aliphatic -CH3 stretching), 2839 (Aliphatic -CH2 stretching), 2200 (C-N 
Stretching),  1662-1599 (N-H bending), 1545,1446 ,1357 (C- H bending), 1294(C-N 
bending),  754 (disubstituted), 690 (monosubstituted) 1H NMR (DMSO-d6) δ ppm: 
1.86 (s, 6H), 4.48 (s, 1H), 7.18-7.22 (t, 1H), 7.31-7.33 (d, 2H), 7.34-7.38 (t, 2H), 7.48-
7.51 (d, 2H, J=8.0Hz), 7.66-7.68 (d,2H), 7.95 (s, 1H ) , 8.90 (s, 1H) MS: m/z = 411 
(M+), 413 (M+2
 
) ; Anal. Calcd. for C24H18ClN5: C, 69.98; H, 4.40; Cl,8.61; N, 17.00 ;  
Found: C, 69.89; H, 4.40; Cl, 8.59; N, 16.98.  
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1,4-Dihydro-2,6-dimethyl-4-(1,3-diphenyl-1H-prazol-4-yl)pyridine-3,5-
dicarbonitrile. (STAB-01)  
Yield: 80% IR (cm-1): 3286 (N-H stretching), 3109, 3012 (Aromatic C-H stretching), 
2841 (Aliphatic -CH2 stretching), 2195 (C-N stretching), 1664-1597 (N-H bending), 
1518, 1448, 1329 (C-H bending), 1284(C-N bending), 705 (mono substituted), MS: 
m/z = 377 (M+
 
) ; Anal. Calcd. for C24H19N5: C, 76.37; H, 5.07; N, 18.55; Found: C, 
76.29; H, 5.04; N, 18.50. 
1,4-Dihydro-2,6-dimethyl-4-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl) pyridine-
3,5-dicarbonitrile. (STAB-04)  
Yield: 84% IR (cm-1): IR (cm-1): 3296 (N-H stretching), 3129 (Aromatic C-H 
strething), 2998 (Aliphatic -CH3 stretching), 2836 (Aliphatic -CH2 stretching), 
2210(C-N stretching),  1668-1599 (N-H bending), 1540,1365 (C-NO2 stretching), 
1510,1458, 1356 (C-H bending), 1296(C-N bending), 758 (disubstituted), 688 
(monosubstituted) MS: m/z = 422 (M+
 
) ; Anal. Calcd. for C24H18N6O2: C, 68.24; H, 
4.29;  N, 19.89; O, 7.57 Found: C, 68.14; H, 4.25; N, 19.80; O, 7.49. 
1,4-Dihyro-4-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-
dimethylpyridine-3,5-dicarbonitrile. (STAB-05)  
Yield: 82% IR (cm-1): 3610 (-OH stretching), 3294 (N-H stretching), 3124 (Aromatic 
C-H stretching), 2990 (Aliphatic -CH3 stretching), 2830 (Aliphatic -CH2 stretching), 
2208(C-N stretching), 1661-1592 (N-H bending), 1508,1456, 1360 (C-H bending) , 
1240 (-OH bending), 1298(C-N bending),  752(1,2-disubstituted ), 678 
(monosubstituted)  MS: m/z = 393 (M+
 
) ; Anal. Calcd. for C24H19N5O: C, 73.27; H, 
4.87; N, 17.80; O, 4.07 Found: C, 73.23; H, 4.79;  N, 17.73; O, 4.03. 
1,4-Dihydro-4-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethylyridine 
-3,5-dicarbonitrile. (STAB-06)  
Yield: 81%  IR (cm-1): 3298 (N-H stretching), 3120 (Aromatic C-H stretching), 2996 
(Aliphatic -CH3 stretching), 2832 (Aliphatic -CH2 stretching), 2210(C-N stretching),  
1660-1582 (N-H bending), 1518,1466, 1361 (C-H bending), 1310 (C-O-C), 1299 (C-
N bending), 751(disubstituted), 670 (monosubstituted)  MS: m/z = 407 (M+) ; Anal. 
Calcd. for C25H21N5O: C, 73.69; H, 5.19; N, 17.19; O, 3.93 Found: C, 73.61; H, 5.17;  
N, 4.05; O, 3.90. 
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1,4-Dihydro-2,6-dimethyl-4-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)pyridine-
3,5-dicarbonitrile. (STAB-07)  
Yield: 80%  IR (cm-1): 3292 (N-H stretching), 3121 (Aromatic C-H stretching), 2986 
(Aliphatic -CH3 stretching),2842 (Aliphatic -CH2 stretching), 2201(C-N stretching), 
1662-1572 (N-H bending), 1542 (C-NO2 stretching)  1508,1476,1360 (C-H bending), 
1289(C-N bending), 750(disubstituted), 671(monosubstituted),  MS: m/z = 422 (M+
 
) ; 
Anal. Calcd. for C24H18N6O2: C, 68.24; H, 4.29; N, 19.89; O, 7.57 Found: C, 68.14; 
H, 4.16;  N, 19.81; O, 7.47. 
4-(3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydro-2,6-dimethylpyridine-
3,5-dicarbonitrile. (STAB-08)  
Yield: 86% IR (cm-1): 3298 (N-H stretching), 3124 (Aromatic C-H stretching), 2996 
(Aliphatic -CH3 stretching), 2852 (Aliphatic -CH2 stretching), 2208(C-N stretching),  
1666-1582 (N-H bending), 1518,1486,1360 (C-H bending) , 1299(C-N bending), 753 
(disubstituted), 672(monosubstituted)  MS: m/z = 395 (M+) , 397 (M+2
 
) ; Anal. Calcd. 
for C24H18FN5: C, 72.90; H, 4.59; F, 4.80; N, 17.71 Found: C, 72.83; H, 4.51;  F, 4.77. 
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1.12   REPRESENTATIVE SPECTRAS 
 
1.12.1 IR Spectrum of STAB-02 
 
 
1.12.2 Mass Spectrum of STAB-02 
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1.12.3 1
 
H NMR Spectrum of STAB-02 
 
 
1.12.4 Expanded 1
 
H NMR Spectrum of STAB-02 
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1.12.5 IR Spectrum of STAB-03 
 
 
 
1.12.6 Mass Spectrum of STAB-03 
 
 
500750100012501500175020002500300035004000
1/cm
-20
0
20
40
60
80
100
%T
32
90
.6
7
32
38
.5
9
31
26
.7
1
30
16
.7
7
28
39
.3
1
22
00
.8
5
16
62
.6
9
15
99
.0
4
15
45
.0
3
15
16
.1
0
15
16
.1
0
15
16
.1
0
14
46
.6
6
13
57
.9
3
13
25
.1
4
12
94
.2
8
12
28
.7
0
10
93
.6
7
10
26
.1
6
95
4.
80
84
0.
99
75
4.
19
69
0.
54
59
9.
88
51
5.
01
STAB-03
N
H
NC
H3C
CN
CH3
NN Cl
MW : 411 g/m
Chapter – 1                                              Rapid synthesis and X-ray crystallography..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              37 
 
1.12.7 1
 
H NMR Spectra of STAB-03 
 
1.12.8 1
 
H Expanded NMR Spectra of STAB-03 
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1.13 X-ray crystallographic study 
 
 Earlier, Crystal structure of 2,6-dimethyl-3-cyanide-5-methyl acetate-4-(4’-
methylthiophenyl)-1,4-dihydropyridine and crystallographic characterization was 
carried out.156
 
 This compounds was obtained by the substitution of cyanide group at 
C3 and acetyl group at C5 position of 1,4-dihydropyridine. A schematic diagram of the 
molecule is shown in figure. 
     
A single crystal of C17H18N2O2S having dimensions of 0.2×0.3×0.25 mm was 
chosen for X-ray diffractions studies. The measurements were made on a Rigaku 
AFC7S diffractometer with graphite monochromated radiation (Mo Kα). The data 
were collected by the ω-2Ө scan technique and reduced using the teXsan data 
reduction program. Lorents and Polarisation corrections were applied. The structure 
was solved using a direct method and refined by least-squares method. 
 
 
 
         
 
 
 
 
 
 
 
[ORTEP diagram of 2,6-dimethyl-3-cyanide 5-methyl acetate-4-(4’-
methylthiophenyl)-1,4-dihydropyridine]  
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The ORTEP diagram of the molecule with thermal ellipsoids at 50% 
probability is given in previous page. Table. No.1 gives the details of the crystal and 
the experimental data. Table No.2 gives the fractional atomic coordinates and the 
equivalent thermal parameters for all the refined atoms. Hydrogen atoms were placed 
at chemically acceptable positions. Tables 3 and 4 give the bond distances and angles 
of the non-hydrogen atoms, respectively. The bond distances and angles are in good 
agreement with the those of reported structures. The packing of the molecules shows a 
layered arrangement along b axis. The structure adopts a flat boat conformation. The 
phenyl ring (C3, C4, C5, C6, C7, C8) is planner with the maximum deviation of 
0.005(2) Ao for C8. The torsion angles connecting between the phenyl and 
dihydropyridine rings determine the conformation around the C-C bind. The observed 
angles are C7-C6-C9-C14(83.09(14)o), C7-C6-C9-C10(155.08(12)o), C5-C6-C9-
C14(92.65(14) o) and C5-C6-C9-C10(29.19(16) o). The dihedral angle found between the 
planes 1(C9-C14) and 2(C3-C8) is 83.26(6)o. The structure exhibits intra and 
intermolecular hydrogen bonds of the type C-H….O and N-H….N. The intra and 
intermolecular hydrogen bonds are: C(18)-H(8A)….O(19) (2.873(2) Ao, 126) and 
N(12)-H(1)…N(16) (3.131(2) Ao, 151o), C(7)-H(13)…O(19) (3.225(2) Ao, 132o
Table-1 : Crystal and experimental data 
) with 
symmetry codes (-1/2 + x, 3/2-y,z) and (1/2+ x, ½-y,z) and (1/2+x, ½-y,z), 
respectively. 
Formula formula : C17H18N2O2S 
Formula weight = 314.39  
Crystal system : monoclinic  
Space group : P21/a z=4 
a=14.2499(14) A b=8.191(2) Ao o 
c=14.5527(16) A ß=107.059(8)o  o 
Volume = 1623.9(5) A  o3 
Density(Calculated)= 1.296 Mg/m  3 
Өmax = 32.49
o   with Mo Kα 
No. of reflections used = 3601[I>2σ(I)]  
R= 0.0473  
(∆/σ)max= 0.001  
(∆/ρ)max= 0.428e A  o3 
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(∆/ρ)min = -0.305 e A  o3 
Measurement : RIgaku AFC7S  
Program system : teXsan  
Structure determination : SHELXS-97  
Refinement : full matrix  
H atoms : geometrically fixed  
 
Table-2 : Atomic coordinates and equivalent thermal parameters 
Atom X Y Z Ueq 
C1 0.30816(16) 0.7344(3) 0.47490(16) 0.0678(6) 
S1 0.17978(3) 0.73927(7) 0.45911(3) 0.06156(17) 
C3 0.16862(10) 0.66112(17) 0.56833(10) 0.0372(3) 
C4 0.07322(10) 0.64499(18) 0.57462(10) 0.0403(3) 
C5 0.05622(9) 0.57931(17) 0.65612(9) 0.0365(3) 
C6 0.13383(8) 0.52805(14) 0.73377(8) 0.0292(2) 
C7 0.22856(9) 0.54539(18) 0.72712(9) 0.0370(3) 
C8 0.24645(10) 0.6119(2) 0.64595(10) 0.0418(3) 
C9 0.11863(8) 0.46531(14) 0.82696(8) 0.0292(2) 
C10 0.01970(9) 0.38369(15) 0.81463(9) 0.0327(2) 
C11 -0.05524(10) 0.46349(18) 0.83458(10) 0.0380(3) 
N12 -0.04015(9) 0.61673(16) 0.87585(10) 0.0461(3) 
C13 0.05162(10) 0.68315(16) 0.91317(10) 0.0372(3) 
C14 0.12947(9) 0.60856(15) 0.89595(9) 0.0317(2) 
C15 0.22485(11) 0.67622(18) 0.93357(10) 0.0404(3) 
N16 0.30304(12) 0.7278(2) 0.96154(13) 0.0631(4) 
C17 0.05525(14) 0.83733(19) 0.96835(13) 0.0516(4) 
C18 -0.15986(11) 0.4076(2) 0.81302(15) 0.0562(4) 
O19 -0.05690(9) 0.12061(15) 0.78261(10) 0.0577(3) 
C20 0.00688(10) 0.21506(17) 0.77834(10) 0.0371(3) 
C21 0.07859(9) 0.17118(14) 0.74021(10) 0.0533(3) 
C22 0.07135(16) 0.0071(2) 0.70254(17) 0.0669(5) 
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Table-3 : Bond lengths (Ao
Atoms 
) 
Length Atoms Length 
S2-C3 1.763(1) N12-C11 1.381(2) 
S2-C1 1.776(2) C5-C4 1.387(2) 
C6-C7 1.389(2) C7-C8 1.391(2) 
C6-C5 1.394(2) C3-C8 1.391(2) 
C6-C9 1.524(2) C3-C4 1.395(2) 
C9-C14 1.522(2) C13-C17 1.489(2) 
C9-C10 1.523(2) O19-C20 1.209(2) 
C10-C11 1.354(2) C11-C18 1.502(2) 
C10-C20 1.471(2) C20-O21 1.347(2) 
C14-C13 1.353(2) C15-C16 1.149(2) 
C14-C15 1.420(2) C22-O21 1.444(2) 
N12-C13 1.373(2)   
Table-4 : Bond lengths (o
Atoms 
) 
Angle Atoms Angle 
C3-S2-C1 103.72(8) C8-C3-C4 118.65(12) 
C7-C6-C5 117.97(12) C8-C3-S2 125.18(10) 
C7-C6-C9 119.42(11) C4-C3-S2 116.15(11) 
C5-C6-C9 122.47(10) C14-C13-N12 119.05(12) 
C14-C9-C10 109.11(9) C14-C13-C17 125.61(14) 
C14-C9-C6 108.27(10) N12-C13-C17 115.33(12) 
C10-C9-C6 114.30(10) C10-C11-N12 120.01(12) 
C11-C10-C20 120.50(12) C10-C11-C18 127.22(14) 
C11-C10-C9 121.59(12) N12-C11-C18 112.72(13) 
C20-C10-C9 117.89(10) O19-C20-C21 121.54(13) 
C13-C14-C15 119.76(12) O19-C20-C10 126.76(13) 
C13-C14-C9 122.70(11) O21-C20-C10 111.67(11) 
C15-C14-C9 117.09(11) C3-C8-C7 120.16(12) 
C13-N12-C11 122.75(11) C5-C4-C3 120.72(13) 
C4-C5-C6 120.93(12) N16-C15-C14 177.51(15) 
C6-C7-C8 121.56(12) C20-C21-C22 115.25(13) 
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 In order to study the unsubstituted structures of DHP at C4 position, synthesis 
and crystal structure of 3,5-dicyano-2,6-dimethyl-4-phenyl-1,4-dihydropyridine was 
undertaken.
 
157 
 `The title compound was synthesized by the Hantzch method and 
characterized by the X-ray diffraction method. It crystallized in monoclinic space 
group P21/c with cell parameters a = 8.722(7) Ao, b= 11.420 (1), Ao, c= 13.307(1) Ao 
and Z = 4. The structure has N-H…
 
N type intermolecular hydrogen bonds and exhibits 
a flattened boat conformation. 
 
 
 
 
 
 
 
 
 
[ORTEP diagram of 3,5-dicyano-2,6-dimethyl-4-phenyl-1,4-dihydropyridine 
Table-5 : Crystal and experimental data] 
Formula C15H13N3 
Formul Weight 235.28 
Crystal system Monoclinic 
Space group P21/c,Z=4 
A 8.722(7) Ao 
B 11.420(1) Ao 
C 13.307(1) Ao 
ß 104.101(5) Ao 
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Γ 1285.5(2) Ao 
Dx 1.210 Mg/m3 
2Өmax 64.8o 
R 0.0625 
(∆/σ)max 0.000 
(∆ρ)max 0.373 e Ao3 
(∆ρ)min -0.330e Ao3 
Measurement DipLabo Kappa 
Program system Denzo 
Structure determination SHELXs-97 
Refinement Fullmatrix : SHELXL-97 
 
Table-6 : Atomic coordinates and equivalent temperature factors (Ao2
Atom 
) 
X Y Z Ueq 
N13 0.8655(2) 0.78752(14) 0.02215(12) 0.0679(4) 
C7 0.8071(2) 0.97909(15) 0.12403(14) 0.0598(4) 
C8 0.7615(2) 0.97578(15) 0.02075(14) 0.0604(4) 
C14 0.9281(2) 0.78180(16) 0.06265(14) 0.0621(5) 
C6 0.6639(2) 0.98761(14) 0.21567(13) 0.0561(4) 
C11 0.7856(2) 0.88537(16) 0.04464(14) 0.0617(5) 
C1 0.6409(3) 1.08230(16) 0.28316(16) 0.0689(5) 
C16 0.9061(2) 0.87090(16) 0.13110(15) 0.0612(4) 
C5 0.5531(2) 0.89846(16) 0.23507(15) 0.0658(5) 
C9 0.6853(2) 1.07891(18) 0.00436(15) 0.0691(5) 
C17 0.9700(2) 0.86490(18) 0.21969(16) 0.0699(5) 
C12 0.7358(3) 0.8798(2) 0.14394(16) 0.0783(6) 
C2 0.5119(3) 1.08631(19) 0.36767(16) 0.0794(6) 
C15 1.0193(3) 0.67317(19) 0.07043(17) 0.0774(6) 
C4 0.4248(2) 0.90351(19) 0.31988(17) 0.0766(6) 
C 3 0.4045(3) 0.9969(2) 0.38603(17) 0.0790(6) 
N18 1.0157(2) 0.8649(2) 0.29337(16) 0.0930(6) 
N10 0.6271(3) 1.16323(18) 0.02184(17) 0.0923(6) 
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Table-7 : Selected bondlengths (Ao) and angles (o
N13-C14 
) 
1.370(3) N13-C11 1.387(2) 
C11-C12 1.490(3) C7-C6 1.521(3) 
C7-C8 1.522(2) C16-C17 1.423(3) 
C7-C16 1.523(2) C5-C4 1.383(3) 
C8-C11 1.333(3) C9-C10 1.139(3) 
C8-C9 1.431(3) C17-C18 1.145(3) 
C14-C16 1.348(2) C14-C15 1.491(3) 
C14-N13-C11 122.5(2) C8-C11-N13 119.4(2) 
C6-C7-C8 112.4(1) C8-C11-C12 125.3(2) 
C6-C7-C16 111.7(2) N13-C11-C12 115.3(2) 
C8-C7-C16 108.2(2) C2-C1-C6 120.8(2) 
C11-C8-C9 119.6(2) C14-C16-C17 120.2(2) 
C11-C8-C7 125.1(2) C14-C16-C7 124.1(2) 
C9-C8-C7 115.4(2) C17-C16-C7 115.6(2) 
C16-C14-N13 120.1(2) C6-C5-C4 120.7(2) 
C16-C14-C15 124.7(2) N10-C9-C8 177.5(2) 
N13-C14-C15 115.1(2) N18-C17-C16 176.2(2) 
 
 A single crystal of 2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-
dicarbonitrile 0.2×0.3×0.2mm was chosen for X-ray differaction studies. The 
measurements were made on a DIPLabo Kappa Imaging Plate system with graphite 
monochromated radiation (Mo K𝛼𝛼). Thirty six frames of data were collected by using 
the oscillation method. Successive frames were scanned in steps of 5OC/min with an 
oscillation range of 5O for an exposure of 400 s/frame. Image processing and data 
reduction were done by using Denzo. All the frames could be indexed with 
monoclinic primitive lattice. The experimental crystallographic details are given in 
Table No.5. The structure was solved by direct methods and refined by full-matrix 
least square methods with anisotropic temperature factors for the non-H atoms. All H 
atoms were placed at chemically acceptable positions and were refined with isotropic 
temperature factors. The final coordinates and equivalent thermal parameters of non-
H atoms are listed in Table No 6.  Table No. 7 gives selected bond distance and bond 
angles; they agree with their standard values. Figure 4 represents the ORTEP diagram 
Chapter – 1                                              Rapid synthesis and X-ray crystallography..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              45 
 
of the molecule with thermal ellipsoids at 50% probability. Both the phenyl ring and 
the DHP ring are independentyly planner with a maximum deviation of 0.055 Ao for 
C7, and are almost perpendicular hydrogen bonds of the type N-H…N. The 
intermolecular distance between atoms is as follows N13-N13…N18 has length 
3.034(3) Ao and an angle of 147O
 The value of the torsion angle C5-C6-C7-C16 i.e.,59.1(2) determines the 
conformation around the inter-ring bond. The closer this angle is to 60.0, the closer 
the aryl group comes to bisecting the DHP ring. The other structure aspect 
characteristic of this compound is the confirmation of cyano groups. Each cyano 
group can be oriented in synperiplanar (cis) or in antiperiplanar (trans) conformation 
with respect to the adjacent C=C of the 1,4-DHP ring. The DHP ring adopts a 
flattened boat conformation. The crystal structure shown that the substitutions of 2,6-
dimethyl and electron-withdrawing 3,5-dicyano groups in dihydropyridine ring may 
have an opposite effect on calcium channels, such as agonist and antagonist activity.  
, with symmetry code (x, 3/2-y, 1/2+z). The 
molecular packing exhibits a linear chain structure (when viewed down b axis). 
 In continuation of this, crystal structure of 3,5-dicyano-2,6-dimethyl-4-(3-
chlorophenyl)-1,4-dihydropyridine was studied. 
 
A single crystal of dimensions 0.2×0.3×0.25 mm was chosen for x-ray 
diffraction studies. 
 The final positional coordinates with equivalent isotropic temperature factors 
for all nonhydrogen atoms are given in Table No.9. Table No. 10 give the bond 
distance  and angles of the non-hydrogen atoms, respectively. The bond lengths and 
angles are in good agreement with their standard values. Figure 6 represents the 
ORTEP diagram of the molecule with thermal ellipsoids at 50% probability. The 
packing of the molecule shows layered stacking when viewed along the b axis. The 
1,4-dihydropyridine ring is planner with a maximum deviation of 0.166 Ao for C8 and 
0.121 Ao for N14. The dihedral angle found between the planes 
1(C2,C3,C4,C5,C6,C7) and 2(C8,C9,C13,N14,C15, C19) is 78.65o. The structure has 
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an intermolecular hydrogen bond of the type N-H…N, and follows accordingly; N14-
H14…N11(2.984(7)Ao, 168 o
 
) with symmetry code x, 3/2-y, +z. 
 
 
 
 
 
 
 
 
 
Table-8 : Crystal and experimental data 
Formula : C15H12ClN3  
Formula weight = 269.73  
Crystal system : monoclinic  
Space group : P21/c Z=4 
a=13.173(2) A  o 
b=8.0298(18) A ß= 112.376(13) o 
c=13.8547(17) A  o 
γ=1355.2(4) A  o 
Dx= 1.322 Mg/m  3 
2Өmax = 46.5o  with Mo Kα 
No. of reflections used = 1425[I>2σ(1)]  
R = 0.0737  
(∆/σ)max = 0.042   
(∆ρ)max = 0.388 e A  o-3 
(∆ρ)min = - 0.533 e A  o-3 
Measurement : Rigaku AFC7S  
Program system : teXsan  5 
Structure determination : SHELXS-97 (Sheldrick, 1990)  
Refinement : SHELXL- 97 (Sheldrick, 1997)  
H atoms : geometrically fixed  
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Table-9 : Atomic coordinates and equivalent thermal parameters 
Atom X y Z Ueq 
C11 0.4886(14) 0.0425(2) 0.20850(13) 0.0849(8) 
C2 0.5602(5) 0.1765(7) 0.1560(4) 0.0580(14) 
C3 0.5173(5) 0.2060(8) 0.0509(4) 0.0689(16) 
C4 0.5741(6) 0.3110(8) 0.0112(4) 0.0730(18) 
C5 0.6726(5) 0.3831(8) 0.0759(4) 0.0640(15) 
C6 0.7148(4) 0.3528(6) 0.1826(3) 0.0490(13) 
C7 0.6565(4) 0.2478(6) 0.2221(4) 0.0556(14) 
C8 0.8200(4) 0.4392(6) 0.2529(4) 0.0495(13) 
C9 0.7983(4) 0.6169(6) 0.2756(3) 0.0465(12) 
C10 0.7813(5) 0.7385(7) 0.1957(4) 0.0540(13) 
N11 0.7687(5) 0.8312(6) 0.1294(4) 0.0737(15) 
C12 0.7580(5) 0.8325(7) 0.3886(4) 0.0619(15) 
C13 0.7892(4) 0.6631(6) 0.3656(3) 0.0499(13) 
N14 0.8134(4) 0.5486(5) 0.4456(3) 0.0527(12) 
C15 0.8655(4) 0.4019(6) 0.4452(3) 0.0494(13) 
C16 0.9089(5) 0.3114(7) 0.5476(4) 0.646(15) 
N17 0.9887(5) 0.0894(7) 0.3556(5) 0.0865(17) 
C18 0.9386(5) 0.2052(7) 0.3577(4) 0.0603(14) 
C19 0.8770(4) 0.3508(6) 0.3569(3) 0.0508(13) 
 
 
Table-10 : Bond lengths (Ao) and bond angles(o
Atom 
) 
Length Atoms Length 
C13-C9 1.350(6) C19-C18 1.420(8) 
C13-N14 1.381(6) C15-N14 1.364(7) 
C13-C12 1.490(7) C15-C16 1.500(7) 
C9-C10 1.428(7) C7-C2 1.376(8) 
C9-C8 1.511(7) C2-C3 1.368(8) 
C6-C7 1.368(7) C2-C11 1.760(6) 
C6-C5 1.389(7) C5-C4 1.392(9) 
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C6-C8 1.524(7) C3-C4 1.373(9) 
C8-C19 1.524(7) C18-N17 1.147(7) 
C19-C15 1.352(7) C10-N11 1.145(6) 
    
C9-C13-N14 118.9(5) C18-C19-C8 117.7(4) 
C9-C13-C12 125.3(4) C19-C15-N14 119.7(4) 
N14-C13-C12 115.7(4) C19-C15-C16 125.1(5) 
C13-C9-C10 119.0(5) N14-C15-C16 115.2(4) 
C13-C9-C8 122.9(4) C2-C7-C6 119.9(4) 
C10-C9-C8 118.1(4) C7-C2-C3 122.7(5) 
C7-C6-C5 118.0(5) C7-C2-C11 118.8(4) 
C7-C6-C8 122.0(4) C3-C2-C11 118.5(4) 
C5-C6-C8 119.9(5) C4-C5-C6 120.7(6) 
C9-C8-C6 111.4(4) C4-C3-C2 117.7(5) 
C9-C8-C19 107.9(4) C3-C4-C5 121.0(5) 
C6-C8-C19 113.1(4) N17-C18-C19 177.9(6) 
C15-C19-C18 120.2(5) N11-C10-C9 177.2(5) 
C15-C19-C8 122.0(5) C15-N14-C13 122.3(4) 
 
Current study on novel 1,4-dihydropyridine (STAB-03)
In continuation of our previous work on 3,5-dicyano 1,4-dihydropyridines, we 
have undertaken to study the crystal structure of 4-(3-(4-Chlorophenyl)-1-phenyl-1H-
pyrazol-4-yl)-1,4-dihydro-2,6-dimethylpyridine-3,5-dicarbonitrile. 
 : 
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Preparation of Crystal: 
0.5 gms of the sample of 1,4-dihydropyridine was taken in a beaker and dissolved in 
mimimum quantity of methanol at room temperature. To the solution, add 0.1 gm of 
activated charcoal and heated to boil. The solution was filtered using wattmann filter 
paper in a 25 ml standard conical flask and corked. The solvent was allowed to 
evaporate by thin layer evaporation and the single crystals were observed after 16 
days. The crystals were filtered and washed with chilled methanol. Please refer for the 
XRD analysis data, ORTEP and packing structures below. 
 
 
 
[ORTEP diagram of 4-(3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-
dihydro-2,6-dimethylpyridine-3,5-dicarbonitrile.] 
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Table 11: Crystal Structure and Refinement Table of STAB-03 
Formula C24 H17 Cl N5 
Formula Weight 410.88 
Wavelength 0.71073 Å 
Temperature 293 K 
Crystal System Monoclinic 
Space Group P21/c 
Cell dimensions a = 6.9730(6) Å 
 b = 22.225(4) Å 
 c = 13.966(2) Å 
  = 103.759(8)
Volume 
o 
2102.3(5) Å
Z 
3 
4 
Density(calculated) 1.298 g/cm
Data / Restraints / Parameters 
3 
3230 / 0 / 272 
F000 852 
Absorption Co-efficient 0.202 mm
Index ranges 
-1 
−7 ≤ h ≤ 7 
 −26 ≤ k ≤ 26 
 −15 ≤ l ≤ 14 
Goodness-of-fit on F 1.51 2 
Final R indices [I > 2σ(I)] R1 = 0.1458, wR2  = 0.4026 
Largest diff. peak and hole 0.83 and -.070 e/Å3 
 
 
The crystal structure studies have shown that it is a monoclinic structure and 
the cell dimentions are in the tune of approximately (a) 6.9730(6) Ao, (b) 22.335 
(4)Ao, (c) 13.966(2) Ao. 
The crystal structure and further refinement and comparative study with other 
molecules in this series is under study. 
The X-ray crystal structure determination of the compounds 
in this series has proved the synthetic methodology adopted and has led to structure 
confirmation. 
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1.14   RESULTS AND DISCUSSION 
 
The chemical entities enlisted above in this chapter, especially the 1,4-
dihydropyridines involving the pyrazole aldehydes, are novel and have been prepared 
by a new synthetic methodology. 
 
1.15   CONCLUSION 
 
In this chapter, along with yield optimization of the 1,4-Dihydropyridines, 
simple, easy and fast method was adopted. Exploration of unreported chemistry and 
their biological activity was the aim behind the work done in this chapter.  
The crystallography study of 4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-
yl)-1,4-dihydro-2,6-dimehylpyridine-3,5-dicarbonitrile confirmed the structure of 
compounds which  are of biological interest. 
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2.1   INRODUCTION  
  
1,4-dihydropyridines are well established as heterocycles having tremendous 
application and still further scope for its pronounced drug activity like calcium 
channel antagonism and antihypertensive action. Many other cardiovascular activities 
are associated with such compounds and they can be presented structure wise as 2, 6-
dimethyl-3, 5-diacetyl or dicarboxylate 1, 4-dihydropyridines substituted at 4-
position. 
 
N
H
R'OC
H3C
COR'
CH3
R H
 
 
All these drugs can be classified into categories: 
(a) Symmetrical compounds having esteric linkage both at 3 and 5 position of 
dihydropyridine. 
(b) Structure having different ester linkage at 3 and 5 position or positional 
variation at 2 or 3. 
(c) Symmetrical compounds having atleast one ester group. 
(d) Symmetrical structure without ester group or having two acyl group at 3 and 5 
position respectively. 
  
  As already known original Hantsch1,2
 Arthur Phillips
 pyridine synthesis consists of the 
reaction of ethyl acetoacetate with different aldehydes and ammonia. This method has 
been widely used for the preparation of dihydropyridines, where at 4-position, an 
aliphatic chain, aromatic or heterocyclic ring is present. α-β-unsaturated aldehydes 
and 1,3-Diketones have occasionally been used instead of ethyl acetoacetate or methyl 
acetoacetate to give 3,5-diacyl 1,4-dihydropyridine derivatives. 
 
3 of Welcome research laboratories, in his well recognized 
work, used Hantzsch synthesis to get symmetrical compound for the curare like 
activity that was the first time reported possible pharmacological activity of these 
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compounds and also reported that such compounds are devoid of undesirable side 
effect during clinical trials. 
 
 Court et al.4 made successful attempt to prepare 3,5-dicyano-1,4-dihydro-4-(2-
nitrophenyl)-2,6-diphenyl pyridine as well as 3,5-dicyano-2,6-dimethyl-(2-
nitrophenyl)-1,4-dihydropyridine and other similar compounds. They initiated 
application of 1,3-diketones likes acetyl acetone and 4-aminopent-3-enl-2-one and 
also a few aldehydes. 
 
 Berson et al.5 has originally prompted the idea involving the condensation of  
an aldehyde, acetoacetic ester and 1,3-dicarbonyl compounds with ammonia on basis 
of the earlier work done by Bayer and Knovenegal, who synthesized 2,6-dimethyl-
3,5-diacetyl-4 (substituted phenyl)-1,4-dihydropyridine. The important of asymmetric 
nature of C4 carbon atom of DHP draw the attention and absolute asymmetric 
synthesis was also studied in detail without the knowledge of it’s pharmacological 
properties, which was discovered in 80’s. 
 
 Love et al.6 investigated thoroughly structure and activity study of Hantzsch 
type dihydropyridines for its potent hypotensive activity. As a result Nifedipine came 
out as a promising compound which exerted its cardiovascular effects through a direct 
action on vascular smooth muscles. Love and other workers of SKF laboratories 
studied the possibility of symmetrical structure and they were found moderately 
active for its hypotensive activity. 
 
 Much work is done in last two decade and many molecules having more 
specific cardiovascular activity have come out as new drug molecules like 
Amlodipine,7 Barnidipine,8 Benidipine,9 Felodipine,10 Flordipine,11 Furaldipine,12 
Nilvodipine, Nimodipine,13 Nitrendipine,14 Riodipine,15 Sagandipine,16 Taludipine.17 
  
The structures of many drugs not covered in the first chapter are presented 
here. 
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 It has been observed in some recent drug like pranidine, lacidipine that a 
center for unsaturation created either at C4-phenyl ring or at C3-position of carbon 
chain, noteworthy change is marked in cardiovascular activity.  
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2.2 LITERATURE REVIEW 
   
Few recent methods leading to 1,4-dihydropyridines are summarized below.  
Sandeep et al.18
CHO
R
O
OC2H5
O
CH3COONH4
90 W
N
H
O
C2H5O
O
OC2H5
R
 discovered a novel method, which is eco-friendly, cost 
effective, solvent free and it was developed for the synthesis of 1,4-dihydropyridines 
from ethyl acetoacetate, aldehyde and ammonium acetate under domestic microwave 
oven. It was facile one-pot synthesis of 1,4-dihydropyridine in which reaction time 
was less with good yields. 
 
    
 
Matloubi et al.19 synthesized an one-pot four-component reaction of 
aldehydes, ethyl acetoacetate/5,5-dimethyl-1,3-cyclohexanedione, ethyl acetoacetate 
and ammonium acetate in the presence of 10 mol% of ZnO as a heterogeneous 
catalyst for the synthesis of corresponding 1,4- dihydropyridine and 
polyhydroquinoline derivatives via the Hantzsch condensation is described. The 
present methodology offers several advantages such as simple procedure, excellent 
yields, and short reaction time. 
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CHO
R
O
OC2H5
O
CH3COONH4
N
H
O
C2H5O
O
OC2H5
R
ZnO
10 mol %
 
 
 Surendra et al.20
O O
OHHO
HO
HO
L-Ascorbic acid
O O
ORRO
HO
PCC, 4A MS,
CH2Cl2,0-30oC
1 hrs
O O
ORRO
OHC
NH4OAC,TBAHS
b-keto compounds
ethylene glycol,90OCO
O
OR
RO
H
H
N
R1R1
Where R=CH3,CH2Ph
 R1,R2=Different substituents
 developed an efficient synthesis of 4-(butenolide-5-
methylidenyl)-1,4-dihydropyridines has been achieved via a three-component reaction 
of β-keto esters or ketones, ammonium acetate and vinylic aldehydes from ascorbic 
acid in the presence of tetrabutylammonium hydrogen sulphate in ethylene glycol. 
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The prominent biological activities associated with 1,4-dihydropyridines are  
Ca++ channel blockers and as drugs for the treatment of cardiovascular diseases and 
hypertension.21 The dihydropyridine skeleton is common in many vasodilator, 
bronchiodilator, anti-atherosclerotic, antitumor, hepatoprotective and anti-diabetic 
agents.22,23 They are also known as neuroprotectants, as anti-platelet treatment of 
aggregators and are important in Alzheimer’s disease, as antiischemic agents24. 
Interest in 1,4-dihydropyridines also relates to nicotinamide dinucleotide (NADH), a 
co-enzyme, and its unique ability to reduce many functional groups in biological 
systems. Although 1,4-dihydropyridines with various aromatic, heteroaromatic, 
aliphatic and sugar substituents at C-4 have been reported,25,26 there is no report of 
1,4-dihydropyridines bearing a (5-ethylidene tetranolactonyl) substituent at C-4. 
  
Farzin et al.2
N
H
R2OOC
H3C CH3
COOR2
N
N
SR1
HCHO
HN(CH3)2 N
H
R2OOC
H3C CH2CH2N(CH3)2
COOR2
N
N
SR1
N
NH
N
H
R2OOC
H3C
COOR2
N
N
SR1
N
N
R1 = CH3, C2H5, CH2C6H5
R2 = CH3, C2H5
 reported the synthesis and antihypertensive activity of newly 
synthesized 1,4-dihydropyridines.They prepared symmetric DHP by conventional 
Hantzch condensation as described previously. 
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A facile and convenient method was developed by Mohammad Nikpassand et 
al.27 for the fast and high yielding (70-90 %) synthesis of fused 1,4-dihydropyridines 
from dimedone in the presence of HY-zeolite as an efficient recyclable heterogeneous 
catalyst. 
 
 
 
  Mohammad et al.28
O
OEt
O
R CHO CH3COONH4
N
H
H3C CH3
COOEtEtOOC
R
 prepared 1,4-dihydropyridine under solvent free condition. 
Ethyl acetoacetate and a range of aldehydes in the presence of ammonium acetate 
were converted into 1,4-dihydropyridines under mild and solvent free conditions with 
good to excellent yields. 
 
 
 
Neamati et al.29
N
H
N
H
O
N
H
O
OH OH
OH OH
NO2
 reported that 1,4-dihydropyridine molecule came out with its 
anti-HIV activity, which has opened up the synthetic as well as pharmacological 
importance in antiviral area also. 
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Recently Mosti et al.30 prepared 2-substituted-5-acetyl-1,6-dihydro-6-oxo-3-
pyridinecarboxylic acid for its positive inotropic as well as cardiotonic activity  and 
structure activity relationship was also studied. 
 
Very Recently Shingare et al.31
N
H
R' R'
R
"R
O
R"
O
R  = Phenyl, O,m,p-nitro phenyl etc...
R"= CH3, OCH3 etc..
R  = CH3
 in a almost parallel work to this laboratory has 
came out with biological activity of a few 1,4-dihydropyridines. Many new 
compounds are prepared using few aldehydes and acetyl acetone for getting Hantzsch 
type dihydropyridines. 
 
 
 
Reddy et al.32
N
H
H3C CH3
N
H
O
N
H
O
R
R = NO2,OH, diOCH3 etc....
 synthesized 4-aryl hetroaryl-2,6-dimethyl-yl-3,5-bis-N-(2-
methyl phenyl) carbamoyl-1,4-dihydropyridines (A) through one-pot synthesis using 
appropriate aromatic aldehydes and liquid ammonia. Pharmacological screening of 
the new 1,4-dihydropyridines were also carried out for CNS depresent (anticonvulsant 
and analgesic) and cardiovascular (inotropic and blood pressure) activities by standard 
methods. 
 
 
 
Earlier Shah et al.33-35 synthesized 3,5-diacetyl-4-(substituted phenyl)-1,4-
dihydropyridine and 3,5-dibenzoyl-4-substituted phenyl-1,4-dihydro pyridine and 
studied their MDR reversal activity in tumor cells. 
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N
H
H3COC
H3C CH3
COCH3
R
N
H
PhOC
H3C CH3
COPh
R
R = OC6H5 , Cl, Br, etc...
 
 
Waldo et al.36
CHO
R OR1
OO
OR2
ONH2
N
H
H3C CH3
O
O
O
O
R2R1
R
 reported a Solvent-free, two-step synthesis of some 
unsymmetrical 4-aryl-1,4-dihydropyridines. 
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2.3  1,4-DIHYDROPYRIDINE IN MDR REVERSAL   
 
 The development of multidrug resistance (MDR) tumor cell population is a 
major problem in the chemotherapy of human cancer37. When tumor cells become 
resistant to anticancer agents such as vinca alkaloids or anthracylines, they often show 
resistance to other antitumor agents with different structures and mechanisms of 
action. Once of the MDR types was proved to involve a membrance bound protein, P-
glycoprotein (Pgp) in MDR cancer cells, Protozoa and bacteria. This protein acts as a 
efflux pump for anticancer drugs38.  
 
Recently various compounds have been shown to inhibit Pgp mediated drug 
efflux39. These compounds include ion channel blockers such as verapamil40, 
dihydropyridines (DHPs), Propafenone41, antipsychotic drugs like phenothazines42, 
quinolones43. Among them DHPs calcium antagonists have been studied extensively 
for the analogy to verapamil. In a combination treatment with antitumor agents, such 
as vinca alkaloids or anthracyclines, calcium antagonist verapamil caused 
cardiovascular side effects. It is very important finding that DHPs, which do not have 
any calcium antagonist activity, possess MDR reversal activity. 
 
Shah et al.44-45 have synthesized 4-phenyl-3,5-diacetyl -1,4-dihydropyridines 
(AcDHPs) and 4-phenyl-3,5-dibenzoly-1,4-dihydropyridines (Bz DHPs) substituted at 
the phenyl ring and compared for their cytotoxic activity and multidrug resistance 
(MDR) reversing activity in in vitro assay systems. Among their synthesized 
compounds (G7), in AcDHPs and compounds having 2-CF3, 2-Cl and 3-Cl showed 
the highest cytotoxic activity against human promyelocytic leukemia HL-60 and 
human squamous cell carcinoma HSC-2 cells. 
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N
H
H3C CH3
Cl
H3C
O O
CH3
N
H
H3C CH3
O O
R
H
G7
AcDHPs
(Bz DHPs)
R= CF3, H, NO2 etc....
 
 
Saponara et al.46 have investigated the effects of AcDHPs and BzDHPs on 
vascular functions in vitro, by comparing their mechanical and electrophysiological 
actions, as well as quantify their MDR reversal properties.  
 
In earlier chapter, an approach was to synthesize symmetric 3,5-dicyano 1,4-
DHPs while in this chapter, 3,5-dibenzoyl 1,4-DHPs synthesized possess symmetric 
structures with respects to C3 & C5
2.4 AIM OF CURRENT WORK 
 position of the ring. 
 
 
 
The structure of many 1,4-Dihydropyridines are important for the treatment of 
cardiovascular diseases,47 multidrug resistance (MDR) during cancer chemotherapy,48 
as possible thromboxane synthetase inhibitors,49 PAF-acether antagonists,50 and 
antithrombotic-antihypertensive agents.51 An alternative to the usual means for the 
synthesis of 1,4-dihydropyridines2 is the partial reduction52 of pyridinium salts. 
 
Thus, the opportunity to synthesize some new chemical entities as well as to 
explore their biological activity was the main rational behind initializing the work 
included in this chapter. 
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2.5   REACTION SCHEMES 
 
2.5.1 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
It was prepared according to method described in Chapter-1 
 
 
2.5.2 PREPARATION OF 1,4- DIHYDROPYRIDINES : 
 
 
STEP-1   PREPARATION OF BENZOYL ACETONES : 
 
 
O
a
O
O
R R
 
 
 
Reagents / Reaction Condition (a): Ethyl Acetate, C2H5ONa/ 0-5°C, 2 hours. 
Where, R = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 
O
O
R
b
N
H
H3C CH3
OO
NN
R1
RR
N
N
OHC
R1
etc.... 
 
STEP-2   PREPARATION OF 1,4-DIHYDROPYRIDINES : 
 
 
 
 
Reagents / Reaction Condition (b): Methanol, Ammonium carbonate/reflux, 12 hours. 
Where, R = 4-H, 4-Cl, & R1=4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 etc.... 
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2.6   PLAUSIBLE REACTION MECHANISM 
 
R
CH3
O
NH3
-H2O
R
CH3
NH2
R
CH3
O
R1-CHO
-H2O
R1
R
OH3C
RH
R
H3C NH2 CH3O
R1 H
H+ Trsnsfer
R
R
H3C
R1 H
CH3ONH2
N
H
R1
RR
H3C CH3
OH
-H2O
N
H
R1
R
H3C
R
CH3
Where R=COPh & R1= Different substituted pyrazole aldehydes
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2.7   EXPERIMENTAL 
 
2.7.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. Formation of all 
compounds was purified by using column chromatography. IR spectra were 
recorded in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass 
spectra were recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection 
Probe technique. 1H NMR was determined in CDCl3
 
/DMSO solution on a Bruker Ac 
400 MHz spectrometer. Elemental analysis of the all the synthesized compounds 
was carried out on Elemental Vario EL III Carlo Erba 1108 model and the results 
are in agreements with the structures assigned. 
 
2.7.2 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
It was prepared according to method described in Chapter-1 
 
 
2.7.3 PREPARATION OF 1,4-DIHYDROPYRIDINES : 
 
STEP-1   PREPARATION OF BENZOYL ACETONES : 
 
Method-(1): 10 gm of acetophenone, 18 gm of ethylacetate and 60 ml of absolute 
ether were taken in 250 mls RBF and finely cut metallic sodium (2 gm) is added. 
  The ether starts boiling somewhat later. When boiling rate was reduced, the 
flask further was heated for 45 minutes in a water bath. After completion of the 
reaction, the reaction mixture was cooled. The sodium benzoyl acetone formed was 
filtered, washed with dry ether and dried immediately. The sodium benzoyl acetone 
was then dissolved in water and filtered off. The filterate was acidified with glacial 
acetic acid while simultaneously cooled with ice and benzoyl acetone was 
precipitated. It was filtered, dried and recrystallized from methanol.  
Similarly other compounds are also prepared. 
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Method-(2): A mixture of Sodium Ethoxide (0.2 moles), Ethyl acetate (0.2 moles) 
were taken in 250 ml RBF then slowely add (0.05 moles) of aceto phenone to the 
mixture below 5OC. After addition of acetophenone to it allow it for one day in freeze 
and pour it to ice water mixture. Then acidify it by glacial acetic acid to get product. 
After that filter the product and wash with chilled to remove acidity and dry it. 
 
STEP-2  PREPARTION OF (4-(SUBSTITUTED)1,3-DIPHENYL-1H-
PYRAZOL-4-YL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-
3,5-DIYL)BIS(PHENYLMETHANONE)  
GENERAL METHOD 
  
To a mixture of benzoyl acetone (0.01 mole), pyrazole aldehyde (0.005) and 
25 ml of methanol, ammonium carbonate (1.2 gm) was added. The mixture was 
refluxed for 12-14 hrs on water bath. During the reaction the progress and the 
completion of reaction were checked by silica gel-G F254 thin layer chromatography 
using ethyl acetate: Hexane (4:6) as a mobile phase. And kept it for room temperature 
for one day.  Then filter it under reduced pressure. Finally, it was purified by column 
chromatography using hexane and ethyl acetate as eluents. 
Similarly other compounds are also prepared. 
The physical constants of newly synthesized compounds are given in Table No.2       
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2.8   PHYSICAL DATA 
 
Physical data of (4-(substituted)1,3-diphenyl-1H-pyrazol-4-yl)-2,6-
dimethyl-1,4-dihydropyridine-3,5-diyl)bis(phenylmethanones)  
 
N
H
CH3H3C
NN
O O
R
R1R1
 
 
   TABLE - 2 
Code Substitution 
 
MF MW MPO Rf 
value 
C 
R R1 
STAB-031 H H C36H29N3O 535 2 220-222 0.50 
STAB-032 4-CH H 3 C37H31N3O 549 2 198-200 0.49 
STAB-033 4-Cl H C36H28ClN3O 570 2 178-200 0.47 
STAB-034 4-NO H 2 C36H28N4O 580 4 186-188 0.43 
STAB-035 2-OH H C36H29N3O 551 3 202-204 0.44 
STAB-036 2-OCH H 3 C37H31N3O 565 3 166-168 0.45 
STAB-037 3-NO H 2 C36H28N4O 580 4 208-210 0.44 
STAB-038 4-F H C36H28FN3O 553 2 222-224 0.48 
STAB-039 H Cl C36H27Cl2N3O 604 2 238-240 0.43 
STAB-040 4-CH Cl 3 C37H29Cl2N3O 618 2 214-216 0.48 
STAB-041 4-Cl Cl C36H26Cl3N3O 639 2 228-230 0.45 
STAB-042 4-NO Cl 2 C36H27Cl2N3O 649 2 232-234 0.39 
STAB-043 2-OH Cl C36H27Cl2N3O 620 3 218-220 0.48 
STAB-044 2-OCH Cl 3 C37H29Cl2N3O 634 3 214-216 0.47 
STAB-045 3-NO Cl 2 C36H26Cl2N4O 649 4 196-198 0.48 
STAB-046 4-F Cl C36H26Cl2FN3O 622 
2 
188-190 0.44 
 
 
Rf value was determined using solvent system = Ethyl Acetate : Hexane (2 : 3) 
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2.9   SPECTRAL DISCUSSION 
 
2.9.1   IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 model using KBr pallet method. Various functional groups present were 
identified by characteristic frequency obtained for them.  
The characteristic bands of Hydroxyl groups were obtained for streching at 
3400-3650 cm-1 and those for bending were obtained at 1050-1250 cm-1.The 
stretching vibrations N-H group showed in the region of 3200 to 3500 cm-1 with a 
deformation due to in plane bending at 1650-1580 cm-1.It gives aromatic C-H 
stretching   frequencies between 3000-3200 cm-1 and bending vibration near 1300-
1500 cm-1 respectively. C-H stretching frequencies for methyl and methylene group 
were obtained near 2950 cm-1 to 2850 cm-1
2.9.2  MASS SPECTRA 
.   
 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 
2.9.3   
ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. Fragmentation pattern can be 
observed to be particular for these compounds and the characteristic peaks obtained 
for each compound.  
 
1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer by making a solution of samples in CDCl3 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons and carbons identified from NMR spectrum and their chemical 
shift (δ ppm) were in the agreement of the structure of the molecule. J values were 
Chapter – 2                                         Synthesis of New dihydropyridines structurally… 
 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              78 
 
calculated to identify o, m and p coupling. In some cases, aromatic protons were 
obtained as multiplet. 1H spectral interpretation can be discussed as under. 
 
1
N
H
NN
O
H3C
O
CH3
1
2
3
4
5
6
7
8 9
10
11
12
13
1415
16
17
18
19
20
2122
23
24
25
H NMR  of (4-1,3-Diphenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-
3,5-diyl)bis(phenylmethanone). (STAB-031) 
 
 
 
1. Proton no. 1 and 3 of total 6H gave a singlet at 2.35 δ ppm. 
2. Proton no. 9 of 1H gave a singlet at 4.48 δ ppm. 
3. Proton no. 5,6,7,11,12 and 13 total 6H gave a multiplate at 7.46 - 7.54 δ ppm. 
4. Proton no. 15,16,17,18,19,20,21,22,23 and 24 of total 10H gave a multiplet at 
7.58 - 7.63 δ ppm. 
5. Proton no. 25 of 1H gave a singlet at 7.73 δ ppm. 
6. Proton no. 2 of 1H gave a singlet at 7.86 δ ppm. 
7. Proton no. 4,8,10 and 14 of total 4H gave a doublet at 7.98 - 8.00 δ ppm. 
 
  Thus, by observing and assigning the signals in the NMR spectrum and 
by the calculation of the J values for above proton, we can clearly suggest that the 
proposed structure for compound no. STAB-031 has been confirmed. The spectrum is 
given on page no. 87. 
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1H NMR of (2,6-Dimethyl-4-(1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)-1,4-
dihydropyridine-3,5-diyl)bis(phenylmethanone). (STAB-032) 
 
 
 
1. Proton no. 1 and 3 of total 6H gave a singlet at 2.36 δ ppm. 
2. Proton no. 17 of 3H gave a singlet at 2.43 δ ppm. 
3. Proton no. 9 of 1H gave a singlet at 4.57 δ ppm. 
4. Proton no. 16 and 18 of 2H gave a double at 7.25 δ ppm - 7.27 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
5. Proton no. 20,21,22,23 and 24 total 5H gave a multiplate at 7.33 δ ppm – 7.40 
δ ppm. 
4. Proton no. 15 and 19 of 2H gave a doublet at 7.47 δ ppm -7.49 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
6. Proton no. 5,6,7,11,12 and 13 of total 6H gave a multiplet at 7.52 δ ppm -7.59 
δ ppm. 
7. Proton no. 25 of 1H gave a singlet at 7.79 δ ppm. 
8. Proton no. 2 of 1H gave a singlet at 7.86 δ ppm. 
9. Proton no. 4,8,10 and 14 of total 4H gave a doublet at 7.98 δ ppm – 8.00 δ 
ppm. 
 
  Thus, by observing and assigning the signal in the NMR spectrum and 
by the calculation of the J values for above proton, we can clearly suggest that the 
proposed structure for compound no. STAB-032 has been confirmed. The spectrum is 
given on page no. 89. 
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2.9.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds.  
The spectral and elemental analysis data are for all individual compounds 
synthesized in this chapter are mentioned below. 
 
2.10 ANALYTICAL DATA  
 
(4-1,3-Diphenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
diyl)bis(phenylmethanone). (STAB-031)  
Yield: 78%   IR (cm-1): 3498, 3419 (N-H stretching), 3128, 3070 (Aromatic C-H 
stretching), 2945 (Aliphatic -CH3 stretching), 2899, 2843 (Aliphatic -CH2 stretching), 
1728 (C=O stretching), 1678-1602 (N-H bending), 1496, 1452, 1340 (C-H bending), 
684, 729 (monosubstituted), 1H NMR (DMSO-d6) δ ppm: 2.35 (s, 6H), 4.48 (s, 1H), 
7.46-7.54 (m, 6H), 7.58-7.63(m,10H), 7.73 (s, 1H), 7.86 (s, 1H), 7.98-8.00 (d,4H), 
MS: m/z =  535.23 ; Anal. Calcd. for C36H29N3O2:  C, 80.72; H, 5.46; N,7.84;O, 
5.97;  Found: C, 80.66; H, 5.36; N, 7.81; O, 5.89. 
 
(2,6-Dimethyl-4-(1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)-1,4-dihydropyridine-3,5-
diyl)bis(phenylmethanone). (STAB-032)  
Yield: 85% IR (cm-1): 3439 (N-H stretching), 3169, 3078 (Aromatic C-H stretching), 
2994 (Aliphatic -CH3 stretching), 1718 (C=O stretching), 1666-1639 (N-H bending), 
1446, 1411, 1356 (C-H bending), 738 (disubstituted), 700(monosubstituted), 1H NMR 
(DMSO-d6) δ ppm: 2.36 (s, 6H), 2.43 (s, 3H), 4.57 (s,1H), 7.25-7.27 (d, 2H, 
J=8.0Hz), 7.33-7.40 (m, 5H), 7.47-7.49 (d, 2H, J=8.0Hz), 7.52-7.59 (m, 6H), 7.79 (s, 
1H), 7.98 – 8.00 (d,4H) MS: m/z = 549.66 ; Anal. Calcd. for C37H31N3O2: C, 80.85; 
H, 5.68; N,7.64; O, 5.82 ;  Found: C, 80.81; H, 5.60; N, 7.59; O, 5.78.  
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(4-(3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis(phenylmethanone). (STAB-033)  
Yield: 81% IR (cm-1): 3419 (N-H stretching), 3109, 3068 (Aromatic C-H stretching), 
2984 (Aliphatic -CH3 stretching), 2864 (Aliphatic -CH2 stretching), 1721 (C=O 
stretching), 1676-1649 (N-H bending), 1456, 1421, 1366 (C-H bending), 748 
(disubstituted), 701 (monosubstituted), MS: m/z = 570(M+), 572(M+2) ; Anal. Calcd. 
for C36H28ClN3O2: C, 75.85; H, 4.95; N, 7.37; O, 5.61; Found: C, 75.79; H, 4.84; N, 
7.30; O,5.59. 
 
(2,6-Dimethyl-4-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydropyridine-
3,5-diyl)bis(phenylmethanone). (STAB-034)  
Yield: 69% IR (cm-1): 3416 (N-H stretching), 3109, 3012 (Aromatic C-H stretching), 
2959 (Aliphatic -CH3 stretching), 2866 (Aliphatic -CH2 stretching), 1729 (C=O 
stretching), 1666-1599 (N-H bending), 1570 (C-NO2 stretching), 1481, 1368 (C-H 
bending), 754 (disubstituted), 705 (mono substituted), MS: m/z = 580.63; Anal. 
Calcd. for C36H28N4O4: C, 74.47; H, 4.86; N, 9.65; O, 11.02; Found: C, 74.39; H, 
4.74; N, 9.55; O, 11.01. 
 
(4-(3-(2-Hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis(phenylmethanone). (STAB-035)  
Yield: 82% IR (cm-1): 3560 (-OH stretching), 3416 (N-H stretching), 3119, 3002 
(Aromatic C-H stretching), 2981 (Aliphatic -CH3 stretching), 2841 (Aliphatic -CH2 
stretching), 1726 (C=O stretching), 1663-1607 (N-H bending), 1458, 1339 (C-H 
bend),1320 (-OH bend.),  751 (disub.)701 (mono sub.), MS: m/z: 551.63 ; Anal. 
Calcd. for C36H29N3O3
Yield: 71% IR (cm
: C, 78.38; H, 5.30; N, 7.62, O, 8.70; Found: C, 78.29; H, 
5.24; N, 7.50, O, 8.61. 
 
(4-(3-(2-Methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis(phenylmethanone). (STAB-036)  
-1): 3494, 3429 (N-H stretching), 3122, 3070 (Aromatic C-H 
stretching), 2955 (Aliphatic -CH3 stretching), 2891 (Aliphatic -CH2 stretching), 1728 
(C=O stretching), 1671-1612 (N-H bending), 1486, 1462, 1342 (C-H bending), 751( 
disubstituted), 694 (monosubstituted), MS: m/z = 565.66 ; Anal. Calcd. for 
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C37H31N3O3: C, 78.56; H, 5.52; N, 7.43; O,8.49;  Found: C, 78.51; H, 5.44; N, 7.40; 
O, 8.41. 
  
(2,6-Dimethyl-4-(3-(3-nitrophenyl)-1-phenyl-1H-4-yl)-1,4-dihydropyridine-3,5-
diyl)bis(phenylmethanone). (STAB-037)  
Yield: 76% IR (cm-1): IR (cm-1): 3446 (N-H stretching), 3119, 3002 (Aromatic C-H 
stretching), 2969 (Aliphatic -CH3 stretching), 2876 (Aliphatic -CH2 stretching), 1719 
(C=O stretching), 1666-1599 (N-H bending), 1570 (C-NO2 stretching), 1481, 1368 
(C-H bending), 754 (disubstituted), 705 (mono substituted), MS: m/z = 580.63 ; Anal. 
Calcd. for C36H28N4O4: C, 74.47; H, 4.86; N, 9.65; O, 11.02; Found: C, 74.39; H, 
4.84; N, 9.60; O, 10.99. 
 
(4-(3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis(phenylmethanone). (STAB-038)  
Yield: 82% IR (cm-1): 3436 (N-H stretching), 3119, 3002 (Aromatic C-H stretching), 
2961 (Aliphatic -CH3 stretching), 2842 (Aliphatic -CH2 stretching), 1720 (C=O 
stretching), 1661-1596 (N-H bending), 1445, 1379 (C-H bending), 755 
(disubstituted), 707 (mono substituted), MS: m/z = 553(M+), 555(M+2) ; Anal. Calcd. 
for C36H28N3O2: C, 78.10; H, 5.10; N,7.59; O,5.78; Found: C, 78.02; H, 5.04; N, 
7.50; O, 5.71. 
 
(4-(1,3-Diphenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-diyl)bis((4-
chlorophenyl)methanone). (STAB-039)  
Yield: 68% IR (cm-1): 3491 (N-H stretching), 3110, 3010 (Aromatic C-H stretching), 
2991 (Aliphatic -CH3 stretching), 2851 (Aliphatic -CH2 stretching), 1724 (C=O 
stretching), 1664 (N-H bending), 1458, 1329 (C-H bending), 761 (disubstituted), 715 
(mono substituted), MS: m/z = 377.44; Anal. Calcd. for C36H27Cl2N5O2
Yield: 74% IR (cm
: C, 71.52; H, 
4.50; N, 6.95; O, 5.27; Found: C, 71.49; H, 4.44; N, 6.90; O, 5.21. 
 
(2,6-Dimethyl-4-(1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)-1,4-dihydropyridine-3,5-
diyl)((4-chlorophenyl)methanone). (STAB-040)  
-1): 3406 (N-H stretching), 3108, 3002 (Aromatic C-H stretching), 
2981 (Aliphatic -CH3 stretching), 2841 (Aliphatic -CH2 stretching), 1722 (C=O 
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stretching), 1654-1567 (N-H bending), 1445, 1339 (C-H bending), 751 
(disubstituted), 709 (mono substituted), MS: m/z = 618.55; Anal. Calcd. for 
C37H29Cl2N3O2: C, 71.84; H, 4.73; N, 6.79;O, 5.17; Found: C, 71.81; H, 4.64; N, 
6.70; O, 5.15. 
 
(4-(3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis((4-chlorophenyl)methanone). (STAB-041)  
Yield: 85% IR (cm-1): 3416 (N-H stretching), 3119, 3013 (Aromatic C-H stretching), 
2931(Aliphatic -CH3 stretching), 2844 (Aliphatic -CH2 stretching), 1731 (C=O 
stretching), 1654-1557 (N-H bending), 1448, 1329(C-H bending), 756 (disubstituted), 
702 (mono substituted), MS: m/z = 639(M+), 641(M+2); Anal. Calcd. for 
C36H26Cl3N3O2: C, 67.67; H, 4.10; N, 6.58; O, 9.85;  Found: C, 67.59; H, 4.04; N, 
6.50; O, 9.81. 
 
(2,6-Dimethyl-4-(3-(4-nitrophenyl)-phenyl-1H-pyrazol-4-yl)-1,4-dihydropyridine-
3,5-diyl)bis((4-chlorophenyl)methanone). (STAB-042)  
Yield: 73% IR (cm-1): 3398 (N-H stretching), 3101, 3019 (Aromatic C-H stretching), 
2942 (Aliphatic -CH3 stretching), 2844 (Aliphatic -CH2 stretching), 1720 (C=O 
stretching), 1654-1591 (N-H bending), 1552 (C-NO2 stretching), 1458, 1339 (C-H 
bending), 761(disubstituted), 705 (mono substituted), MS: m/z = 649.52; Anal. Calcd. 
for C36H26Cl2N5O4: C, 66.57; H, 4.03; N, 8.63; O, 9.85; Found: C, 66.49; H, 4.01; N, 
8.60; O, 9.81. 
 
(4-(3-(2-Hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis((4-chlorophenyl)methanone). (STAB-043)  
Yield: 71% IR (cm-1): 3510 (-OH stretching), 3431 (N-H stretching), 3119, 3017 
(Aromatic C-H stretching), 2991 (Aliphatic -CH3 stretching), 2851 (Aliphatic -CH2 
stretching), 1719 (C=O stretching), 1654-1598 (N-H bending), 1458, 1343 (C-H 
bending), 1325 (-OH bending), 761(disubstituted), 710 (mono substituted), MS: m/z = 
620.52 ; Anal. Calcd. for C36H27Cl2N3O3: C, 69.68; H, 4.39; N, 6.77; O, 7.74;  
Found: C, 69.59; H, 4.24; N, 6.70; O, 7.72. 
 
 
Chapter – 2                                         Synthesis of New dihydropyridines structurally… 
 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              84 
 
(4-(3-(2-Methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-diyl)bis(4-chlorophenyl)methanone). (STAB-044)  
Yield: 84% IR (cm-1): 3406 (N-H stretching), 3129 (Aromatic C-H stretching), 
2978(Aliphatic -CH3 stretching), 2841 (Aliphatic -CH2 stretching), 1718(C=O 
stretching), 1664 (N-H bending), 1442, 1349 (C-H bending), 753 (disubstituted), 715 
(mono substituted), MS: m/z = 634.55; Anal. Calcd. for C37H29Cl2N3O3: C, 70.03; H, 
4.61; N, 6.62; O, 7.56;  Found: C, 70.02; H, 4.54; N, 6.56; O, 7.51. 
 
(2,6-Dimethyl-4-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydropyridine-
3,5-diyl)bis((4-chlorophenyl)methanone). (STAB-045)  
Yield: 70% IR (cm-1): 3409 (N-H stretching), 3149, 3012 (Aromatic C-H stretching), 
2941 (Aliphatic -CH3 stretching), 1711 (C=O stretching), 1665-1587 (N-H bending), 
1562 (C-NO2 stretching), 1448, 1329 (C-H bending), 763(disubstituted), 709 (mono 
substituted), MS: m/z = 649.52 ; Anal. Calcd. for C36H26Cl2N4O4: C, 66.57; H, 4.03 ; 
N, 8.63; O, 9.85;  Found: C, 66.49; H, 4.01; N, 8.50; O, 9.81. 
 
(4-(3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine 
-3,5-diyl)bis((4-chlorophenyl)methanone). (STAB-046)  
Yield: 73% IR (cm-1): 3386 (N-H stretching), 3119, 3021 (Aromatic C-H stretching), 
2981(Aliphatic -CH3 stretching), 2841 (Aliphatic -CH2 stretching), 1731 (C=O 
stretching), 1668-1597 (N-H bending), 1458, 1339 (C-H bending), 759 
(disubstituted), 709 (mono substituted), MS: m/z = 622.51(M+), 624(M+2); Anal. 
Calcd. for C36H2Cl2FN3O2: C, 69.46; H, 4.21; N, 6.75; O, 5.14;  Found: C, 69.39; H, 
4.14; N, 6.60; O, 5.11. 
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2.11   RESULTS AND DISCUSSION 
 
Several dihydropyridines were prepared by reactiong the benzoyl acetone with 
different substituted pyrazol aldehydes. The compounds prepared in this chapter 
possess 1,4-dihydropyridine(DHP) nucleus and are basically pyrazole core structure at 
C4 
2.12   CONCLUSION 
position. 
  
 
 
In conclusion, 16 compounds enlisted in this chapter are newly synthesized  
bioactive compounds for various biological activities. 
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2.13 REPREENTATIVE SPECTRAS 
 
2.13.1 IR Spectrum of STAB-031 
 
 
2.13.2 Mass Spectrum of STAB-031 
 
 
500750100012501500175020002500300035004000
1/cm
-15
0
15
30
45
60
75
%T
35
68
.4
3
35
68
.4
3
34
98
.9
9
34
19
.9
0
31
28
.6
4
30
70
.7
8
29
45
.4
0
28
99
.1
1 2
84
3.
17
17
72
.6
4
17
28
.2
8
16
76
.2
0
16
02
.9
0
14
96
.8
1
14
52
.4
5
14
08
.0
8
13
40
.5
7
13
25
.1
4
12
67
.2
7
12
24
.8
4
11
66
.9
7
10
62
.8
1 1
02
6.
16
96
6.
37
92
5.
86
88
5.
36
83
7.
13
76
3.
84 72
9.
12
68
4.
75 6
38
.4
6
STAB-031
N
H
H3C CH3
NN
O O
MW : 535 g/m
Chapter – 2                                         Synthesis of New dihydropyridines structurally… 
 
 
Department of Chemistry, Saurashtra University, Rajkot-360005                              87 
 
2.13.3 1
 
 
2.13.4 Expanded 
H NMR Spectrum of STAB-031 
 
1
 
H NMR Spectrum of STAB-031 
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2.13.5 IR Spectrum of STAB-032 
 
 
 
2.13.6 Mass Spectrum of STAB-032 
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2.13.7 1
 
 
2.13.8 Expanded 
H NMR Spectrum of STAB-032 
 
1
  
H NMR Spectrum of STAB-032 
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Chapter-3 
Synthesis of ethyl 5-cyano-1,4-dihydro-2,6-
dimethyl-4-(1,3(substituted)-diphenyl-1H-
pyrazol-4-yl)pyridine-3-carboxylates. 
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3.1   INRODUCTION  
 
Dihydropyridines are the largest and most studied class of drugs calcium 
channel blocker. In addition to their proven clinical utilities in cardiovascular 
medicine, dihydropyridines are employed extensively as biological tools for the study 
of voltage-activated calcium channel. 
 
  Many 1,4-dihydropyridine derivatives have been synthesized and developed as 
calcium channel antagonists which inhibit smooth and cardiac muscle contractions  
blocking the influx of Ca+2
  
 through calcium channels and antihypertensive action .  
3.2  LITERATURE REVIEW   
 
Recently much effort has been expended to develop more efficient methods 
for the preparation of 1,4-DHPs such as using microwave1,  metal triflates as catalyst2,  
reaction in ionic liquid3, p-TSA4, HY-Zeolite5, and HClO4 -SiO26
  
. 1,4-DHPs are 
synthesized by the Hantszch method, which involves cyclocondensation of aldehyde, 
β-ketoester, and ammonia either in acetic acid at room temperature or refluxing in 
alcohol for a long time. 
R CHO
O
O
NH4OAc
ASA,MeOH
70OC-2h
N
H
O
OC2H5
O R
 
 
  Joshi et al.7 has used molecular iodine as a catalyst for the preparation of 1,4-
dihydropyridine. Molecular iodine8-11 has attracted attention as an inexpensive, non 
toxic, readily available catalyst for various organic transformations to afford the 
corresponding products in excellent yields with high selectivity. It has been used as a 
mild Lewis acid in the dehydration of tertiaryalcohols to alkenes, in the formation of 
ethers, as well as β-keto enol ethers,12-14 for esterification,15 transesterification,16 
acetylation9 and benzothiophene17 formation, but there are only a few reports about its 
use for the synthesis of 1,4-DHPs.  Its use for the synthesis of 1,4-DHPs.18-19 
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R CHO
R1
O O
R2
NH4OAc
I2
rt
N
H
O O
R2R1
R
R=Diff substituted phenyl groups
R1=Methyl, Isopropyl
R2=methoxy, isopropxy
 
 
 Xin Ying Zhang et al.20 developed an efficient and green method for the 
synthesis of 1, 4-dihydropyridine derivatives mediated in an ionic liquid, 
[bmim][BF4
 
], through a four-component condensation process of aldehydes, 1, 3-
dione, Meldrum’s acid and ammonium acetate. 
 
 
By this investigation they showed that not only aromatic aldehydes, but also 
heterocyclic and aliphatic aldehydes could undergo the above reaction effectively to 
afford the corresponding products in good yields. 
 
 Further more, 1, 3-cyclohexanedione and an acyclic 1, 3-dione, pentane-2, 4-
dione were also tried in place of 5, 5-dimethyl-1, 3-cyclohexanedione for this multi-
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component condensation process, respectively and it also gives the good results in 
preparation of DHP. 
 
Nandkishor et al.21
 
 found that L-Proline has been found as an effective catalyst 
for the one pot synthesis of polyhydroquinoline derivatives via four component 
Hantzsch reaction. This method provides several advantages such as being 
environmentally benign, possessing high yields with increased variations of the 
substituents in the product and preparative simplicity. 
 
 
Many MCR for synthesis of DHP and it’s aza analog dihydropyridines are 
revieved by several authors.22
 
 The multicomponent reaction often affords the target 
compounds in good yields and this experimental method remains the most widely 
used protocol to access to 1,4-DHP differently substituted in position 4. Some 
modified procedures have later been proposed and they involve the use of preformed 
Knoevenagel adducts between the aldehyde and the keto ester or the use of preformed 
enaminoesters (represented in the E form to clarify the scheme).  
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R4 H
O
CO2R3
O R2
CO2R5
OR6
NH4OH
N
H
R2 R6
R4 H
R3O2C CO2R5
 
 
The Unsymmetric23-27
CHO
R H3C
NH2
CN H3C
NH2
COOR1
N
H
NC
H3C
COOR1
CH3
H
R
 3-cyano-5-carboxy ester 1,4-diydrpyridine was 
prepared by condensation of aldehyde, 3-aminocrotononitrile with alkyl 3-
aminocrotonate. 
 
 
The other methods for the preparation28
 
 of unsymmetric cyano 1,4-
dihydropyridine are reported as under. 
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CHO
R H3C
NH2
CN
N
H
NC
H3C
COOR1
CH3
H
R
OR1
O O
 
 
Two different routes of synthesis in single step are reported29
CHO
CF3
H3C
NH2
COOC2H5
O
O
O
CN
N
H
CF3
H3CH2COOC COOCH2CH2CN
CH3H3C
CF3
O
C2H5OOC
H3C
NH2
COOCH2CH2CN
 for 3-cyano 
ethoxycarbonyl-2,6-dimethyl-4-(2-trifluromethyl phenyl)-1,4-dihydropyridine.Firstly, 
the condensation of aldehyde with ethyl-3-aminocrotonate and 2-cyanoethyl-3-
oxobutanoate. In another method, the condensation of ethyl-2-(2-triflouromethyl 
phenyl benzylidene ) acetoacetate was carried out with 2-cyanoethyl(2Z)-3-aminobut-
2-enoate. 
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Bossert et al.30
 
 have prepared anti-inflammatory agents such as 2-amino-3-
benzoyl cyano-1,4-dihydropyridine. 
N
H
H3C NH2
H3CH2COOC
O
H
R
 
 
Scoane et al.31
 
 reported a facile method for synthesis of 3,5-dicyano-2,6-
diphenyl-1,4-dihydropyridine(compound-1).When 3,5-dicyano-6-aminopyran was 
reacted with ammonium acetate in acetic acid gave the. While 3-cyano-5-carethoxy-6-
aminopyran afforded to give fully aromatized pyridine. 
 
 
Berson et al.32
N
H
H3C CH3
H3COC COOCH2CH3H
N
 reported earlier for first time the synthesis of a quinoline 
containing unsymmetrical compound 4-(4-quinolyl)-2,6-dimethyl-3-carbethylxy-5-
acetyl-1,4-dihydropyridne.  
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Bossert et al.33 also put in their efforts to preparing coronary dilator and 
antihypertensive 1,4-dihydropyridines containing a quinoline group at C4 position. 
Ethyl 2-amino-4-(4-quinolyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate have 
been prepared by the cyclization of 1,3-cyclohexanedione with aldehyde and CH3-
CH2-CH2-C(NH)-NH
 
2. 
N
CHO
O
O
NH
NH2
N
H
O
NH2
COOCH2CH3
N
H
 
Other unsymmetric 2,6-diamino-4-(4-quinolyl)-1,4-dihydropyridine was 
synthesized by a different route.
 
34 
N
COOC2H5
CN
H2N
NH
O
O
N
H
C2H5OOC
N
H2N NH2
COOCH
CH3
CH3
H
 
 
Sachio et al.35 prepared antihypertensive 1,4-dihydropyridine containing a 
benzo furazanyl moiety at C4
 
 Position. 
N
O
N
Br
H3CH2COOC
COCH3
H2N CHCOOCH2CH3
CH3
N
H
H3C CH3
COOCH2CH3H3CH2COOC
N
O
N
 
Ozbey et al.36 synthesized some 1,4-dihydropyridine derivatives containing 
the flavones ring system. 
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N
H
H3C CH3
COOR1R1OOC H
O
O
C6H5
N
H
H3C CH3
COORR1OOC H
O
O
C6H5
N
H
H3C CH3
CONHR1R1HNOC H
O
O
C6H5
N
H
H3C CH3
CONHRR1HNOC H
O
O
C6H5
 
 
Cozzi et al.37
 
 prepared unsymmetric 4-[3-(1H-imidazol-1-yl-) Phenyl]-1,4-
dihydropyridines and studied their antitumor activity. 
N
H
H3C CH3
COCH3H3COOC
N
N
H
 
 
Shah et al.38 has reported a unsymmetrical 1,4-dihydropyridines having cyano 
and ester group in it’s 3 & 5 position respectively and the compounds were 
synthesized adopting the Hantzsch synthesis.  
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N
H
CNH3COOC
H3C CH3
S
CH3
 
 
A new positive inotropic agent with high cardio selectivity, found in Bay-y-
595939
 
 with calcium channel-modulating activity and devoid of vasoconstricting 
effects. Compound increased dP/dt max by up to 300% at 30-1000mcg/kg i.v. in dogs, 
and it increased coronary blood flow at all doses was reported and currently 
undergoing phase II trials for the treatment of congestive heart failure. 
N
H
CN
H2N CH3
O
O
N
Bay-y-5959
 
 
Antineoplastic agent, (FCE-29013) an aromatase inhibitor (IC50 = 1.5 nM 
against human placental enzyme) found to be potentially useful for the treatment of 
estrogen-dependent tumors and prostatic hyperplasia40
 
. 
N
H
CN
H2N CH3
O
O
N
N
 
 
Christiaans et al.41 studied new molecules like CV-159 SM-6586 for possible 
variation at 3-position. CV-159 shows an increase in coronary flow, aortic flow and 
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heart rate and decrease in mean blood pressure as incardipine after intravenous 
administration in anaesthetized open chest dogs. 
 
N
H
H3C CH3
H3CO
O
O
O
NO2
(CH2)6
NHN
O
CV-159
N
H
H3C
H3C CH3
NO2
N
NO N
H3C
SM-6568
 
Shah et al.42
 
 synthesized some newly unsymmetrical 1,4-DHP derivatives as 
potent antitubercular agents and also reported some unsymmetrical 1,4-
dihydropyridine derivatives as potent antitubercular agents. 
 
 
In last few years, researchers of our laboratory synthesized and studied 1,4-
dihydropyridine derivatives bearing pyrazoline, Isooxazole at C3 position. They 
reported these derivatives as bactericidal, fungicidal and surprisingly antitubercular 
also43
 
. 
Another examples of hybrid molecule which combine 1,4-DHP and piperazine 
are BMY 20064 and BMY 20014. The compound BMY 20064 has potent 
antihypertensive effects in both normotensive and spontaneously hypotensive rats and 
is effective against myocardial ischemia, being more potent than Nifedipine.  
Furthermore BMY 20064 is a selective α–adrenergic antagonist.   
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N
H
CH3H3C
H3COOC
NO2
X
O
N
N OCH3
Where X=NH, BMY-20014
Where X=O  , BMY-20064
 
 
A hybrid molecule which combines 1, 4-DHP with benzodioxan moiety has 
been synthesized by Marciniak et al.44 which also appeared as α1
 
 – adrenergic 
blockers. The most potent hybrid molecule shown in figure consists of four stereo 
isomers. 
N
H
CH3H3C
H3COOC
NO2
O
O
N
CH3
O
O
 
 
Carlos et al.45
 
 reported 1,4-dihydropyridines with a 1,2-benzothiazol-3-One 1-
sulphoxide group, linked  through an alkylene bridge to the C-3 carboxylete of the 
DHP ring, with  both vasoconstricting and vasorelaxant properties were obtained. In 
blocking Ca+2 evoked contractions of K+ depolarized rabbit aortic strips. Many 
compounds were 10 times more potent than Nifedipine. Their vascular versus cardiac 
selectivity was very pronounced. 
Schramm et al.46
 
 have proved that phenyl carbamoyl moiety in 
dihydropyridine either cardiovascular selective activity. 
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3.3 AIM OF CURRENT WORK 
 
 The aim of current work was to prepare the dihydropyridine which have a 
hybrid ‘motif’ where at C3- position possess a cyano group, while at C5
 
 position 
various esteric groups are present. This will ultimately give structural and molecular 
diversity of unsymmetric nature.  
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3.4   REACTION SCHEMES 
 
3.4.1 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
 It was prepared according to method described in Chapter-1 
 
 
3.4.2 PREPARATION OF ALKYL 5-CYANO-4-(1,3-DIPHENYL-1H-
PYRAZOL-4-YL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3-
CARBOXYLATES : 
 
CHO
NN R
a
NN R
N
H
H3C CH3
R1NC
H2N
CH3
CN
 
 
Reagents/ Reaction Condition (a): EAA/MAA, Glacial Acetic acid / 60-70°C, 1 hours. 
Where R1= COOCH3/COOC2H5 
R = 4-H, 4-Cl, 4-F, 4-NO
& 
2, 3-NO2 
 
etc..... 
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3.5   PLAUSIBLE REACTION MECHANISM 
 
 
R
CH3
O
H H
R1
O
H
Base
-H+
R
H
CH3
O
R1
O
H
R
H
R1
O
H
OH3C
-H2O
H3C
O
R2
CH3
H2N
R
R1
R1
R2
H
R
+H2N
CH3H3C
O_
H
R1
R2
H
R
+H2N
CH3O_
CH3
H
-H+
R1
R2
H
R
N O_
CH3
H
H
H
H3CN
R1 H
R2
H3C
R
H
OH
CH3
H
N
H
R1
R2
H3C CH3
R
H
Where R = CN
 R1 = DIfferent aldehydes
 R2 = COOC2H5/COOCH3
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3.6   EXPERIMENTAL 
 
3.6.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in CDCl3
 
/DMSO solution on a Bruker Ac 400 
MHz spectrometer. Elemental analysis of the all the synthesized compounds was 
carried out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
3.6.2 PREPARATION OF PYRAZOLE ALDEHYDE : 
 
 It was prepared according to method described in Chapter-1 
 
 
3.6.3 PREPARATION OF 5-CYANO-4-(1-PHENYL, 3(SUBSTITUTED)-
PHENYL-1H-PYRAZOL-4-YL)-2,6-DIMETHYL-1,4-
DIHYDROPYRIDINE-3-CARBOXYLATE  
GENERAL PROCEDURE 
 
A mixture of pyrazole aldehyde (0.01 mol), 3-amino crotononitrile (0.01 mol) 
and Methyl acetoacetate or Ethyl acetoacetate (0.01 mol) in 10 ml glacial CH3COOH 
was stirred at 60-70OC for 1 hrs in a flat bottom stoppered flask. The progress and the 
completion of reaction were checked by silica gel-G F254
Similarly other compounds are also prepared. 
 thin layer chromatography 
using ethyl acetate : hexane  (3 :2 ) as a mobile phase. The solid product was obtained 
after cooling and then filtered and washed with hexane.   
The Physical constants of newly synthesized compounds are given in Table No.3  
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3.7  PHYSICAL DATA  
 
Physical data of  5-Cyano-4-(1-phenyl, 3(Substituted)phenyl-1H-
pyrazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylates.  
 
NN R
N
H
H3C CH3
R1NC
 
 
TABLE – 3 
 
Code 
Substitution 
 
 
MF 
 
MW 
 
MP 
O
 
C 
Rf 
Value R R1 
STAB-051 H COOCH C3 25H22N4O 410 2 182-184 0.40 
STAB-052 4-CH COOCH3 C3 26H24N4O 424 2 198-200 0.43 
STAB-053 4-Cl COOCH C3 25H21ClN4O 444 
2 
178-180 0.43 
STAB-054 4-NO COOCH2 C3 25H21N5O 455 4 202-204 0.46 
STAB-055 2-OH COOCH C3 25H22N4O 426 3 208-210 0.44 
STAB-056 2-OCH COOCH3 C3 26H24N4O 440 3 192-194 0.43 
STAB-057 3-NO COOCH2 C3 25H21N5O 455 4 188-190 0.47 
STAB-058 4-F COOCH C3 25H21FN4O 428 2 172-174 0.42 
STAB-061 H COOC2H C5 26H24N4O 424 2 206-208 0.44 
STAB-062 4-CH COOC3 2H C5 27H26N4O 438 2 222-224 0.43 
STAB-063 4-Cl COOC2H C5 26H23ClN4O 458 
2 
212-214 0.47 
STAB-064 3-NO COOC2 2H C5 26H23N5O 469 4 188-190 0.42 
STAB-065 4-NO COOC2 2H C5 26H23N5O 469 4 192-194 0.42 
STAB-066 2-OH COOC2H C5 26H24N4O 440 3 178-180 0.43 
STAB-067 2-OCH COOC3 2H C5 27H26N4O 454 3 192-194 0.44 
STAB-068 4-F COOC2H C5 26H23FN4O 442 2 202-204 0.46 
 
Rf 
 
value was determined using solvent system = Ethyl Acetate : Hexane  (3 : 2) 
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3.8   SPECTRAL DISCUSSION 
 
3.8.1   IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 model using KBr pallet method. Various functional groups present were 
identified by characteristic frequency obtained for them.  
The characteristic bands of -OH groups were obtained for streching at 3400-
3650 cm-1 and those for bending were obtained at 1050-1250 cm-1.The stretching 
vibrations N-H group showed in the region of 3200 to 3500 cm-1 with a deformation 
due to in plane bending at 1650-1580 cm-1. It gives aromatic C-H stretching   
frequencies between 3000-3200 cm-1 and bending vibration near 1300-1500 cm-1 
respectively. C-H stretching frequencies for methyl and methylene group were 
obtained near 2950 cm-1 to 2850 cm-1. Characteristic frequency of C-N stretching 
showed near 2100-2300 cm-1 and bending vibration near 1250-1400 cm-1
   
.  
3.8.2  MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 
  
ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. Fragmentation pattern can be 
observed to be particular for these compounds and the characteristic peaks obtained 
for each compound.  
3.8.3   1H NMR SPECTRA 
 
1H & NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer by making a solution of samples in CDCl3 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons and carbons identified from NMR spectrum and their chemical 
shift (δ ppm) were in the agreement of the structure of the molecule. J values were 
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calculated to identify o, m and p coupling. In some cases, aromatic protons were 
obtained as multiplet. 1
 
H spectral interpretation can be discussed as under. 
1
 
H NMR of Methyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(1,3-diphenyl-1H-
pyrazol-4-yl)pyridine-3-carboxylate.(STAB-051)  
N
H
CN
CH3H3C
H3COOC
NN
H
1
23
4
5
6
7
8
9
10
11
12
13
14
15
16
 
 
1. Proton no. 1 and 3 of 6H gave singlet at 2.14 δ ppm. 
2. Proton no. 4 of 3H gave a singlet at 2.58 δ ppm. 
3. Proton no. 5 of 1H gave a singlet at 4.91 δ ppm. 
4. Proton no. 8 and 10 of 2H gave a doublet and triplet at 6.91 δ ppm - 6.99 δ 
ppm. 
5. Proton no. 7 and 11 of 2H gave a triplet at 7.20 δ ppm - 7.22 δ ppm 
6. Proton no. 9 of 1H gave a triplet at 7.29 δ ppm - 7.31 δ ppm. 
7. Proton no. 13 and 15 of 2H gave a triplet at 7.45 δ ppm - 7.49 δ ppm. 
8. Proton no.14 of 1H gave a doublet at 7.60 δ ppm - 7.62 δ ppm. 
9. Proton no. 12 and 16 of 2H gave a doublet at 7.71 δ ppm - 7.73 δ ppm. 
10. Proton no. 6 of 1H gave a singlet at 7.95 δ ppm. 
11. Proton no. 2 of 1H gave a singlet at 8.74 δ ppm. 
 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
structure for compound no. STAB-051 has been confirmed. The spectrum is given on 
page no. 120. 
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1
 
H NMR of Methyl 5-cyano-1,4-dihydro-4-(3-(2-methoxyphenyl)-1-phenyl-1H-
pyrazol-4-yl)-2,6-dimethylpyridine-3-carboxylate. (STAB-056) 
N
H
CN
CH3H3C
H3COOC
NN
H3CO
H
1
23
4
5
6
7
8
9
10
11 12 13
14
15
16
 
 
1. Proton no. 1 and 3 of 6H both gave a singlet at 1.83 δ ppm. 
2. Proton no. 4 of 3H gave a singlet at 3.34 δ ppm. 
3. Proton no. 12 of 3H gave a singlet at 3.72 δ ppm. 
4. Proton no. 5 of 1H gave a singlet at 4.32 δ ppm. 
5. Proton no. 13 and 15 of 2H gave multiplate at 6.98 δ ppm - 7.08 δ ppm. 
6. Proton no. 16 of 1H gave a doublet at 7.21 δ ppm - 7.24 δ ppm. 
7. Proton no. 9 of 1H gave a triplet at 7.27 - 7.32 δ ppm. 
8. Proton no.14 of 1H gave a triplet at 7.37 - 7.42 δ ppm. 
9. Proton no. 8 and 10 of 2H gave a triplet at 7.47 δ ppm - 7.52 δ ppm. 
10. Proton no. 7 and 11 of 2H gave a doublet at 7.86 - 7.88 δ ppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling. 
11. Proton no. 6 of 1H gave a singlet at 8.52 δ ppm. 
12. Proton no. 2 of 1H gave a singlet at 9.11 δ ppm. 
 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
structure for compound no. STAB-56 has been confirmed. The spectrum is given on 
page no. 122. 
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3.8.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds.  
The spectral and elemental analysis data are all for individual compounds 
synthesized in this chapter are mentioned below. 
 
 
3.9 ANALYTICAL DATA  
 
Methyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine-
3-carboxylate.  (STAB-051) 
 Yield : 79 % IR (cm-1): 3489,3367 (N-H stretching), 3198 (Aromatic C-H stretching), 
2974 (Aliphatic -CH3stretching), 2897 (Aliphatic -CH2 stretching), 2260,2332 (C-N 
stretching),  1707(C=O stretching), 1660-1587 (N-H bending), 1519,1435,1356 (C-H 
bending) ,1282 (C-N bending), 744-688 (disubstituted), MS: m/z = 426.17; Anal. 
Calcd. for C25H22N4O3: C, 70.41; H, 5.20; N, 13.14; O, 11.25 Found: C, 70.33; H, 
5.19;  N, 13.13; O, 11.13. 1H NMR (DMSO-d6) δ ppm: 2.14 (s, 6H), 2.58(s, 3H), 4.91 
(s, 1H), 6.91-6.99 (d, 2H), 7.20 - 7.22 (t, 2H), 7.29 - 7.31(t, 1H), 7.45 - 7.49 (t, 2H), 
7.60 - 7.62(d, 1H), 7.71 - 7.73(d, 2H), 7.95(s, 1H),8.74 (s, 1H),  MS: m/z: 410.17; 
Anal. Calcd. for C25H22N4O2
 
:  C, 73.15; H, 5.40; N,13.65; O,7.80; Found: C, 73.06; 
H, 5.36; N, 13.61; O,7.79. 
Methyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(1-phenyl-3-p-tolyl-1H-pyrazol-
4yl)pyridine-3-carboxylate. (STAB-052)  
Yield : 79 % IR (cm-1):  3469,3307 (N-H stretching), 3191 (Aromatic C-H stretching), 
2984 (Aliphatic -CH3 stretching), 2857 (Aliphatic -CH2 stretching), 2250,2312 (C-N 
stretching),  1727(C=O stretching), 1650-1577 (N-H bending), 1509,1455,1366 (CH 
bending) ,1289 (CN bending), 749 (disubstituted), 698 (monosubstituted)  MS: m/z = 
424.49; Anal. Calcd. for C26H24N4O2: C, 73.56; H, 5.70; N, 13.20; O,7.54   Found: 
C, 73.49; H, 5.60; N, 13.19; O, 7.48.  
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Methyl 4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-5-cyano-1,4-dihydro-2,6-
dimethylpyridine-3-carboxylate. (STAB-053)  
Yield : 77 % IR (cm-1): 3459,3347 (N-H stretching), 3190 (Aromatic -C-H 
stretching), 2984 (Aliphatic -CH3 stretching ) 2898 (Aliphatic -CH2 stretching), 
2262,2342 (C-N stretching),  1707(C=O stretching), 1662-1587 (N-H bending), 
1509,1455,1346 (C-H bending) ,1292 (C-N bend.), 1241,1108 (-OH bend.), 745-689 
(disub. ), MS: m/z = 444(M+), 446(M+2) ; Anal. Calcd. for C25H21ClN4O2
  
: C, 67.49; 
H, 4.76; N, 12.59; O, 7.19 Found: C, 76.29; H, 5.04; N, 18.50. 
Methyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(3-(4-nitrophenyl)-1-phenyl-1H-
pyrazol-4-yl)pyridine-3-carboxylate. (STAB-054)  
Yield : 87 % IR (cm-1): 3459,3347 (N-H stretching), 3188 (Aromatic C-H stretching), 
2954 (Aliphatic -CH3 stretching), 2857 (Aliphatic -CH2 stretching), 2240,2342 (C-N 
stretching),  1717(C=O stretching), 1669-1581 (N-H bending), 1545 (C-NO2 
stretching), 1518,1445,1366 (C-H bending) ,1272 (C-N bending), 749 (disubstituted ), 
689 (monosubstituted) MS: m/z = 455.47; Anal. Calcd. for C25H21N5O4
 
: C, 65.93; H, 
4.65;  N, 15.38; O, 14.05 Found: C, 65.84; H, 4.55; N, 15.30; O, 14.01. 
Methyl 5-cyano-1,4-dihydro-4-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-
dimethylpyridine-3-carboxylate. (STAB-055)  
Yield : 81 %  IR (cm-1): 3611,3581 (OH stretching), 3489,3367 (N-H stretching), 
3198 (Aromatic C-H stretching), 2974 (Aliphatic -CH3stretching), 2897 (Aliphatic -
CH2 stretching), 2260,2332 (C-N stretching),  1707(C=O stretching), 1660-1587 (N-H 
bending), 1519,1435,1356 (C-H bending) , 1282 (C-N bending), 1250,1117 (-OH 
bending), 744 (disubstituted), 688(monosubstituted)  MS: m/z = 426.17; Anal. Calcd. 
for C25H22N4O3
 
: C, 70.41; H, 5.20; N, 13.14; O, 11.25 Found: C, 70.33; H, 5.19;  N, 
13.13; O, 11.13. 
Methyl 5-cyano-1,4-dihydro-4-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-
2,6-dimethylpyridine-3-carboxylate. (STAB-056)  
Yield : 83 % IR (cm-1): 3574,3473,3429,3402 (N-H stretching), 3203,3097 (Aromatic 
C-H stretching), 2999 (Aliphatic -CH3 stretching), 2347,2196 (C-N stretching),  1780 
(C=O stretching), 1658-1508 (N-H bending), 1464,1375,1323 (C-H bending) ,1247 
(CN bending), 1134,1022 (-OH bending), 758(disubstituted), 709 (monosubstituted), 
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1H NMR (DMSO-d6) δ ppm: 1.83 (s, 6H), 3.34 (s, 3H), 3.72 (s, 3H), 4.32 (s, 1H), 
6.98 - 7.08 (m, 2H),7.21-7.24 (d, 1H), 7.27 - 7.32 (t, 1H), 7.37 - 7.42 (t, 1H), 7.47 - 
7.52 (t, 2H),7.86 - 7.88 (d, 2H, J= 8.0 Hz), 8.52 (s, 1H), 9.11 (s, 1H), MS: m/z = 
440.49; Anal. Calcd. for C26H24N4O3
 
: C, 70.89; H, 5.49; N, 12.72; O, 10.90 Found: 
C, 70.71; H, 5.47;  N, 12.65; O, 10.90. 
Methyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(3-(3-nitrophenyl)-1-phenyl-1H-
pyrazol-4-yl)pyridine-3-carboxylate. (STAB-057) 
Yield : 79 %  IR (cm-1): 3479,3368 (N-H stretching), 3192 (Aromatic C-H stretching), 
2934 (Aliphatic -CH3 stretching), 2893 (Aliphatic -CH2 stretching), 2261,2331 (C-N 
stretching), 1717(C=O), 1661-1577 (N-H bending), 1530 (C-NO2 stretching), 
1518,1445,1354 (C-H bending) ,1283 (C-N bending), 1241,1101 (-OH bending), 
745(disubstituted), 689 (monosubstituted),  MS: m/z = 455.16; Anal. Calcd. for 
C25H21N5O4
 
: C, 65.93; H, 4.65; N, 15.38; O, 14.05 Found: C, 65.84; H, 4.56;  N, 
15.31; O, 14.07. 
Methyl 5-cyano-4-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydro-2,6-
dimethylpyridine-3-carboxylate. (STAB-058)  
Yield : 69 %  IR (cm-1):  3509,3357 (N-H stretching), 3190 (Aromatic C-H 
stretching), 2984 (Aliphatic -CH3 stretching), 2898 (Aliphatic -CH2 stretching), 
2261,2330 (C-N stretching), 1717(C=O stretching), 1661-1589 (N-H bending), 
1518,1434,1354 (C-H bending),`1281 (C-N bending), 1241,1108 (-OH bending), 
745(disubstituted), 689 (monosubstituted), MS: m/z = 428 (M+), 430 (M+2) ; Anal. 
Calcd. for C25H21FN5O2
 
: C, 70.08; H, 4.94; N, 13.08; O,7.47  Found: C, 70.03; H, 
4.91;  N, 13.07; O,7.41. 
Ethyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine-
3-carboxylate. (STAB-061)  
Yield : 78 %  IR (cm-1):  3479,3368 (N-H stretching), 3188 (Aromatic C-H 
stretching), 2978 (Aliphatic -CH3 stretching), 2887 (Aliphatic -CH2 stretching), 
2250,2342 (C-N stretching), 1727(C=O stretching), 1665-1581 (N-H bending), 
1529,1425,1346 (C-H bending) ,1272 (C-N bend.), 1245,1117 (-OH bending), 689 
(monosubstituted), MS: m/z = 424.19; Anal. Calcd. for C26H24N4O2: C,73.56; H, 
5.70; N, 13.20; O, 7.54 Found: C, 73.43; H, 5.61;  N, 13.07; O,7.49. 
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Ethyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(1-phenyl-3-p-tolyl-1H-pyrazol-4-
yl)pyridine-3-carboxylate. (STAB-062) 
Yield : 76 %  IR (cm-1): 3479,3387 (N-H stretching), 3158 (Aromatic C-H stretching), 
2975 (Aliphatic -CH3 stretching), 2877(Aliphatic -CH2 stretching), 2268,2352 (C-N 
stretching),  1717(C=O stretching), 1669-1589 (N-H bending), 1529,1445,1346 (C-H 
bending) ,1283 (C-N bending), 1244,1109 (-OH bending), 748(disubstituted), 689 
(monosubstituted), MS: m/z = 438.52; Anal. Calcd. for C27H26N4O2
 
: C, 73.95; H, 
5.98; N, 12.78; O, 7.30 Found: C, 73.83; H, 5.91;  N, 12.77; O,7.29. 
Ethyl 4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-5-cyano-1,4-dihydro-2,6-
dimethylpyridine-3-carboxylate. (STAB-063)  
Yield : 79 %  IR (cm-1): 3489,3389 (N-H stretching), 3159 (Aromatic C-H stretching), 
2979 (Aliphatic -CH3 stretching), 2879(Aliphatic -CH2 stretching), 2288,2332 (C-N 
stretching),  1707(C=O stretching), 1679-1569 (N-H bending), 1529,1455,1356 (C-H 
bending) ,1282 (C-N bending), 1245,1119 (-OH bending), 749 (disubstituted), 687 
(monosubstituted),  MS: m/z = 458 (M+), 460 (M+2); Anal. Calcd. for C26H23ClN4O2
 
: 
C, 68.04; H, 5.05; N, 12.21; O, 6.97 Found: C, 68.03; H, 5.01;  N,12.17; O,6.94. 
Ethyl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-
4-yl)pyridine-3-carboxylate. (STAB-064)  
Yield : 89 %  IR (cm-1): 3489,3397 (N-H stretching), 3168 (Aromatic C-H stretching), 
2985 (Aliphatic -CH3 stretching), 2878(Aliphatic -CH2 stretching), 2278,2352 (C-N 
stretching), 1707(C=O stretching), 1689-1586 (N-H bending), 1520 (C-NO2 
stretching), 1539,1435,1345 (C-H bending) ,1284 (C-N bending), 1245,1108 (-OH 
bending), 749(disubstituted), 687 (monosubstituted), MS: m/z = 469.18; Anal. Calcd. 
for C26H23N5O4
 
: C,66.51; H, 4.94; N, 14.92; O, 13.63 Found: C, 66.43; H, 4.91;  N, 
14.87; O,13.59. 
Ethayl 5-cyano-1,4-dihydro-2,6-dimethyl-4-(3-(4-nitrophenyl)-1-phenyl-1H-
pyrazol-4-yl)pyridine-3-carboxylate. (STAB-065)  
Yield : 81 %  IR (cm-1): 3459,3377 (N-H stretching), 3058 (Aromatic C-H stretching), 
2976 (Aliphatic -CH3 stretching), 2878(Aliphatic -CH2 stretching), 2261,2322 (C-N 
stretching), 1727(C=O stretching), 1689-1588 (N-H bending), 1551 (C-NO2 
stretching), 1539,1435,1343 (C-H bending) ,1273 (C-N bending), 1234,1101 (-OH 
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bending), 738(disubstituted), 679 (monosubstituted), MS: m/z = 469.18; Anal. Calcd. 
for C26H23N5O4
 
: C,66.51; H, 4.94; N, 14.92; O, 13.63 Found: C, 66.43; H, 4.91;  N, 
14.87; O,13.59. 
Ethyl 5-cyano-1,4-dihydro-4-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-
dimethylpyridine-3-carboxylate. (STAB-066)  
Yield : 78 % IR (cm-1): 3611,3581 (OH stretching), 3479,3347 (N-H stretching), 3108 
(Aromatic C-H stretching), 2974 (Aliphatic -CH3 stretching), 2897 (Aliphatic -CH2 
stretching), 2260,2332 (C-N stretching), 1707(C=O stretching), 1660-1587 (N-H 
bending), 1519,1435,1356 (C-H bending) ,1282 (C-N bending), 1240,1107 (-OH 
bending), 744 (disubstituted), 688(monosubstituted, MS: m/z = 440.49; Anal. Calcd. 
for C26H24N4O3
 
: C, 70.89; H, 5.49; N, 12.72; O, 10.90 Found: C, 70.83; H, 5.51;  N, 
12.77; O,10.89. 
Ethyl 5-cyano-1,4-dihydro-4-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-2,6-
dimethylpyridine-3-carboxylate. (STAB-067)  
Yield : 76 %  IR (cm-1): 3489,3357 (N-H stretching), 3118 (Aromatic C-H stretching), 
2984 (Aliphatic -CH3 stretching), 2887 (Aliphatic -CH2 stretching), 2261,2342 (C-N 
stretching), 1717(C=O stretching), 1661-1581 (N-H bending), 1518,1445,1346 (C-H 
bending) ,1281 (C-N bending), 1241,1117 (-OH bending), 744(disubstituted), 689 
(monosubstituted), MS: m/z = 454.52; Anal. Calcd. for C27H26N4O3
 
: C, 71.35; H, 
5.77; N, 12.33; O, 10.56 Found: C, 71.31; H, 5.61;  N, 12.27; O,10.49. 
Ethyl 5-cyano-4-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1,4-dihydro-2,6-
dimethylpyridine-3-carboxylate. (STAB-068)  
Yield : 89 %  IR (cm-1):  3419,3307 (N-H stretching), 3101 (Aromatic C-H 
stretching), 2970 (Aliphatic -CH3 stretching), 2890 (Aliphatic -CH2 stretching), 
2261,2322 (C-N stretching),  1707(C=O stretching), 1669-1586 (N-H bending), 
1509,1425,1326 (C-H bending) ,1283 (C-N bending), 1241,1117 (-OH bending), 745 
(disubstituted), 685 (monosubstituted),  MS: m/z = 442 (M+), 444 (M+2); Anal. Calcd. 
for C26H23FN4O2
 
: C, 70.57; H, 5.24; N, 12.66; O, 7.23 Found: C, 70.53; H, 5.21;  N, 
12.77; O,7.19. 
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3.10  RESULTS AND DISCUSSION 
 
This chapter deals with the preparation of unsymmetric dihydropyridine by 
three component reaction using normal conventional methodologies. Ethyl 
acetoacetate/Methyl acetoacetate, methyl 3-aminocrotonate and Pyrazole aldehydes 
have been employed to synthesize these DHPs. Under normal conditions, the DHPs 
were prepared by refluxing the aldehydes, 3-aminocrotononitrile and  Methyl 
acetyoacetate/Ethyl acetoacetate  more than 10 hrs.  
    
 
3.11   CONCLUSION 
 
Our experimental protocols have developed an easy, faster and most 
convenient optimized conditions for preparing new dihydropyridines. 
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3.12  REPRESENTATIVE SPECTRAS 
 
3.12.1 IR Spectrum of STAB-051 
 
 
3.12.2 Mass Spectrum of STAB-051 
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3.12.3 1
 
H NMR Spectrum of STAB-051 
 
 
3.12.4 Expanded 1
 
H NMR Spectrum of STAB-051 
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3.12.5 IR Spectrum of STAB-056 
 
 
3.12.6 Mass Spectrum of STAB-055  
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3.12.7 1
 
H NMR Spectrum of STAB-056 
 
 
3.12.8 Expanded 1
 
H NMR Spectrum of STAB-056 
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A Rapid Microwave assisted synthesis of new 
coumarinyl chalcones. 
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4.1   INTRODUCTION 
 
Coumarin is a chemical compound (2H-chromen-2-one, 1-benzopyran-2-one, 
benzopyrone; C9H6O2
 
); a toxin found in many plants, notably in high concentration 
in the tonka bean, vanilla grass, woodruff, mullein, and bison grass. It has a sweet 
scent, readily recognized as the scent of newly-mown hay, and has been used in 
perfumes since 1882. It has clinical medical value as the precursor for several 
anticoagulants, notably warfarin, and is used as a gain medium in some dye lasers. 
O O
1
2
3
45
6
7
8
 
 
The isolation of coumarin was first reported by Vogel 1 in 1820. He isolated 
coumarin from tonka beans, bearing the characteristic aroma of cutted grass. The 
name of coumarin originates 2 from a Caribbean word “coumarou” for the tonka tree, 
which was known botanically at one time as Coumarouna odorta Aubl, coumarin is 
now the accepted trival name. Coumarin was first synthesized in 1868 on treatment of 
sodium salt of o-hydroxy benzaldehyde with acetic anhydride.3a, 3b Compounds 
containing coumarin subunit possess a wide range of activities and show an 
interesting reactivity.4-7
 
 This is consequence of the rich electronic structure of 
coumarin which offers abundant possibilities for diversified activity and reactivity of 
the system. 
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4.1.1   SYNTHESIS OF 4-HYDROXY COUMARINS 
 
Perkin 3
1 Anschutz method 
 synthesized coumarin and then several methods are reported for the 
synthesis of 4-hydroxy coumarins and their 4-hydroxy substituted derivatives namely: 
2 Pauli Lockemann synthesis 
8 
3 Sonn's synthesis 
9 
4 Mentzer's synthesis 
10 
5 Robertson synthesis 
11 
6 Ziegler and Junek method 
12 
7 Garden's method 
13 
8 Shah, Bose and Shah's method 
14 
9 Kaneyuki method 
15 
10 Resplandy's method 
16 
11 Jain, Rohatagi and Sheshadri's method 
17 
12 Shah, Bhatt and Thakor's method 
18 
 
19 
Shah and et al.15, 19
 
 have prepared 4-hydroxy coumarin derivatives in good 
yield by condensation of different phenols with malonic acid in the presence of zinc 
chloride and phosphorous oxychloride. The method is useful as single step 
preparation of 4-hydroxy coumarin derivatives substituted in benzenoid part. 
Recently many researchers 20-51
 
 have reported synthetic strategies for 4-
hydroxy coumarin. 
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4.1.2   BIOLOGICAL ACTIVITIES  
 
Numerous biological activities have been associated with coumarins and its 
analogues. Among them, antimicrobial, antiviral, anticancer, enzyme inhibition, anti-
inflammatory, antioxidant, anticoagulant and effect on central nervous system are 
most prominent. Coumarin nucleus possesses diversified biological activities that can 
be briefly summarized as under: 
 
1 Antimicrobial and Molluscicidal 
2 Antiviral 
52-73 
3 Anticancer 
74-78 
4 As Enzyme Inhibition 
79-89 
5 Antioxidant 
90-95 
6 Anti-inflammatory 
96-99 
7 Anticoagulant and Cardiovascular 
100-104 
8 Effect on Central Nervous System 
105-108 
 
109-111 
 4-hydroxycoumarin is a versatile scaffold and is being consistently used as a 
building block in organic chemistry as well as in heterocyclic chemistry for the 
synthesis of different heterocycles. The synthetic versatility of 4-hydroxycoumarin 
has led to the extensive use of this compound in organic synthesis. 4-hydroxy 
coumarin shows diversified chemical reactivity. Preparation of 3-acetyl-4-
hydroxycoumarinyl chalcones, condensation reaction of 4-hydroxycoumarin with 
aldehydes and use of 4-hydroxycoumarin as a β-keto ester in dihydropyrimidine 
synthesis have been discussed herein.  
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4.1.3   COUMARINYL CHALCONES 
   
The compound 1, 3–diphenyl-2-propene-1-one is known by its trivial name 
chalcone. Many naturally occurring flavonoids share structural features with chalcone 
and are referred by the generic term “chalcones”. This is well illustrated by benzal-
acetophenone or phenyl styryl ketone or phenyl acreloacetophenone named first time 
as chalcones by Kostanecki and Tambor. 112
 
 Certain flavonoids also include chalcone 
subunit and found to have anticancer activity and chemopreventive activity in some 
tumors. 
Additionally, some natural or synthetic chalcones are proved to have 
significant antiproliferation activity on different cell lines. Though the mechanism of 
antiproliferative activity of flavonoids and Chalcones is still unknown, it is believed 
to be linked with the interaction of type II estrogen receptors. 
 
The in vivo action of these polyphenol substances is certainly much more 
complicated. All these compounds are generally characterized by an almost complete 
solubility in water and, in vivo, by a very poor bioavailability linked to a rapid 
metabolism of phenols and a marked affinity for lipids and proteins. It has now been 
found that certain novel chalcones, chalcone derivatives and chalcone analogues, in 
particular ones in which the phenyl ring at the 1st
 
 position is substituted or replaced by 
the rings containing one or more heteroatoms, possess greater antiproliferation 
activity both on sensitive cancer cells or on cells which are resistant to common 
chemotherapeutic drugs, including the latest generation of anti-neoplastic agents, 
pacitaxel and docetaxel. 
In recent patent literature, compounds of the general formula shown in Fig. 
4.10 are a pharmaceutically acceptable salt or solvate there of wherein Ar represents a 
substituted or unsubstituted, (preferably aromatic), carbocycilc or heterocyclic group, 
said carbocyclic or heterocyclic group containing from 5 to 10 ring atoms, said ring 
atoms forming one or two rings, wherein each ring contains 5 or 6 ring atoms, any 
heteroatoms being selected from N, O and S, any substituents on the Ar group being 
independently selected from the group consisting of: (a) Cl, (b) Br, (c) F, (d) OH, (e) 
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NO2, (f) CF3, (g) C1-4 lower alkyl (in particular CH3), (h) SCH3, (i) NHCOCH3, (j) 
N(R)(R1) wherein R and R1 are the same or different and each represents H or lower 
C1-4
O
R1
O
COCH=CHAr
R
 alkyl.  
 
 
 
 
 
 
   
Several 2'-hydroxy chalcones are found to exist as 
pigments. The natural chalcones are found to contain phloroglucinol, pyraogallol, 
catechol and hydroquinone nuclei. 
 
113-117 
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Chalcones contain keto-ethylenic linkage and therefore reactive towards 
reagents like phenyl hydrazine, hydrazine hydrate and ethyl acetoacetate to produce 
heterocyclic derivatives. Chalcones have close relationship to flavones, flavanones, 
flavanols and dihydroflavanols. They are useful as intermediates in the synthesis of 
certain heterocyclic compounds like flavones, anthocyanins and benzal coumarones. 
118-121 Butein, phloretin and hissopin are found to be naturally occurring chalcones. 
Sometimes, chalcones are found to occur in nature as glycosides like carthamin and 
isocarthamin present in Carthamus tinctorious. 
 
122 
2'-Hydroxy chalcones are used as starting material to synthesize naturally 
occurring flavanones, flavones, flavonols, etc. The chalcones are also natural biocides 
123-125 and are well known intermediates in the synthesis of heterocyclic compounds 
exhibiting various biological activities like antimalarial, 126 antiviral, 127 antitumor, 128 
herbicidal 129 and also bactericidal 130, 131 activities. They are also identified as 
antioxidants. 
 
132 
Curcumin is a yellow pigment isolated from the rhizome of the perennial herb 
Curcuma longa L (turmeric). The chemical structure of curcumin was elucidated by 
Lampe et. al. 
 
133 
Curcumin has several biological activities. It possesses anti-inflammatory, 
antioxidant, antibacterial, antihepatotoxic, hypotensive and hypocholesterolemic 
properties. 134-137 Tonneses 138 describes curcumin as a non-toxic compound even at 
high dosages. It has a dual effect in oxygen radical reactions, thus it can act as a 
scavenger of hydroxyl radicals or catalyse the formation of hydroxyl radicals 
depending on the experimental conditions. 
 
  Curcumin inhibits in vitro lipid peroxide formation by liver homogenates of 
oedemic mice. 
138, 139 
140 The inflammatory response induced experimentally in animals 
appeared to be correlated with disturbances of the regulation of cellular oxidative 
process, as is evident from the anti-inflammatory action of well known antioxidants. 
There is evidence of a parallel between the inhibition of aedema formation in mice 
induced by carrageenan and the decrease in the production of lipid peroxides in liver 
homogenate. 140 Modification of groups on the terminal aromatic rings of curcumin 
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reveals that electron donating groups increase anti-inflammatory activity. 141
 
 The 
structural similarity of chalcone like molecules is expected to exhibit either 
antagonize or potentiate the biological activity in question and therefore it was very 
essential to study further, the coumarin derivatives possessing such ethylenic 
linkages-discussed earlier. 
The Chalcones or Phenyl styryl ketones are α:β unsaturated ketones, 
containing the reactive keto-ethylenic group : 
 
   
C
O
C
H
C
H
 
 
These compounds are also known as a benzylideneacetophenones or 
benzalacetophenones, which are named “Chalcones” by Kostanecki and J.Tambor 
142
  
,In American chemical society Abstracts, they are also termed as 3-phenyl 
acrylophenones, while 2’–hydroxyl – chalcones are known  as O-cinnamoylphenols. 
The presence of a keto-ethylenic linkage in general and in vicinity to a 
hydroxyl group in particular, has given these compounds a great synthetic importance. 
 
The 2’-hydroxy chalcones are used as starting compounds to synthesize 
naturally occurring flavanones , flavones , flavanols etc.,and the unambiguous 
methods of synthesis are useful in arriving at the  constitution of these naturally 
occurring pigments. The structure of chrysin, galangin, apegenin, lutionlin, 
kaempferol, morin and quercetrol were established by their synthesis from suitably 
substituted chalcone.
  
143 
 Thus, Chalcones are intermediate compound useful for the synthesis of 
various heterocyclic compounds such as flavanones, flavanols, flavones anthocyanins, 
banzal coumaranones, phlobathannins as well as certain compounds like 
deoxybenzoins and hydantoins, which are of some therapeutic value. 
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Chalcones are natural boicides144 and are well known intermediates in the 
synthesis of herterocyclic compounds exhibiting various biological activities145. The 
coumarins also show activity such as antifungal146, anticoagulant147, antibactarial148 
and insecticidal.
 
149 
 Some flavanones and flavanols are reported to have stabilizing effect on 
vitamin A.150 Setnikar et al.151
 
 reported that 3-methyl-6-diethylaminomethyl flavones 
are highly antispasmodic (about 14 times more active than papavarine). 
 Schraufstatter et al.152
 
 who observed the bacterostatic activities of chalcones 
against S.Aureus, have tested a number of natural and synthetic 
chalconesm,flavanones,flavones and flavanols, and have concluded that the activity is 
due to their unsaturation. 
 α-Methyl chalcone and 4-chlorochalcones are patented as light stabilizing 
agents for polyvinylidene chloride or polyvinylidene polymers.
 
153 
 Berger et al.154 have panted a preparation of light fast, water disperisible wood 
stain obtained from chalcones and flavanoid derivatives like hesperdin and narignain 
by the action of aluminium chloride in carbon disulphide. Enagaki and Hisada155
 
 have 
measured the anhelmintic coefficient of chalcones and their derivatives.  
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4.2  PREPARATION METHODS OF CHALCONES  
 
 Jairo Quiroga et al.156 
 
reported the method for preparation of chalcones. 
N
N
N
H3C R
CHO
Cl
Ph
20% NaOH
O CH3
R'
N
N
N
H3C R
Cl
Ph
O
R'
R,R'=different substituent
 
 
Daniela Batovska et al.157
O
R1R
 synthesized a large number chalcones and studied 
against Staphylococcus aureus and scherichia coli. 
 
 
Anastasia Detsi et al.158
 
 reported method for synthesis of chalcones and also 
reported its antioxidant activity. 
OH
R1 R2
O CHO
R3
R4
R5
20% KOH
rt, 24-36 hrs
OOH
R1 R2
R3
R4
R5
R1,R2,R3,R4,R5= H,Cl,OCH3 etc..
 
 
Bandgar et al.159 reported a series of β-chloro vinyl chalcones which have 
been synthesized by Claisen–Schmidt condensation. All the compounds were 
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evaluated for their anti-inflammatory activity (against TNF-a and IL-6) and 
antimicrobial (antibacterial and antifungal) activity. 
 
 
Shiva kumar et al.160
 
 reported the method and antimycobacterial activity for 
the synthesis of chalcones. 
CHO O CH3
2M NaOH
3 hrs
O
 
 
Nidhi Mishra et al.161
 
 have reported the Synthesis of novel substituted 1,3-
diaryl propenone derivatives and their antimalarial activity in vitro. 
F
O CH3
K2CO3, DMF
18 hrs, 110OC
Cyclic amine
R
O CH3
CHO
R
NaOH,MeOH
16-20 hrs, rt
O
R
R
 
 
Lorena et al.162 reported the Synthesis of new 1-phenyl-3-{4-[(2E)-3-
phenylprop-2-enoyl]phenyl}-thiourea and urea derivatives with anti-nociceptive 
activity. 
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NCX
Cl NH2
O CH3
Me2CO
rt
H
N
H
N
X O
CH3X= O,S
MeOH
NaOH
CHO
R
Cl
H
N
H
N
X
O
Cl
R
R= H,Cl,etc..
 
 
Satyanarayana et al.163
 
 have reported the Synthesis and antihyperglycemic 
activity of chalcone based aryloxypropanolamines. 
O
R2O
N
HO
 
 
Jinming Zhou et al.164
 
reported synthesis and potential anti-prostate cancer 
activities of ionone-based chalcones. 
O
R-CHO
NaOH/H2O
O
R
O
R-CHO
NaOH/MeOH
O
R
O OH
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In the presence of SOCl2/EtOH as a catalyst, various substituted chalcones are 
synthesized by aldol condensation. The HCl is generated in situ by the reaction of 
SOCl2 with absolute ethanol165
 
. 
CHO
R
CH3O
R'
SOCl2 , rt
Abs. EtOH
O
R'R
 
 
Romeo Romagnoli et al.166
 
 reported the synthesis of Hybrid α-
bromoacryloylamido chalcones. 
Ar
O
O2N O2N
O
Ar
Ar= C6H5, 4-Cl C6H5 etc...
 
 
Said Eddarir et al.167
 
 reported an efficient synthesis of chalcones by Suzuki 
reaction. 
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Narender et al.168 reported a simple and highly efficient method for the 
synthesis of chalcones by using borontrifluoride-etherate. Chalcones are secondary 
metabolites of terrestrial plants, precursors for the biosynthesis of flavonoids and 
exhibit various biological activities. Condensation of substituted acetophenones with 
various aromatic aldehydes in the presence of BF3–Et2
 
O at room temperature gave 
chalcones in good yields. 
 
 
  New series of chalcones have been synthesized by reacting 1-(4-piperazin-1-
yl-phenyl) ethanone and 1-(2,5-dichloro-3-thienyl)-1-ethanone with different 
substituted benzaldehydes in turn by Claisen–Schmidt condensation. All the 
synthesized compounds have been evaluated for antimicrobial activity. Some of these 
derivatives are potentially active against Gram-positive bacteria169
 
. 
HO
O O
OH
 
 
Susanne et al.170 reported a synthesis of chalcones. and also reported 
cytotoxicity and anti-oxidative activity. 
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OCH3
OMOMMOMO
CH3
O
CHO
OCH3
OMOMMOMO
H
C
O
R
A
A=KOH,EtOH/H2O, 1h (ice)
 
 
Hyun-Mo Yang et al.171
 
 reported the method for the synthesis of chalcone. 
CH3O
HO
CHO
R1 R2
KOH
Methanol
OH O
R1 R2
 
 
The inhibition of tyrosinase is one of the major strategies to treat 
hyperpigmentation. Various limitations are associated with many of these inhibitors, 
such as high cytotoxicity, poor skin penetration and low stability in formulations. In 
continuation of study, showing that isoliquiritigenin chalcone (ILC) is a potent 
tyrosinase inhibitor. 
  
At this laboratory, the researchers of our group have reported the improved 
and rapid synthesis of new coumarinyl chalcones derivatives and their antiviral 
activity.172
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4.3  TEST FOR CHALCONES  
   
The Chalcones can be tested with simple chemical test. Few of them are listed 
as under. 
 
(A) By Sulfuric Acid :- It develops red or bright orange colouration with 
concentrated sulfuric acid. 
 
(B) By  Ethanolic Ferric Chloride Solution :- Chalcones develops a red brown 
colouration with ethanolic ferric chloride. 
 
(C) By Wilson Test :- A Solution of a Chalcone in dry acetone is first treated with 
citric acid and then boric acid is added in the absence of moisture. The addition 
of the latter develops gradually a deep red or orange colouration which is 
destroyed by a traces of water. 
 
(D) Dibromo Derivatization :- The Chalcones are also well confirmed by their 
dibromo derivatives formed on treatment with bromine in acetic acid. 
 
 
 
4.4 AIM OF CURRENT WORK 
 
Microwave assisted organic synthesis has drawn a remarkable attention of 
researchers towards its advantages. There are many reactions reported involving 
microwave assisted organic synthesis. Microwave chemistry is one of the best tools to 
carry out different reactions on desired molecules with lesser reaction time, lesser 
energy, easy work up and higher yield with better purity.  
 
 In this chapter, the coumarinyl chalcones were aimed at using microwave 
assisted method. 
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4.5   REACTION SCHEMES 
 
4.5.1 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
 It was prepared according to method described in Chapter-1 
 
4.5.2 PREPARATION OF 3-ACETYL 4-HYDROXY COUMARINS : 
 
STEP-1 : 
 
 
 
Reagents / Reaction Condition (A): Anhydrous ZnCl2, POCl3
 
 / 70°C, 36 hours. 
STEP-2 : 
O O
OH
R
b O O
OH
R CH3
O
 
 
Reagents / Reaction Condition (b) : POCl3
 
, Glacial acetic acid / Reflux, 2-3 hrs. 
4.5.3 PREPARATION OF 4-HYDROXY-3-((E)-3-(1-PHENYL-3-
(SUBSTITUTED)-1H-PYRAZOL-4-YL) ACRYLOYL)-2H-CHROMEN-
2-ONES. 
 
 
 
Reagents / Reaction Condition (c): MW (320 Wt),Piperidine, Chloroform, 10-15 min. 
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4.6   PLAUSIBLE REACTION MECHANISM 
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4.7   EXPERIMENTAL 
 
4.7.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. All the reactions were 
carried out in Q-pro microwave synthesizer. IR spectra were recorded in Shimadzu 
FT-IR-8400 instrument using KBr pellet method. Mass spectra were recorded on 
Shimadzu GC-MS-QP-2010 model using Direct Injection Probe technique. 1H NMR 
was determined in CDCl3
 
/DMSO solution on a Bruker Ac 400 MHz spectrometer. 
Elemental analysis of the all the synthesized compounds was carried out on Elemental 
Vario EL III Carlo Erba 1108 model and the results are in agreements with the 
structures assigned. 
4.7.2 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
 It was prepared according to method described in Chapter-1 
 
4.7.3 PREPARATION OF 3-ACETYL 4-HYDROXY COUMARINS : 
 GENERAL METHOD 
 
STEP-1 
Phenol (0.01mole) and malonic acid (0.01mole) were added to a mixture of 
phosphorous oxychloride (40ml) and anhydrous zinc chloride (30gm) which is 
preheated to 600OC and the reaction mixture was heated on a water bath at 70OC for 
36 hrs. It was cooled and decomposed with ice and water to afforded solid mass, 
which was filtered and washed with water. It was then treated with 10% sodium 
bicarbonate and filtered. The filterate was slowly acidify with dilute hydrochloric 
acid. At the neutral point, some oily product was separated which was filtered and 
washed with water, dried and recrystallized from ethanol as colourless needles. Yield. 
60% m.p. 210O
Similarly other compounds are also prepared. 
C. 
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STEP-2  
4-hydroxy coumarin (0.017 mole) was mixed with glacial acetic acid (15 ml), 
and  phosphorous oxychloride (14ml) was added slowly, the mixture was further 
reflux for 2-3 hrs. and then poured on crushed ice with stirring. The solid separated 
out was filtered, washed with water and crystallize from alcohol. Yield.65% m.p. 
117O
Similarly other compounds are also prepared. 
C  
 
4.7.4 PREPARATION OF 4-HYDROXY-3-((E)-3-(1-PHENYL-3-
(SUBSTITUTED)-1H-PYRAZOL-4-YL) ACRYLOYL)-2H-CHROMEN-
2-ONE   
GENERAL METHOD  
 
 A mixture of 3-Acetyl 4-hydroxy coumarin (0.01mole) and substituted 
aromatic aldehyde (0.01mole)   were dissolved in 30 ml of chloroform. The catalytic 
amount of piperidine (0.02 ml) was added and the reaction mixture was subjected to 
microwave for a specific time (see Physical data table) at lower power (320W).The 
progress of the reaction was monitored by TLC examination at an interval of every 
minutes. On completion of reaction distilled out excess of chloroform and cool it and 
add methanol to it, filter it and wash with methanol, dried.  
Similarly other compounds are also prepared.   
The physical constants of newly synthesized compounds are given in the Table No. 4 
 
 
 
 
 
 
 
 
 
 
 
Chapter – 4                                                                A Rapid Microwave assisted..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  146 
 
4.8   PHYSICAL DATA   
 
Physical data of 4-Hydroxy-3-((E)-3-(1-phenyl-3-(substituted)-1H-
pyrazol-4-yl) acryloyl)-2H-chromen-2-ones.  
 
O O
OH O
N
N
R
R1
 
TABLE - 4 
Code Substitution 
 
MF MW M.P. Rf 
Value 
Time 
R R1 
SAT-01 H H C27H18N2O 434 4 186-188 0.40 8 
SAT-02 4-CH H 3 C28H20N2O 448 4 172-174 0.43 5 
SAT-03 2-OCH H 3 C27H18N2O 450 5 198-200 0.43 9 
SAT-04 4-NO H 2 C27H17N3O 479 6 174-176 0.42 7 
SAT-05 2-OCH H 3 C28H20N2O 464 5 172-174 0.44 11 
SAT-06 4-Cl H C27H17ClN2O 468 
4 
184-186 0.43 14 
SAT-07 3-NO H 2 C27H17N3O 479 6 202-204 0.47 7 
SAT-08 4-F H C27H17FN2O 452 4 192-194 0.42 9 
SAT-09 H 8-CH C3 28H20N2O 448 4 218-220 0.44 8 
SAT-10 4-CH 8- CH3 C3 29H22N2O 462 4 178-180 0.47 7 
SAT-11 4-Cl 8- CH C3 28H19ClN2O 482 
4 
212-214 0.42 5 
SAT-12 4-NO 8- CH2 C3 28H19N3O 493 6 166-168 0.45 5 
SAT-13 2-OH 8- CH C3 28H20N2O 464 5 158-160 0.43 3 
SAT-14 2-OCH 8- CH3 C3 29H22N2O 478 5 192-194 0.40 7 
SAT-15 3-NO 8- CH2 C3 28H19N3O 493 6 200-202 0.40 8 
SAT-16 4-F 8- CH C3 28H19FN2O 466 4 218-220 0.43 5 
SAT-17 H 5,8-di CH C3 29H22N2O 462 4 188-190 0.43 9 
SAT-18 4-CH 5,8-di CH3 C3 30H24N2O 476 4 210-212 0.42 6 
SAT-19 4-Cl 5,8-di CH C3 29H21ClN2O 496 
4 
204-206 0.44 8 
SAT-20 4-NO 5,8-di CH2 C3 29H21N3O 507 6 186-188 0.43 7 
SAT-21 2-OH 5,8-di CH C3 29H22N2O 478 5 176-178 0.47 5 
SAT-22 2-OCH 5,8-di CH3 C3 30H24N2O 492 5 192-194 0.42 9 
SAT-23 3-NO 5,8-di CH2 C3 29H21N3O 507 6 196-198 0.48 7 
SAT-24 4-F 5,8-di CH C3 29H21FN2O 480 4 202-204 0.49 8 
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Rf 
4.9   SPECTRAL DISCUSSION 
value was determined using solvent system = Hexane : Ethyl Acetate (2 : 3) 
 
4.9.1   IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 model using KBr pallet method. Various functional groups present were 
identified by characteristic frequency obtained for them.  
The characteristic bands of Hydroxyl groups were obtained for streching at 
3400-3650 cm-1 and those for bending were obtained at 1050-1250 cm-1. It gives 
aromatic C-H stretching   frequencies between 3000-3200 cm-1 and bending vibration 
near 1300-1500 cm-1 respectively. C-H stretching frequencies for methyl and 
methylene group were obtained near 2950 cm-1 to 2850 cm-1.  The Characteristic 
frequency of C=C (Vinyl) stretching showed near 900-1000 cm-1.  
 
  
4.9.2  MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 
  
ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. Fragmentation pattern can be 
observed to be particular for these compounds and the characteristic peaks obtained 
for each compound. 
4.9.3   1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer by making a solution of samples in CDCl3 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons and carbons identified from NMR spectrum and their chemical 
shift (δ ppm) were in the agreement of the structure of the molecule. J values were 
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calculated to identify o, m and p coupling and it gives approximately 8.0 Hz which 
indicates the presence of cis isomers of compounds. In some cases, aromatic protons 
were obtained as multiplet. 1
 
H spectral interpretation can be discussed as under. 
1
 
H NMR of 4-Hydroxy-3-((E)-3-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)acryloyl)-
2H-chromen-2-one. (SAT-02) 
O O
OH O
N
N
CH3
1
2
3
4
5
6
7
8
9
10 11
12
13
14
15
16
17
18
 
 
1. Proton no. 16 of 1H gave a singlet at 2.16 δ ppm. 
2. Proton no. 3 of 1H gave a doublet at 7.04 δ ppm – 7.07 δ ppm. 
3. Proton no. 6 and 7 of 2H gave a doublet at 7.08 δ ppm and 7.09 δ ppm 
respectively which shows the presence of CH=CH cis isomer. 
4. Proton no.10, 11 and 12 of 3H gave a multiplate at 7.23 δ ppm – 7.27 δ ppm 
5. Proton no. 9 and 13 of 2H gave a triplet at 7.38 δ ppm- 7.40 δ ppm. 
6. Proton no. 15 and 17 of 2H gave a doublet at 7.44 δ ppm and 7.46 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
7. Proton no.5 of 1H gave a triplet at 7.51 δ ppm- 7.56 δ ppm. 
8. Proton no. 3 of 1H gave a doublet at 7.59 δ ppm - 7.63 δ ppm. 
9. Proton no. 14 and 18 of 2H gave a doublet at 7.70 δ ppm -7.72 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
10. Proton no. 2 of 1H gave a doublet at 8.08 δ ppm – 8.10 δ ppm. 
11 Proton no. 8 of pyrazol ring of 1H gave a singlet at 8.46 δ ppm. 
12. Proton no. 1 of 1H is become highest deshielded and did not appear till 10      
δ ppm. 
Chapter – 4                                                                A Rapid Microwave assisted..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  149 
 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
structure for compound no. SAT-02 has been confirmed. The spectrum is given on 
page no. 159. 
 
1
 
H NMR of 4-Hydroxy-3-((E)-3-(1,3-diphenyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one. (SAT-03) 
O O
OH O
N
N
1
2
3
4
5
6
7
8
9
10 11
12
13
14
15
1617
18
OH
 
 
1. Proton no. 14 of 1H gave a singlet at 7.14 δ ppm. 
2. Proton no. 3 of 1H gave a triplet at 7.16 δ ppm – 7.19 δ ppm. 
3. Proton no. 10, 11 and 12 of 3H gave a multiplate at 7.21 – 7.36 δ ppm. 
4. Proton no. 6 and 7 of 2H gave a doublet at 7.45 δ ppm – 7.47 δ ppm. 
5. Proton no. 4 of 1H gave a triplet at 7.48 δ ppm – 7.50 δ ppm. 
6. Proton no. 15,16,17 and 18 of 4H gave a multiplate at 7.58 δ ppm – 7.76 δ 
ppm. 
7. Proton no. 9 and 13 of 2H gave a doublet at 7.77 δ ppm – 7.79 δ ppm.    
8. Proton no. 5 of 1H gave a doublet at 7.95 δ ppm – 7.99 δ ppm. 
9. Proton no. 2 of 1H gave a doublet at 8.06 δ ppm – 8.08 δ ppm. 
10. Proton no. 8 of 1H gave a singlet at 8.42 δ ppm. 
11. Proton no. 1 of 1H is become highest deshielded and did not appear till 10      
δ ppm. 
 
Thus, by observing and assigning the signal in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
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structure for compound no. SAT-03 has been confirmed. The spectrum is given on 
page no. 161. 
 
4.9.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds.  
The spectral and elemental analysis data for individual compounds 
synthesized in this chapter are mentioned below. 
 
4.10 ANALYTICAL DATA  
 
4-Hydroxy-3-((E)-3-(1,3-di phenyl-1H-pyrazol-4-yl) acryloyl)-2H-chromen-2-one. 
(SAT-01) 
Yield: 84 %  IR (cm-1): 3587 (OH stretching), 3101, 3015 (Aromatic C-H stretching), 
2978 (Aliphatic -CH3 stretching), 2898 (Aliphatic -CH2 stretching), 1708 (C=O 
Stretching), 1497, 1433, 1363 (C-H bending), 1291, 1236, 1215, 1134 (OH bending), 
987,933 (C=C stretching), 690(monosubstituted), MS: m/z: 434.44(M+); Anal. Calcd. 
for C27H18N2O4
 
:  C, 74.64; H, 4.18; N,6.45; O,14.73; Found: C, 74.60; H, 4.06; N, 
6.31; O,14.69. 
4-Hydroxy-3-((E)-3-(1-phenyl-3-p-tolyl-1H-pyrazol-4yl)acryloyl)-2H-chromen-2-
one. (SAT-02)  
Yield: 72% IR (cm-1): 3581,3522 (OH stretching), 3001 (Aromatic C-H stretching), 
2968 (Aliphatic -CH3 stretching), 2897 (Aliphatic -CH2 stretching), 1707 (C=O 
Stretching), 1498,1431,1383 (C-H bending),1290, 1226,1205,1139 (OH bending), 
997,923 (C=C stretching), 731(disubstituted), 1H NMR (DMSO-d6) δ ppm: 2.16 (s, 
1H), 7.04-7.07 (d, 1H ) 7.08-7.09 (d, 2H ), 7.23-7.27 (m, 3H ), 7.38-7.40 (t, 2H), 7.44-
7.46 (d,2H, J=8.0Hz), 7.51-7.56 (t, 1H), 7.59-7.63(d, 1H), 7.70-7.72 (d, 2H, J=8.0Hz), 
8.08-8.10 (d, 1H ), 8.46 (s, 1H ), MS: m/z: 448.47(M+); Anal. Calcd. for C28H20N2O4: 
C, 74.99; H, 4.50; N,6.25; O, 14.27 ;  Found: C, 74.89; H, 4.40; N, 6.19; O, 14.18.  
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4-Hydroxy-3-((E)-3-(3-(2-hydroxypenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one. (SAT-03)  
Yield: 68%  IR (cm-1): 3581,3477 (OH stretching), 3194,3084 (Aromatic C-H 
stretching), 3003 (Aliphatic -CH3 Stretching), 2899 (Aliphatic -CH2 Stretching), 1705 
(C=O Stretching), 1454,1429,1294 (C-H bending),1226,1138,1062 (OH bending), 
819,761 (C=C stretching), 756(disubstituted), 690(monosubstituted), 1H NMR 
(DMSO-d6) δ ppm: 7.14 (s, 1H), 7.16 - 7.19 (t, 1H), 7.21 - 7.36 (m, 3H), 7.45 - 7.47 
(d, 2H), 7.58 -7.76 (m, 4H), 7.77 - 7.79 (d, 2H), 7.95 – 7.99(d, 1H ) , 8.06 – 8.08(d, 
1H), 8.42(s, 1H), MS: m/z: 450.44(M+); Anal. Calcd. for C27H18N2O5
  
: C, 71.99; H, 
4.03; N, 6.22; O,17.76 Found: C, 71.89; H, 4.01; N, 6.10; O,17.66. 
4-Hydroxy-3-((E)-3-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one. (SAT-04)  
Yield: 58% IR (cm-1): 3582, 3532 (OH stretching), 3031,3010 (Aromatic C-H 
stretching), 2966 (Aliphatic -CH3 stretching), 2887 (Aliphatic -CH2 stretching), 1717 
(C=O Stretching), 1545 (C-NO2 stretching), 1499, 1433, 1373 (C-H bending), 1291, 
1236,(OH bending), 996 (C=C stretching), 745(disubstituted), 689 (monosubstituted), 
MS: m/z: 479.44(M+); Anal. Calcd. for C27H17N3O6
 
: C, 67.64; H, 3.57;  N, 8.76; O, 
20.02 Found: C, 67.54; H, 3.45; N, 8.70; O, 20.00. 
4-Hydroxy-3-((E)-3-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one.  (SAT-05)  
Yield: 83% IR (cm-1): 3571 (OH stretching), 3101, 3010 (Aromatic C-H stretching), 
2961 (Aliphatic -CH3stretching), 2891 (Aliphatic -CH2 stretching), 1727 (C=O 
Stretching), 1497, 1432, 1384 (C-H bending), 1291, 1227,1215,1149 (OH bending), 
987,913 (C=C stretching), 731(disubstituted),705 (monosubstituted), MS: m/z: 
464.47(M+); Anal. Calcd. for C28H20N2O5
 
: C, 72.41; H, 4.34; N, 6.03; O,17.22  
Found: C, 72.23; H, 4.29;  N, 6.00; O, 17.13. 
3-((E)-3-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-4-hydroxy-2H-
chromen-2-one. (SAT-06)  
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Yield: 64% IR (cm-1): 3582, 3532 (OH stretching), 3011 (Aromatic C-H stretching), 
2978 (Aliphatic -CH3 stretching), 2887 (Aliphatic -CH2 stretching), 1707 (C=O 
Stretching), 1498, 1432, 1393 (C-H bending), 1291, 1236, 1215, 1149 (OH bending), 
987,925 (C=C stretching), 755(disubstituted),715 (monosubstituted), MS: m/z: 468 
(M+), 470 (M+2); Anal. Calcd. for C27H17ClN2O4
 
: C, 69.16; H, 3.65; N, 5.97; O, 
13.65 Found: C, 69.11; H, 3.57;  N, 5.85; O, 13.60. 
4-Hydroxy-3-((E)-3-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one. (SAT-07)  
Yield: 84% IR (cm-1): 3561, 3532 (OH stretching), 3121 (Aromatic C-H stretching), 
2969 (Aliphatic -CH3 stretching), 2890 (Aliphatic -CH2 stretching), 1717 (C=O 
Stretching), 1551 (C-NO2 stretching), 1499, 1432, 1373 (C-H bending), 1291, 1236, 
1215, 1149 (OH bending), 998,943 (C=C stretching), 731(disubstituted), 
688(monosubstituted), MS: m/z: 479.44(M+); Anal. Calcd. for C27H17N3O6
 
: C, 67.64; 
H, 3.57; N, 8.76; O, 20.02 Found: C, 67.54; H, 3.46;  N, 8.71; O, 20.00. 
3-((E)-3-(3-(4-flourophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-4-hydroxy-2H-
chromen-2-one. (SAT-08)  
Yield: 73% IR (cm-1): 3566, 3542 (OH stretching), 3021 (Aromatic C-H stretching), 
2989 (Aliphatic -CH3 stretching) 2898 (Aliphatic -CH2 stretching), 1707 (C=O 
stretching), 1489, 1442,1372 (C-H bending), 1281, 1246, 1205, 1159 (OH bending), 
988,942 (C=C stretching), 739(disubstituted), 712(monosubstituted), MS: m/z: 
452(M+), 454 (M+2) ; Anal. Calcd. for C27H17FN2O4
 
: C,71.68; H, 3.79; N,6.19; 
O,14.15 Found: C, 71.63; H, 3.59;  N, 6.17; O,14.10. 
4-Hydroxy-8-methyl-3-((E)-3-(1,3-diphenyl-1H-pyrazol-4-yl)acryloyl)-2H-chromen-
2-one. (SAT-09)  
Yield: 84% IR (cm-1): 3606, 3540 (OH stretching), 3026 (Aromatic C-H stretching), 
2980 (Aromatic -CH3 stretching), 2891 (Aliphatic -CH2 stretching), 1717 (C=O 
stretching), 1479, 1443, 1371 (C-H bending), 1282, 1236, 1215 (OH bending), 998, 
962 (C=C stretching), 704(monosubstituted), MS: m/z: 448.47(M+); Anal. Calcd. for 
C28H20N2O4
 
: C,74.99; H, 4.50; N, 6.25; O,14.27 Found: C, 74.83; H, 4.41;  N, 6.17; 
O,14.18. 
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4-Hydroxy-8-methyl-3-((E)-3-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one. (SAT-10)  
Yield: 78% IR (cm-1): 3616, 3560 (OH stretching), 3036 (Aromaticd C-H stretching), 
2981 (Aliphatic -CH3stretching), 2892 (Aliphatic -CH2 stretching), 1707 (C=O 
Stretching), 1489, 1453, 1372 (C-H bending), 1281, 1246, 1205 (OH bending), 
997,961 (C=C stretching), 735 (disubstituted), MS: m/z: 462.50(M+); Anal. Calcd. for 
C29H22N2O4
 
: C, 75.31; H, 4.79; N, 6.06: O,13.84 Found: C, 75.23; H, 4.71;  F, 6.01; 
O,13.79. 
3-((E)-3-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-4-hydroxy-8-
methyl-2H-chromen-2-one. (SAT-11)  
Yield: 66% IR (cm-1): 3616, 3560 (OH stretching), 3036 (Aromatic C-H stretching), 
2981 (Aliphatic -CH3 stretching), 2892 (Aliphatic -CH2 stretching), 1707 (C=O 
Stretching), 1489, 1453, 1372 (C-H bending), 1281, 1246, 1205 (OH bending), 
997,961 (C=C stretching), 735 (disubstituted), MS: m/z: 482(M+), 484(M+2) ; Anal. 
Calcd. for C28H19ClN2O4
 
: C, 69.64; H, 3.97; Cl, 7.34; N, 5.80 ;O, 13.25 Found: C, 
69.63; H, 3.81; Cl,7.27; N,579; O,13.19. 
4-Hydroxy-8-methyl-3-((E)-3-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-
yl)acryloyl)-wH-chromen-2-one. (SAT-12)  
Yield: 81% IR (cm-1): 3536, 3561 (OH stretching), 3046 (Aromatic C-H stretching), 
2991 (Aliphatic -CH3stretching), 2890 (Aliphatic -CH2 stretching), 1717 (C=O 
Stretching), 1541 (C-NO2 stretching), 1481, 1451, 1382 (C-H bending), 1291, 1266, 
1215 (OH bending), 996, 966 (C=C stretching), 731 (disubstituted), MS: m/z: 
493(M+); Anal. Calcd. for C28H19N3O6
 
: C,68.15; H, 3.88; N, 8.52; O,19.45 Found: 
C,68.13; H, 3.81;  N,8.47; O,19.41. 
4-Hydroxy-3-((E)-3-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazolyl-4-yl)acrylolyl)-8-
methyl-2H-chromen-2-one. (SAT-13)  
Yield: 72% IR (cm-1): 3546, 3521 (OH stretching), 3056 (Aromatic C-H stretching), 
2981 (Aliphatic -CH3 stretching), 2891 (Aliphatic -CH2 stretching), 1707 (C=O 
Stretching), 1471, 1461, 1372 (C-H bending), 1292, 1276, 1205 (OH bending), 997, 
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965 (C=C stretching), 745 (disubstituted), MS: m/z: 464.47(M+); Anal. Calcd. for 
C28H20N2O5
 
: C,72.41; H, 4.34; N, 6.06; O,17.22 Found: C, 72.33; H, 4.31;  N, 6.01; 
O,17.11. 
4-Hydroxy-3-((E)-3-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-8-
methyl-2H-chromen-2-one. (SAT-14)  
Yield: 83% IR (cm-1): 3556, 3541 (OH stretching), 3016 (Aromatic C-H stretching), 
2998 (Aliphatic -CH3 stretching), 2892 (Aliphatic -CH2 stretching), 1707 (C=O 
Stretching), 1491, 1461, 1392 (C-H bending), 1282, 1281, 1225 (OH bending), 997 
(C=C), 735 (disubstituted), 698(monosubstituted), MS: m/z: 478.50(M+); Anal. Calcd. 
for C29H22N2O5
 
: C, 72.79; H, 4.63; N, 5.85; O, 16.72 Found: C, 72.73; H, 4.61;  N, 
5.77; O,16.69. 
4-Hydroxy-8-methyl-3-((E)-3-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-
yl)acryloyl)-2H-chromen-2-one. (SAT-15)  
Yield: 73% IR (cm-1): 3576, 3521 (OH stretching), 3016 (Aromatic C-H stretching), 
2996 (Aliphatic -CH3 stretching), 2881 (Aliphatic -CH2 stretching), 1711 (C=O 
Stretching), 1556 (C-NO2 stretching), 1491, 1442, 1372 (C-H bending), 1272, 1256, 
1235 (OH bending), 986 (C=C stretching), 741 (disubstituted), 701(monosubstituted), 
MS: m/z: 493.47(M+); Anal. Calcd. for C28H19N3O6
 
: C,68.15; H, 3.88; N, 8.52; 
O,19.45 Found: C, 68.13; H, 3.71;  N, 4.77; O, 19.41. 
3-((E)-3-(3-(4-flourophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-4-hydroxy-8-
methyl-2H-chromen-2-one. (SAT-16)  
Yield: 85% IR (cm-1): 3606, 3561 (OH stretching), 3006 (Aromatic C-H stretching), 
2998 (Aliphatic -CH3 stretching), 2891 (Aliphatic -CH2 stretching), 1701 (C=O 
stretching), 1498, 1452, 1371 (C-H bending), 1273, 1246, 1215 (OH bending), 996 
(C=C stretching), 745(disubstituted), 702 (monosubstituted), MS: m/z: 466(M+), 
468(M+2) ; Anal. Calcd. for C28H19FN2O4
 
: C,72.10; H, 4.11; N, 6.01; O, 13.72 
Found: C, 72.03; H, 4.05; N,5.98; O,13.69. 
4-Hydroxy-5,8-dimethyl-3-((E)-3-(1,3-diphenyl-1H-pyrazol-4-yl)acryloyl)-2H-
chromen-2-one. (SAT-17)  
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Yield: 89% IR (cm-1): 3616, 3501 (OH stretching), 3016 (Aromatic C-H stretching), 
2988 (Aliphatic -CH3 stretching), 2892 (Aliphatic -CH2 stretching), 1711 (C=O 
stretching), 1488, 1381 (C-H bending), 1272, 1256, 1225 (OH bending), 997 (C=C 
stretching), 715 (monosubstituted), MS: m/z: 462.50(M+) ; Anal. Calcd. for 
C29H22N2O4
 
: C, 75.31; H, 4.79;  N, 6.06; O,13.84 Found: C, 75.23; H, 4.71; N, 6.01; 
O,13.79. 
4-Hydroxy-5,8-dimethyl-3-((E)-3-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)acryloyl-2H-
chromen-2-one. (SAT-18)  
Yield: 82% IR (cm-1): 3661, 3521 (OH stretching), 3046 (Aromatic C-H stretching), 
2981 (Aliphatic -CH3 stretching), 2899 (Aliphatic -CH2 stretching), 1715 (C=O 
Stretching), 1498, 1382 (C-H bending), 1271, 1257, 1235 (OH bending), 987 (C=C 
stretching), 732 (disubstituted), MS: m/z: 476.52(M+) ; Anal. Calcd. for C30H24N2O4
 
: 
C, 75.61; H, 5.08; N, 5.88; O, 13.43 Found: C, 75.58; H, 5.01; N, 5.77; O,13.39. 
3-((E)-3-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-4-hydroxy-5,8-
dimethyl-2H-chromen-2-one. (SAT-19)  
Yield: 85% IR (cm-1): 3651, 3591 (OH stretching), 3041 (Aromatic C-H stretching), 
2991 (Aliphatic -CH3 stretching), 2879 (Aliphatic -CH2 stretching), 1705 (C=O 
stretching), 1488, 1392 (C-H bending), 1281, 1267, 1245 (OH bending), 989 (C=C 
stretching), 744 (disub.), 701 (monosubstituted), MS: m/z: 496(M+), 498(M+2); Anal. 
Calcd. for C29H21ClN2O4
 
: C,70.09; H, 4.26; N, 5.64; O,12.88 Found: C, 70.03; H, 
4.11;  N, 5.57; O,12.81. 
4-Hydroxy-5,8-dimethyl-3-((E)-3-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-
yl)acryloyl)-2H-chromen-2-one. (SAT-20)  
Yield: 78%  IR (cm-1): 3601, 3581 (OH stretching), 3011 (Aromatic C-H stretching), 
2998 (Aliphatic -CH3 stretching), 2899 (Aliphatic -CH2 stretching), 1715 (C=O 
stretching), 1542 (C-NO2), 1498, 1382 (C-H bending), 1282, 1245 (OH bending), 979 
(C=C stretching), 755(disubstituted), 701 (monosubstituted), MS: m/z: 507.49(M+) ; 
Anal. Calcd. for C29H21N3O6
 
: C, 68.63; H, 4.17; N, 8.28; O, 18.92  Found: C, 68.56; 
H, 4.11;  N, 4.07; O,18.90. 
 
Chapter – 4                                                                A Rapid Microwave assisted..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  156 
 
 
4-Hydroxy-3-((E)-3-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-5,8-
dimethyl-2H-chromen-2-one. (SAT-21)  
Yield: 83% IR (cm-1): 3611, 3561 (OH stretching), 3021 (Aromatic C-H stretching), 
2988 (Aliphatic -CH3 stretching), 2889 (Aliphatic -CH2 stretching), 1717 (C=O 
Stretching), 1497, 1392 (C-H bending), 1292, 1255 (OH bending), 989 (C=C 
stretching), 749 (disubstituted), 711(monosubstituted), MS: m/z: 478.50 (M+); Anal. 
Calcd. for C29H22N2O5
 
: C, 72.79; H, 4.63; N, 5.85; O, 16.72 Found: C, 72.73; H, 
4.51;  N, 5.77; O,16.68. 
4-Hydroxy-3-((E)-3-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-5,8-
dometyl-2H-chromen-2-one. (SAT-22)  
Yield: 86% IR (cm-1): 3610, 3551 (OH stretching), 3031 (Aromatic C-H stretching), 
2989 (Aliphatic -CH3 stretching), 2879 (Aliphatic -CH2 stretching), 1712 (C=O 
stretching), 1498, 1362 (C-H bending), 1299, 1265 (OH bending), 979 (C=C 
stretching), 741(disubstituted), 698 (monosubstituted), MS: m/z: 492.52 (M+); Anal. 
Calcd. for C30H24N2O5
 
: C, 73.16; H, 4.91; N, 5.69; O, 16.24 Found: C, 73.13; H, 
4.81;  N, 5.67; O,16.20. 
4-Hydroxy-5,8-dimethyl-3-((E)-3-(3-(-nitrophenyl)-1-phenyl-1H-pyrazol-4-
yl)acryloyl)-2H-chromen-2-one. (SAT-23)  
Yield: 68% IR (cm-1): 3610, 3541 (OH stretching), 3041 (Aromatic C-H stretching), 
2928 (Aliphatic -CH3 stretching), 2859 (Aliphatic -CH2 stretching), 1727 (C=O 
stretching), 1551 (C-NO2 stretching), 1491, 1390 (C-H bending), 1293, 1235 (OH 
bending), 979 (C=C stretching), 739(disubstituted), MS: m/z: 507.49 (M+); Anal. 
Calcd. for C29H21N3O6
 
: C,68.63; H, 4.17; N, 8.28; O, 18.92  Found: C, 68.53; H, 
4.11;  N, 8.17; O, 18.88. 
3-((E)-3-(3-(4-flourophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-4-hydroxy-5,8-
dimethyl-2H-chromen-2-one. (SAT-24)  
Yield: 81% IR (cm-1): 3591, 3521 (OH stretching), 3071 (Aromatic C-H stretching), 
2985 (Aliphatic -CH3 stretching), 2829 (Aliphatic -CH2 stretching), 1727 (C=O 
stretching), 1487, 1362 (C-H bending), 1252, 1225 (OH bending), 969 (C=C 
stretching), 749(disubstituted), 689 (monosubstituted), MS: m/z: 480 (M+), 482 (M+2) 
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; Anal. Calcd. for C29H21FN2O4
 
: C, 72.49; H, 4.41; N, 5.83; O, 13.32 Found: C, 
72.43; H, 4.31;  N, 5.77; O,13.28. 
4.11   RESULTS AND DISCUSSION 
 
This chapter is related to modification in the previous work done by our group 
as well as others but the scaffolds reported here are new. It is very well known that C3
Earlier chalcones were prepared by previous workers in the presence of 
piperidine using conventional methods which takes almost 36-48 hrs. It was further  
modified by reducing reaction time drastically upto 1 hrs only in conventional 
method. However, in this chapter, the compounds were prepared by microwave 
method below 15 min.   
 
position of 4-hydroxycoumarin is highly reactive. 3-acetyl-4-hydroxycoumarin was 
synthesized by acetylation on 4-hydroxycoumarin adopting cited literature method. 
The importance of chalcones  was discussed in the introduction of this chapter. 
 
4.12   CONCLUSION 
 
The chemical entities enlisted above in this chapter, especially the chalcone 
involving the pyrazole aldehydes have been prepared by a microwave methodology 
and it is much faster giving very good yields. 
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4.13   REPRESENTATIVE SPECTRAS 
4.13.1 IR Spectrum of SAT-02 
 
 
4.13.2 MASS Spectrum of SAT-02 
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4.13.3 1
 
H  NMR Spectrum of SAT-02 
 
4.13.4 Expanded 1
 
H NMR Spectrum of SAT-02 
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4.13.5 IR Spectrum of SAT-03 
 
 
 
4.13.6  MASS Spectrum of SAT-01 
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4.13.7 1
 
H NMR Spectrum of SAT-03 
 
 
4.13.8 Expanded 1
 
H NMR Spectrum of SAT-03 
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5.1   INRODUCTION  
 
Pyridine has its own importance in the field of Chemistry, Agriculture, 
Medicine and Industrial chemistry. Although many polysubstituted pyridine 
compounds like other heterocyclic compounds are synthesized with their functional 
group present from acyclic compounds, most derivatives are prepared by manipulatin 
of pyridine and it’s simple homologues in a manner similar to the chemistry of the 
benzenoid chemistry. However, the simple pyridine compounds are prepared by the 
cyclization of aliphatic raw materials. 
 The availability of 3-Cyanopyridines, nicotinamide and nicotinic acid make 
possible their use as synthetic intermediates. 
 
Among all Cyanopyridines 3-cyanopyridine is the most important 
commercially since partial hydrolysis occurs radily with base catalysis to give 
nicotinamide (Niacinamide) which could be further hydrolyzed to nicotinic acid. 
 
N
CH3
N
CN
N
CONH2
N
COOH
 
 
The availability of 2-cyanopyridines, nicotinamide and nicotinic acid makes 
possible their use as synthetic intermediate. 
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5.2 REVIEW OF LITERATURE 
 
Synthesis methods of Cyanopyridines 
Different methods for preparation of 3-cyanopyridines are as follows: 
(1) 3-cyanopyridine can be prepared by the vapour phase air oxidation of nicotine 
over V2O51 or alkenyl substituted pyridines in presence of ammonia.
(2) Oxley and co-worker
2 
3 synthesized pyridine benzenesulphonate by heating 
nicotinicacid benzensulphonate and PhSO2NH2 at 230
(3) 3-cyanopyridines can be synthesized by the reaction of an alkali cyanide with 
3-pyridine sulphonate
C for 40 min. 
4 or 3-bromopyridine.
(4) Taylor and Crovetti
5 
6 synthesized by the reaction of an alkali cyanide with 3-
pyridine sylphonate4 or 3-bromopyridine.5They also synthesized 2-amino 3-
cyanopyridine from pyridine-1-oxide.
(5) Pyridine-3-carboxylic acid is converted to 3-cyanopyridine when it is mixed 
with ammonia and heated in the present presence of dehydrating catalyst at 
275-450
6 
OC.
(6)
7-8 
 3-Cyanopyridine can be synthesized by heating the potassium salt of 3-
pyridine sulphonic acid with sodium cyanide at 350-400OC.
(7) Dornow and Nense
9 
10
(8) Aromatic nitriles
 synthesized substituted 3-cyanopyridine by boiling 
ethylcyanoacetate and ethylacetoacetate with ammonia. 
11 can be prepared from the corresponding primary carboxylic 
acid amine in presence of TiCl4 an a base like triethylamine at 0O
(9) Sumour and co-workers
C.   
12
(10) Sukari and Midorikawa
 prepared substituted Cyanopyridines by the 
condensation of Chalcones with ethylcyanoacetate and Malononitrile in the 
ammonium acetate. 
13-14
 
 have reported that Malononitrile reacts with alpha, 
beta-unsatutated ketones to give 2-amino-3-cyano-4,6-disubstituted pyridines. 
 
 
 
Chapter – 5                                      Conventional and microwave assisted synthesis.... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  174 
 
Among a wide variety of heterocycles that have been explored for developing 
pharmaceutically important molecules such as cyanopyridines15 and 
triazolopyridines16 and have played an important role in medicinal chemistry. They 
are reported to possess a broad spectrum of biological activity such as potential 
cardiovascular agents antiviral17, CNS depressant18, bactericidal19, ulcer inhibitors20 
etc. Furthermore researchers have also revealed that cyanopyridine derivatives 
constitute an important class of compounds possessing diverse type of biological 
properties including antiviral,21 antiparasitic,22 antiparkinsonian,23 anticonvulsant,24 
antihistaminic25 as well as anthelmintic26
 
 properties. 
 Raval et al.27
 
 have reported the synthesis and antimicrobial activity of new 
triazolopyridinyl phenothiazines through cyanopyridine ring. 
N
H
S
CHO
R
NaOH
MeOH N
H
S
O
R
CH2(CN)2CH3COONH4
N
H
S
N
NH2
CN
R
R = H, 4-OCH3, 4-N(CH3)2 etc....
 
 
Many naturally occurring and synthetic compounds bearing pyridine scaffold 
possess interesting biological properties.28 2-amino-3-cyanopyridine derivatives have 
been identified as IKK-β inhibitors.29-30 Various routes for the synthesis of 2-amino-3-
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cyanopyridine derivatives have been reported using two-component as well as three-
component reactions.31-35 Tu and coworkers31
 
 have reported a facile synthesis of 2- 
amino-3-cyanopyridine derivatives in a one-pot reaction using aromatic aldehyde, 
methyl ketone, malononitrile and ammonium acetate.   
  Mungra et al.36 have reported an efficient one-pot multicomponent synthesis 
of 2-amino-3-cyanopyridine derivatives having tetrazoloquinoline nucleus which have 
also been recognized as promising new scaffold to endow good biological 
properties37,38 such as anti-inflammatory and antimicrobial activity.
 
39-42 
N
N N
N
CHOR1 CN
CN R2 CH3
O
CH3COONH4absolute alcohol
reflux
N
CN
NH2
N
N
N
N
R1
R2
Where R1 = H, CH3, OCH3 etc...
               R2 = C6H5,2-furyl, 4-CH3C6H5 etc...
 
   
Kachhadia et al.43
 
 have reported the Synthesis of cyanopyridines bearing 
benzo thiophene nucleus as potential antitubercular and antimicrobial agents. 
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S
Cl
CONH
O
R
S
Cl
CONH
N
CN
NH2
R
CH3COONH4
CH2(CN)2
R = Aryl groups
 
 
Vyas et al.44
  
 have extended studied on cyanopyridine and reported the 
synthesis and antimicrobial activity of some new cyanopyridines and cyanopyrans 
towards mycobacterium tuberculosis and other microorganism.  
O
CH3
Br
Br
O
H3C R
O
H
Malononitrile Malononitrile
PyridineCH3COONH4
N O
Br
O
Br
Br
O
Br
NH2
CN
R
NH2
CN
R
Where R= Aryl groups
 
 
Konda et al.45 reported the synthesis and antibacterial activities of some new 
cyanopyridines. 
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NH2
Acetic anhydride
Acetic acid
NH
CH3
O
Ar-CHO
KOH/MeOH
NH
HC
O
Ar
CN
CN
AcONH4
MeOH
HN N NH2
CN
Ar
 
 
2-amino-6-aryl-3-cyano-4-piperidinylpyridine core structure can be 
constructed using a one-pot coupling reaction of acetophenone, piperidine, 
malononitrile and ammonium acetate in conventional heating mode.46 In addition to 
that, Microwave activation as a non-conventional energy source has become an 
important method that can be used to carry out a wide range of reactions within short 
time and with high yields, especially in the absence of solvents47-50. Satya et al. has 
also prepared 2-amino-3-cyanopyridines from arylidene malononitrile, ketone and 
ammonium acetate under microwave irradiation.51
 
 However, arylidene malononitriles 
as one of the starting materials must be synthesized from malononitrile and aromatic 
aldehyde. 
 Feng et al.52
 
 have reported the synthesic method of 2-amino-3-cyanopyridine 
derivatives by one-pot condensation from malononitrile, aromatic aldehyde, methyl 
ketone and ammonium acetate under microwave irradiation without solvent. This 
method has the advantage of short routine, high yields and being environmentally-
friendly. 
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Ar CHO R CH3
O
CN
CN
NH4OAC
MWI N
H
CN
NH2
Ar
R
R=CH3C6H5 etc....
Ar=4-Cl Phenyl,4-Methoxy phenyl etc.....
 
 
Chromone derivatives drew much attention because of their activity against 
the human immunodeficiency virus (HIV-1)53-55 and their broad anti-inflammatory56, 
antitumor,57 antibacterial,58 antimicrobial,59 antifungal,61,61 antibiotic,62 and 
insecticidal activities.63 Chromones bearing an allyl group at position 8 have a special 
medicinal importance; 8-allyl-2-styrylchromones were used as inhibitors for the 
growth of tumors.64 Also, the 8-allyl derivatives were used as a precursor for the 
synthesis of the 8-acetic acid derivatives which exhibit anticancer properties.65-67  
eteroannulated chromones showed significant biological activity including 
pharmacological,68 anti-inflammatory and antiplatelet activities.
 
69 
Salah et al.70
 
 have reported the Synthesis of 8-allylchromone-3-
carboxaldehyde and further they studied its reaction with malononitrile, 
cyanoacetamide, ethyl cyanoacetate, phenylthioacetonitrile, ethyl acetoacetate, ethyl 
benzoylacetate and barbituric acid. 
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O
O
CHO
NH2
67 %
CN
CN
SPh
CN
34 %
CN
CONH2
NC
COOEt
O
O
N
CN
NH2
DBU
EtOH
O
O
N
SPh
NH2
R
R
60 %
43 %
O
O
N
CONH2
NH2
R
O
O
N
COOEt
NH2
R
Where R = H3C
 
 
At this laboratory previous work on Cyanopyridine moiety is reported.71
 
 The 
synthesized compounds were screened for their antimicrobial, antifungal activity 
against various strains of bacteria and fungi. 
N
H
H3C
H3COOC
CH3
SCH3
N
R
NH2
CN
Where R= Different substituent
 
 
The Cyanopyridines were explored for other biological activities too. 
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5.3   Biological Profile 
 
Cyanopyridine derivatives have been found to possess wide range of therapeutic 
activities as shown below.  
 
1. Antiviral
2. CNS depressant
72 
3. Bactericial
73 
74
4. Ulcer inhibitors
  
5. Antiparasitic
75
 
 
6. Antiparkinsonian
76 
7. Anticonvulsant
77 
8. Antihistaminic
78 
 
79 
 It also possess antibacterial80-82, antifungal83-84, antidiabatic, anticholestrimic 
and antihypertensive activities. They are also used as dyes for cotton and polyester 
fabrics. Substituted-3-cyanopyridines are useful as chemical buffer. Francis and 
coworkers studied the effect of some substituted pyridines on the growth of the 
walker carcinosarcome-256 in tissue culture. Streightoff80 and seydel81-82
 
 have studied 
the bacteriostatic effect of some substituted 3-cyanopyridines.  
Kadlac et al.83 showed that 2-methyl-3-nitro-4-methoxymethyl-5-cyano-6-
chloropyridines caused occupational health hazard like eczema. Rigterink et al.84 
studied the Pesticidal activity of 3-cyano-pyridine derivatives. Hoefling and et al.85
 
 
prepared 3 and 4-cyanpyridines, which possess antitubercular activity. 
 
Barton et al.86
 
 prepared 2-substituted-3-cyano-5-nitro-pyridines which possess 
fungicidal and insecticidal properties. 
Kurt et al.87 studied the antiphogistic and analgestic properties of substituted 
3-cyanopyridines. Latif et al.88 have reported the antibacterial and antifungal activity 
of 2-amino-3-cyano-4,6disubstituted pyridines. Scott and Joseph89-90 have prepared 2-
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aminopyridine derivatives, which were found to be useful as antipsoriasis 
pharmaceuticals. Baldwin91-93
 
 studied antihypertensive activity of Cyanopyridines. 
 Taylor et al.94 have prepared N-substituted-2-aminopyridines which possess 
anticonvulsant activity. Engel and Benenburg95 synthesized 2-amino-3,6-disubstitued 
pyridine derivatives as antiepileptic agents. 3-cyanopyridine derivative synthesized by 
Castedo et al.96 had a MIC of 1.56 µg/ml against S.aureus
 
. 
 
5.4 AIM OF CURRENT WORK 
 
 
In recent years, environmentally benign synthesis methods have received 
considerable attention. In present work, multistep synthesis in which the final step is 
performed by using microwave synthesizer for rapid synthesis. 
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5.5   REACTION SCHEMES 
 
5.5.1 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
 It was prepared according to method described in Chapter-1 
 
5.5.2 PREPARATION OF 3-ACETYL 4-HYDROXY COUMARINS : 
 
It was prepared according to method described in Chapter-4 
 
5.5.3 PREPARATION OF CHALCONES : 
 
It is prepared according to method described in Chapter-4 
 
 
5.5.4 PREPARATION OF 3 AMINO-4-(3-(SUBSTITUTED) PHENYL)-1-
PHENYL-1H-PYRAZOL-4-YL)-6-(4-HYDROXY-2-OXO-2H-
CHROMEN-3-YL) PYRIDINE-2-CARBONITRILE: 
 
 
O O
OH O
N
N
R
R1
a
O O
OH
N NH2
CN
N N R1
R
 
 
Reagents/ Reaction Condition (a): Mw, 400Wt, CH2 (CN)2 , CH3COONH4
Where R= H, 5-CH
, MeOH,. 
3, 5, 8-diCH3 
R
& 
1 = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 
 
etc..... 
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5.6   PLAUDIBLE REACTION MECHANISM 
 
 
R
R1 O
HH
CN CN
R CH
HCN
CN
R1 OH
R CH2
HCN
CN
R1 O
-CH3COOH
R CH2
HCN
CN
R1 N
O-
CH3COONH4
H
H
H
+
HCN
CN
R
R1 N
H
H+
HCN
CN
R
R1 NH
H
HH
C
CN
CN
HH
R
H N
R1
H
H
N
H
R1
NH
CN
R
N NH2
CN
R1
R
HH
-2H+
N
CN
NH2R1
R
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5.7   EXPERIMENTAL 
 
5.7.1 MATERIALS AND METHODS : 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. All the reaction were 
carried out in Q-pro microwave synthesizer. IR spectra were recorded in Shimadzu 
FT-IR-8400 instrument using KBr pellet method. Mass spectra were recorded on 
Shimadzu GC-MS-QP-2010 model using Direct Injection Probe technique. 1H NMR 
was determined in CDCl3
 
/DMSO solution on a Bruker Ac 400 MHz spectrometer. 
Elemental analysis of the all the synthesized compounds was carried out on Elemental 
Vario EL III Carlo Erba 1108 model and the results are in agreements with the 
structures assigned. 
5.7.2 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
 It was prepared according to method described in Chapter-1 
 
5.7.3 PREPARATION OF 3-ACETYL 4-HYDROXY COUMARINS : 
 
It was prepared according to method described in Chapter-4 
 
5.7.4 PREPARATION OF CHALCONES : 
 
It was prepared according to method described in Chapter-4 
 
5.7.5 PREPARATION OF 3 AMINO-4-(3-(SUBSTITUTED) PHENYL)-1-
PHENYL-1H-PYRAZOL-4-YL)-6-(4-HYDROXY-2-OXO-2H-
CHROMEN-3-YL) PYRIDINE-2-CARBONITRILE: 
GENERAL METHOD 
(A) CONVENTIONAL METHOD : 
A mixture of Chalcone (0.01 mole) , Malononitrile (0.01 mole), ammonium 
acetate (0.08 mole) and 20 mls of methanol was refluxed for 4-6 hrs. The progress 
and the completion of the reaction were checked at interval of every one min. by silica 
gel-G F254
Similarly other compounds are also prepared using different methods. 
 thin layer chromatography using hexane : ethyl acetate (2 : 3) as a mobile 
phase. After that it was cool to room temperature and filtered it and wash with 
methanol. Dry it. 
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(B) MICROWAVE METHOD : 
 
A mixture of chalcone (0.01 mole), Malononitrile (0.01 mole), ammonium 
acetate (0.08 mole) and 20 mls of methanol were taken in 100 ml microwave flask. 
The reaction mixture was irradiated under microwave irradiation using Qpro-M 
microwave synthesizer for the desired time at 400 Watt. The progress and the 
completion of the reaction were checked at interval of every one minute by using 
silica gel-G F254
Similarly other compounds are also prepared using different methods.  
 thin layer chromatographic plates using hexane : ethyl acetate (2 : 3) 
as a mobile phase. It was then cooled to room temperature and filtered, washed with 
chilled methanol and dried.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter – 5                                      Conventional and microwave assisted synthesis.... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  186 
 
Comparative Results of conventional method (A) and microwave 
method (B)  
 
TABLE – 5.1 
Code No. 
Reaction Condition % Yield 
Conventional 
Method (A) Microwave Method (B) Method 
(A) 
Method 
(B) Temp.  
(°C) 
Time  
(hrs.) 
Watt 
(W) 
Temp. 
(°C) 
Time 
(min.) 
STAB-1001 70-75  4.0  400 110  6.0  62 76 
STAB-1002 70-75  5.0  400 110  5.0 72 78 
STAB-1003 70-75  4.0  400 110  5.0 68 81 
STAB-1004 70-75 5.0  400 110  6.0 66 79 
STAB-1005 70-75  5.0  400 110  7.0 62 78 
STAB-1006 70-75 5.0 400 110 8.0 72 81 
STAB-1007 70-75 4.0 400 110 8.0 74 82 
STAB-1008 70-75 5.0 400 110 6.0 66 81 
STAB-1009 70-75 5.0 400 110 8.0 70 78 
STAB-1010 70-75 4.0 400 110 7.0 71 80 
STAB-1011 70-75 4.5 400 110 9.0 73 82 
STAB-1012 70-75 4.0 400 110 6.0 60 71 
STAB-1013 70-75 5.0 400 110 7.0 72 76 
STAB-1014 70-75 5.0 400 110 9.0 69 74 
STAB-1015 70-75 4.0 400 110 8.0 67 79 
STAB-1016 70-75 4.5 400 110 5.0 64 72 
STAB-1017 70-75 4.5 400 110 8.0 64 74 
STAB-1018 70-75 5.5 400 110 6.0 71 83 
STAB-1019 70-75 5.5 400 110 9.0 66 80 
STAB-1020 70-75 4.5 400 110 4.0 70 79 
STAB-1021 70-75 6.0 400 110 6.0 62 72 
STAB-1022 70-75 5.5 400 110 5.0 71 78 
STAB-1023 70-75 5.5 400 110 6.0 68 72 
STAB-1024 70-75 6.0 400 110 6.0 72 74 
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5.8   PHYSICAL DATA 
Physical data of 3-Amino-4-(3-(substituted)phenyl)-1-phenyl-1H-
pyrazol-4-yl)-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)pyridine-2-
carbonitrile. 
O O
OH
N NH2
CN
N N
R1
R
 
TABLE – 5.2 
Code Substitution 
 
MF MW MP 
O
Rf 
Value C 
R R1 
STAB-1001 4-Cl H C30H18ClN5O 531 3 178-180 0.46 
STAB-1002 4-CH H 3 C31H21N5O 511 3 192-194 0.52 
STAB-1003 H H C30H19N5O 497 3 202-204 0.44 
STAB-1004 4-NO H 2 C30H18N6O 542 5 238-240 0.48 
STAB-1005 2-OH H C30H19N5O 513 4 222-224 0.50 
STAB-1006 2-OCH H 3 C31H21N5O 527 4 216-218 0.40 
STAB-1007 3-NO H 2 C30H18N6O 542 5 168-170 0.44 
STAB-1008 4-F H C30H18FN5O 515 3 198-200 0.48 
STAB-1009 H 8- CH C3 31H21N5O 511 3 224-228 0.42 
STAB-1010 4-CH 8- CH3 C3 32H23N5O 525 3 236-238 0.46 
STAB-1011 4-Cl 8- CH C3 31H20ClN5O 545 3 180-182 0.42 
STAB-1012 4-NO 8- CH2 C3 31H20N6O 556 5 178-180 0.54 
STAB-1013 2-OH 8- CH C3 31H21N5O 527 4 192-194 0.50 
STAB-1014 2-OCH 8- CH3 C3 32H23N5O 541 4 222-224 0.48 
STAB-1015 3-NO 8- CH2 C3 31H20N6O 556 5 212-214 0.40 
STAB-1016 4-F 8- CH C3 31H20FN5O 529 3 232-234 0.46 
STAB-1017 H 5,8-di CH C3 32H23N5O 525 3 244-246 0.44 
STAB-1018 4-CH 5,8-di CH3 C3 33H25N5O 539 3 166-168 0.48 
STAB-1019 4-Cl 5,8-di CH C3 32H22ClN5O 559 3 212-214 0.40 
STAB-1020 4-NO 5,8-di CH2 C3 32H22N6O 570 5 232-234 0.42 
STAB-1021 2-OH 5,8-di CH C3 32H23N5O 541 4 178-180 0.48 
STAB-1022 2-OCH 5,8-di CH3 C3 33H25N5O 555 4 192-194 0.46 
STAB-1023 3-NO 5,8-di CH2 C3 32H22N6 570 O5 180-182 0.52 
STAB-1024 4-F 5,8-di CH C3 32H22FN5O 543 3 212-214 0.42 
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate (2 : 3) 
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5.9   SPECTRAL DISCUSSION 
 
5.9.1   IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 model using KBr pallet method. Various functional groups present were 
identified by characteristic frequency obtained for them.  
The characteristic bands of  Hydroxyl groups were obtained for streching at 
3400-3650 cm-1 and those for bending  were obtained at 1050-1250 cm-1.The 
stretching vibrations N-H group showed in the region of 3200 to 3500  cm-1 with a 
deformation due to in plane bending at 1650-1580 cm-1. It gives aromatic C-H 
stretching   frequencies between 3000-3200 cm-1 and bending vibration near 1300-
1500 cm-1 respectively. C-H stretching frequencies for methyl and methylene group 
were obtained near 2950 cm-1 to 2850 cm-1.  Characteristic frequency of C-N 
stretching showed near 2100-2400 cm-1 and bending vibration near 1300-1400 cm-1
 
.  
5.9.2  MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 
 
ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. Fragmentation pattern can be 
observed to be particular for these compounds and the characteristic peaks obtained 
for each compound.  
5.9.3   1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer by making a solution of samples in CDCl3 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons and carbons identified from NMR spectrum and their chemical 
shift (δ ppm) were in the agreement of the structure of the molecule. J values were 
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calculated to identify o, m and p coupling. In some cases, aromatic protons were 
obtained as multiplet. 1
 
H spectral interpretation can be discussed as under. 
1
 (STAB-1001) 
H NMR of 3-Amino-4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-(4-
hydroxy-2-oxo-2H-chromen-3-yl)pyridine-2-carbonitrile 
O O
OH
N NH2
CN
N N Cl
1
2
3
4
5
6
7
8
9
10
11 12
13
14 15
1617
 
 
1. Proton no. 7 of total 2H gave a Broad singlet at 3.74 δ ppm. 
2. Proton no. 11 of 1H gave a doublet at 7.21 δ ppm - 7.23 δ ppm. 
3. Proton no. 4 of 1H gave a triplet at 7.26 δ ppm - 7.30 δ ppm. 
4. Proton no. 15 and 16 of 2H gave a doublet at 7.34 δ ppm 
5. Proton no. 5 of 1H gave a doublet at 7.38 δ ppm
-7.36 δ ppm and J 
value of this proton is 8.0 Hz it suggest ortho coupling. 
 
6. Proton no. 3 of 1H gave a doublet at 7.51 δ ppm. 
-7.40 δ ppm. 
7. Proton no. 9,13,10 and 12 of 4H gave a triplet at 7.55 δ ppm - 7.60 δ ppm.  
8. Proton no. 14 and 17 of 2H gave a doublet at 7.78 δ ppm -7.85 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
9. Proton no. 2 of coumarin ring gave a doublet at 8.03 δ ppm - 8.05 δ ppm. 
10. Proton no. 6 of pyridine ring of 1H gave a singlet at 8.27 δ ppm.
11. Proton no. 8 of pyrazol ring of 1H gave a singlet at 8.50 δ ppm. 
  
12. Proton no. 1 of 1H gave a singlet at 18.35 δ ppm. 
 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
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structure for compound no. STAB-1001 has been confirmed. The spectrum is given 
on page no.201. 
 
1
 (STAB-1002) 
H NMR of 3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(1-phenyl-3-p-
tolyl-1H-pyrazol-4-yl) pyridine-2-carbonitrile 
 
1. Proton no. 18 of total 3H gave a singlet at 2.36 δ ppm. 
2. Proton no. 7 of total 2H gave a Broad singlet at 3.76 δ ppm. 
3. Proton no. 10 and 12 of 2H gave a doublet at 7.16 δ ppm – 7.18 δ ppm. 
4. Proton no. 3 of 1H gave a doublet at 7.20 δ ppm. 
5. Proton no. 11 of 1H gave a triplet at 7.25 δ ppm 
6. Proton no. 4 of 1H gave a Triplet at 7.34 δ ppm -7.38 δ ppm.  
-7.27 δ ppm. 
7. Proton no. 9 and 13 of 2H gave a dublet at 7.44 δ ppm -7.46 δ ppm. 
8. Proton no. 15 and 17 of 2H gave a doublet at 7.50 δ ppm – 7.52 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling. 
9. Proton no. 5 of 1H gave a triplet at 7.59 δ ppm – 7.77 δ ppm.
10. Proton no. 14 and 16 of 2H gave a doublet at 7.86 δ ppm – 7.88 δ ppm and J 
value of this proton is 8.0 Hz. It suggest ortho coupling.  
  
11. Proton no. 2 of 1H gave a doublet at 8.02 δ ppm – 8.05 δ ppm. 
12. Proton no. 6 of pyridine ring of 1H gave a singlet at 8.25 δ ppm. 
13. Proton no. 8 of pyrazole ring of 1H gave a singlet at 8.50 δ ppm. 
14. Proton no. 1 of 1H gave a singlet at 18.30 δ ppm. 
 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
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structure for compound no. STAB-1002 has been confirmed. The spectrum is given 
on page no.203. 
 
5.9.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds.  
The spectral and elemental analysis data are for individual compounds 
synthesized in this chapter is mentioned below. 
 
5.10 ANALYTICAL DATA  
 
3-Amino-4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-(4-hydroxy-2-oxo-2H-
chromen-3-yl)pyridine-2-carbonitrile. (STAB-1001)  
IR (cm-1): 3645,3562 (OH Stretching), 3475,3400,3317 (N-H stretching), 3082,3014 
(Aromatic C-H stretching), 2974,2901 (Aliphatic -CH3 stretching), 2829 (Aliphatic -
CH2 Stretching. ), 2424,2322 (C-N Stretching), 1768(C=O Stretching),1560 (N-H 
bending), 1429,1381 (C-H bending) , 1253 (C-N bending), 1159 (OH bending), 762 
(disubstituted), 715(monosubstituted), 1H NMR (DMSO-d6) δ ppm: 3.74 (s, 2H), 
7.21-7.23 (d, 1H), 7.26-7.30 (t, 1H), 7.34-7.36 (d, 2H, J=8.0 Hz), 7.38-7.40 (d, 1H), 
7.51 (d, 1H), 7.55-7.60 (t, 4H), 7.78-7.85(d, 2H, J=8.0 Hz), 8.03-8.05(d, 1H), 8.27 (s, 
1H), 8.50 (s, 1H),8.35 (s, 1H)  MS: m/z = 531(M+), 533(M+2) ; Anal. Calcd. for 
C30H18ClN5O3
 
:  C, 75.56; H, 4.61; N,10.68; O, 9.15; Found: C, 75.46; H, 4.56; N, 
10.68; O, 9.09. 
3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(1-phenyl-3-p-tolyl-1H-pyrazol-
4-yl)pyrimidine-2-carbonitrile. (STAB-1002)  
IR (cm-1): 3626,3568 (OH Stretching), 3421,3392,3275 (N-H stretching), 3189,3086 
(Aromatic C-H stretching), 2908,(Aliphatic -CH3 stretching), 2891 (Aliphatic -CH2 
Stretching), 2424,2333 (C-N Stretching), 1782(C=O Stretching), 1668,1618 (N-H 
bending), 1554,1379 (C-H bending) , 1165 (OH bending),  790 (disubstituted ), 
Chapter – 5                                      Conventional and microwave assisted synthesis.... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  192 
 
717(monosubstituted),  1H NMR (DMSO-d6) δ ppm: 2.36 (s, 3H), 3.76 (s, 2H), 7.16-
7.18 (d, 2H), 7.20 (d, 1H), 7.25-7.27 (t, 1H), 7.34-7.38 (t, 1H), 7.44-7.46 (d, 2H), 
7.50-7.52 (d, 2H, J=8.0 Hz), 7.59-7.77(t, 1H),7.86-7.88 (d, 2H, J=8.0Hz), 8.02-8.05 
(d, 2H), 8.25 (s, 1H), 8.50 (s, 1H), 8.30 (s, 1H) MS: m/z = 511.16; Anal. Calcd. for 
C34H26N4O3
 
: C, 75.82; H, 4.87; N, 10.40; O, 8.91;  Found: C, 75.81; H, 4.80; N, 
10.38; O,8.81.  
3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(1,3-diphenyl-1H-pyrazol-4-
yl)pyridine-2-carbonitrile. (STAB-1003)  
IR (cm-1): 3635,3542 (OH Stretching), 3465,3401 (N-H stretching), 3032,3024 
(Aromatic C-H stretching), 2984 (Aliphatic -CH3 stretching), 2823 (Aliphatic -CH2 
Stretching), 2332 (C-N Stretching), 1778(C=O Stretching), 1570 (N-H bending), 
1428,1382 (C-H bending), 1263 (C-N bending), 1158 (OH bending), 793 
(disubstituted), 716(monosubstituted), MS: m/z = 497.50; Anal. Calcd. for 
C30H19N5O3
 
: C, 72.43; H, 3.85;  N, 14.08;  O,9.65, Found: C, 72.34; H, 3.75; N, 
14.00; O,9.59. 
3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(1-(4-nitrophenyl)-3-phenyl-1H-
pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1004)  
IR (cm-1): 3552 (OH Stretching), 3450,3417 (N-H stretching), 3062,3034 (Aromatic 
C-H stretching), 2984,2901 (Aliphatic -CH3 stretching), 2839 (Aliphatic -CH2 
Stretching), 2332 (C-N Stretching), 1767(C=O Stretching), 1562 (N-H bending),  
1560 (C-NO2 stretching), 1439,1382 (C-H bending), 1263 (C-N bending), 1160 (OH 
bending), 794(disubstituted), 717(monosubstituted), MS: m/z = 542.50; Anal. Calcd. 
for C30H18N6O5
 
: C,66.42; H, 3.34; N, 15.49; O,14.75  Found: C, 66.40; H, 3.29;  N, 
15.33; O,14.73. 
3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(1-(2-hydroxyphenyl)-3-phenyl-
1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1005)  
IR (cm-1): 3602 (OH stretching), 3451,3427 (N-H stretching), 3032,3014 (Aromatic 
C-H stretching), 2974,2961 (Aliphatic -CH3 stretching), 2838 (Aliphatic -CH2 
stretching), 2342 (C-N stretching), 1769(C=O stretching), 1572 (N-H bending),   
1438,1381 (C-H bending), 1262 (C- N bending), 1161 (OH bending), 795 
(disubstituted), 716 (monosubstituted), MS: m/z = 513.14; Anal. Calcd. for 
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C30H19N5O4
 
: C, 70.17; H, 3.73; N, 13.64; O,12.46 Found: C, 70.13; H, 3.69;  N, 
13.53; O,12.43. 
 3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(2-methyoxyphenyl)-3-phenyl-
1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1006)  
IR (cm-1): 3562 (OH stretching), 3456,3427 (N-H stretching), 3072,3024 (Aromatic 
C-H stretching), 2983,2911 (Aliphatic -CH3 stretching), 2849(Aliphatic -CH2 
Stretching), 2342 (C-N stretching), 1768(C=O stretching), 1552(N-H bending),   
1449,1372 (C-H bending), 1262 (C-N bending), 1161 (OH bending), 792 
(disubstituted), 715 (monosubstituted), MS: m/z = 542.50; Anal. Calcd. for 
C30H18N6O5
 
: C, 66.42; H, 3.34; N, 15.49; O, 14.75 Found: C, 70.51; H, 3.99;  N, 
13.15; O, 12.06. 
3-Amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(1-(3-nitrophenyl)-3-phenyl-1H-
pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1007)  
IR(cm-1): 3552 (OH stretching), 3450,3417 (N-H stretching), 3062,3034 (Aromatic C-
H stretching), 2984,2901 (Aliphatic -CH3 stretching), 2839 (Aliphatic -CH2 stretching 
), 2332 (C-N stretching), 1767(C=O stretching), 1562 (N-H bending),  1565 (C-NO2 
stretching), 1439,1382 (C-H bending), 1263 (C- N bending), 1154 (OH bending), 794 
(disubstituted), 717(monosubstituted),  MS: m/z = 569.57; Anal. Calcd. for 
C33H23N5O5
 
: C, 69.59; H, 4.07; N, 12.30; O,14.05 Found: C, 69.54; H, 4.06;  N, 
12.21; O, 14.02. 
3-Amino-4-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-(4-hydroxy-2-oxo-2H-
chromen-3-yl)pyridine-2-carbonitrile. (STAB-1008)  
IR (cm-1): 3602 (OH stretching), 3430,3407 (N-H stretching), 3061,3024 (Aromatic 
C-H stretching), 2994,2911 (Aliphatic -CH3 stretching), 2849 (Aliphatic -CH2 
stretching), 2339 (C-N stretching), 1777(C=O stretching), 1560 (N-H bending),   
1449,1389 (C-H bending), 1253 (C-N bending), 1169 (OH bend.),  790 (disub. ), 
710(monosub.)  MS: m/z = 515(M+), 517(M+2); Anal. Calcd. for C30H18FN5O3
 
: C, 
69.90; H, 3.52; N, 10.33; O, 8.85 Found: C, 69.80; H, 3.41; N, 10.23; O, 8.75. 
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3-Amino-6-(4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-(1,3-diphenyl-1H-
pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1009)  
IR (cm-1): 3562 (OH stretching), 3421,3402 (N-H stretching), 3042,3014 (Aromatic 
C-H stretching), 2984 (Aliphatic -CH3 stretching), 2819 (Aliphatic -CH2 stretching), 
2232 (C-N stretching), 1760(C=O stretching), 1572 (N-H bending), 1429,1372 (C-H 
bending), 1269 (C-N bending), 1161 (OH bending), 792 (disubstituted), 
707(monosubstituted), MS: m/z = 511.53; Anal. Calcd. for C34H26N4O3
 
: C,72.79; H, 
4.14 ; N, 13.69; O, 9.38 Found: C, 72.83; H, 4.11; N,13.59 ; O,9.39 . 
3-Amino-6-(4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-(1-phenyl-3-p-tolyl-1H-
pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1010)  
IR (cm-1): 3602 (OH stretching), 3431,3407 (N-H stretching), 3012 (Aromatic C-H 
stretching), 2981 (Aliphatic -CH3 stretching), 2829 (Aliphatic -CH2 stretching), 2331 
(C-N stretching), 1768(C=O stretching), 1572 (N-H bending), 1419,1381 (C-H 
bending), 1261 (C-N bending), 1161 (OH bending), 764 (disubstituted), 
727(monosubstituted),  MS: m/z = 525(M+) ; Anal. Calcd. for C32H23N5O3
 
: C, 73.13; 
H, 4.41; N, 13.33; O, 9.13 Found: C, 73.03; H, 4.31;  N, 13.17; O,9.10. 
3-Amino-4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-(4-hydroxy-8-methyl-
2-oxo-2H-chromen-3-yl)pyridine-2-carbonitrile. (STAB-1011)  
IR (cm-1): 35562 (OH stretching), 3420, (N-H stretching), 3069 (Aromatic C-H 
stretching), 2991 (Aliphatic -CH3 stretching), 2849 (Aliphatic -CH2 stretching), 2342 
(C-N stretching), 1777(C=O stretching), 1582 (N-H bending), 1429,1372 (C-H 
bending), 1273 (C-N bending), 1140 (OH bending), 758 (disubstituted), 
719(monosub.)    MS: m/z = 545(M), 547(M+2); Anal. Calcd. for C31H20ClN5O3
 
: C, 
68.20; H, 3.69; N, 12.83; O, 8.79  Found: C, 68.23; H, 3.51;  N,12.71; O,8.89. 
3-Amino-6-(4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-(3-(4-nitrophenyl)-1-
phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1012)  
IR (cm-1): 3550 (OH stretching), 3470,3407 (N-H stretching), 3092 (Aromatic C-H 
stretching), 2974,2921 (Aliphatic -CH3 stretching), 2859 (Aliphatic -CH2 stretching), 
2322 (C-N stretching), 1787(C=O stretching), 1563 (N-H bending),  1571 (C-NO2) 
1432,1381 (C-H bending), 1262 (C-N bending), 1168 (OH bending),  751 
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(disubstituted), 711(monosub.)  MS: m/z = 556.15; Anal. Calcd. for C31H20N6O5
 
: C, 
66.90; H, 3.62; N, 15.10; O,14.37 Found: C, 66.83; H, 3.61;  N, 15.07; O,14.49. 
3-Amino-6-(4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-(3-(2-hydroxyphenyl)-
1-phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1013)  
IR (cm-1): 3552 (OH stretching), 3452,3407 (N-H stretching), 3063,3014 (Aromatic 
C-H stretching), 2983,2911 (Aliphatic -CH3 stretching), 2890 (Aliphatic -CH2 
stretching), 2330 (C-N stretching), 1787(C=O stretching), 1561 (N-H bending),   
1429,1382 (C-H bending), 1253 (C-N bending), 1161 (OH bending), 761 
(disubstituted), 717 (monosubstituted) MS: m/z = 527.16; Anal. Calcd. for 
C31H21N5O4
 
: C,70.58; H, 4.01; N, 13.28; O,12.13 Found: C, 70.53; H, 4.01;  N, 
13.17; O,12.11. 
3-Amino-6-(4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-(3-(2-methoxyphenyl)-
1-phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1014)  
IR (cm-1): 3651 (OH stretching), 3420,3407 (N-H stretching), 3052,3014 (Aromatic 
C-H stretching), 2994,2921 (Aliphatic -CH3 stretching), 2829 (Aliphatic -CH2 
stretching ), 2341 (C-N stretching), 1787(C=O stretching), 1562 (N-H bending), 
1433,1372 (C-H bending) ,1262 (C-N bending), 1161 (OH bending), 764 
(disubstituted), 714(monosubstituted)   MS: m/z = 541.56; Anal. Calcd. for 
C32H23N5O4
 
: C, 70.97; H, 4.28; N, 12.93; O, 11.82 Found: C, 70.83; H, 4.21;  N, 
12.87; O,11.75. 
3-Amino-6-(4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-(3-(3-nitrophenyl)-1-
phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1015)  
IR (cm-1): 3602 (OH stretching), 3490,3457 (N-H stretching), 3012,3031 (Aromatic 
C-H stretching), 2994,2981 (Aliphatic -CH3 stretching), 2829 (Aliphatic -CH2 
stretching), 2382 (C-N stretching), 1777(C=O stretching), 1563 (N-H bending), 1560 
(C-NO2), 1429,1381 (C-H bending), 1253 (C-N bending), 1161 (OH bending), 755 
(disubstituted), 702(monosubstituted),  MS: m/z = 556.53; Anal. Calcd. for 
C31H20N6O5
 
: C, 66.90; H, 3.62; N, 15.10; O, 14.37 Found: C, 66.91; H, 3.51;  N, 
15.07; O,14.39. 
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3-Amino-4-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-(4-hydroxy-8-methyl-
2-oxo-2H-chromen-3-yl)-pyridine-2-carbonitrile. (STAB-1016)  
IR (cm-1): 3552 (OH stretching), 3450,3417 (N-H stretching), 3062,3034 (Aromatic 
C-H stretching), 2984,2901 (Aliphatic -CH3 stretching), 2839 (Aliphatic -CH2 
stretching), 2332 (C-N stretching), 1767(C=O stretching), 1562 (N-H bending),   
1439,1382 (C-H bending), 1263 (C-N bending), 1160 (OH bending), 754 
(disubstituted), 717(monosubstituted), MS: m/z = 529(M+), 531(M+2); Anal. Calcd. 
for C31H20FN5O3
 
: C, 70.31; H, 3.81; N, 13.23; O,9.06 Found: C, 70.21; H, 3.71; 
N,13.21; O,9.01. 
3-Amino-6-(4-hydroxy-5,8-dimethyl-2-oxo-2H-chromen-3-yl)-4-(1,3-diphenyl-1H-
pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1017)  
IR (cm-1): 3642 (OH stretching), 3451,3427 (N-H stretching), 3069,3014 (Aromatic 
C-H stretching), 2994 (Aliphatic -CH3 stretching) 2831 (Aliphatic -CH2 stretching), 
2334 (C-N stretching), 1787(C=O stretching), 1564 (N-H bending), 1439,1382 (C-H 
bending), 1269 (C-N bending), 1159 (OH bending), 759 (disubstituted), 
711(monosubstituted),  MS: m/z = 525.56; Anal. Calcd. for C33H23N5O3
 
: C, 73.13; 
H, 4.41; N, 13.33; O, 9.13 Found: C, 73.05; H, 4.31;  N,13.27; O,9.08. 
3-Amino-6-(4-hydroxy-5,8-dimethyl-2-oxo-2H-chromen-3-yl)-4-(3-phenyl-1-p-tolyl-
1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1018)  
IR (cm-1): 3602 (OH stretching), 3460,3417 (N-H stretching), 3068,3024 (Aromatic 
C-H stretching), 2989,2911 (Aliphatic -CH3 stretching)d 2829 (Aliphatic -CH2 
stretching), 2342 (C-N stretching), 1747(C=O stretching), 1532 (N-H bending),   
1439,1382 (C-H bending), 1268 (C-N bending), 1169 (OH bending), 748 
(disubstituted), 719(monosubstituted), MS: m/z = 539.58; Anal. Calcd. for 
C33H25N5O3
 
: C,73.46; H, 4.67; N, 12.98; O, 8.90 Found: C, 73.33; H, 4.61;  N, 
12.97; O,8.84. 
3-Amino-4-(1-(4-chlorophenyl)-3-phenyl-1H-pyrazol-4-yl)-6-(4-hydroxy-5,8-
dimethyl-2-oxo-2H-chromen-3-yl)pyridine-2-carbonitrile.(STAB-1019) 
IR (cm-1): 3552 (OH stretching), 3450,3417 (N-H stretching), 3061,3031 (Aromatic 
C-H stretching), 2974,2911 (Aliphatic -CH3 stretching), 2839 (Aliphatic -CH2 
stretching), 2332 (C-N stretching), 1767(C=O stretching), 1561 (N-H bending),   
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1438,1381 (C-H bending), 1262 (C-N bending), 1162 (OH bending), 795 
(disubstituted), 717(monosub.)  MS: m/z = 559(M+), 561(M+2); Anal. Calcd. for 
C32H22ClN5O3
 
: C, 68.63; H, 3.96; N, 12.51; O,8.57  Found: C, 68.53; H, 3.91;  
N,12.41; O,8.47. 
3-Amino-6-(4-hydroxy-5,8-dimethyl-2-oxo-2H-chromen-3-yl)-4-(1-(4-nitrophenyl)-
3-phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1020)  
IR (cm-1): 3556 (OH stretching), 3456,3467 (N-H stretching), 3162,3024 (Aromatic 
C-H stretching), 2994,2981 (Aliphatic -CH3 stretching), 2829 (Aliphatic -CH2 
stretching), 2331 (C-N stretching), 1768(C=O stretching), 1562 (N-H bending),  1560 
(C-NO2 stretching), 1429,1392 (C-H bending), 1253 (C-N bending), 1161 (OH 
bending), 754 (disubstituted), 707(monosubstitute),  MS: m/z = 570.55; Anal. Calcd. 
for C32H22N6O5
 
: C, 67.36; H, 3.89; N, 14.73; O,14.02  Found: C, 67.33; H, 3.81;  N, 
14.67; O,14.06. 
3-Amino-6-(4-hydroxy-5,8-dimethyl-2-oxo-2H-chromen-3-yl)-4-(1-(2-
hydroxyphenyl)-3-phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1021)  
IR (cm-1): 3612 (OH stretching), 3460,3427 (N-H stretching), 3065,3014 (Aromatic 
C-H stretching), 2994,2911 (Aliphatic -CH3 stretching), 2839 (Alipharic -CH2 
strething), 2332 (C-N stretching), 1767(C=O stretching), 1562 (N-H bending),   
1449,1383 (C-H bending), 1253 (C-N bending), 1169 (OH bending), 759 
(disubstituted), 717(monosubstituted), MS: m/z = 541.56; Anal. Calcd. for 
C32H23N5O4
 
: C,70.97; H, 4.28; N, 12.93; O, 11.82 Found: C, 70.83; H,4.17;  N, 
12.77; O,11.74. 
3-Amino-6-(4-hydroxy-5,8-dimethyl-2-oxo-2H-chromen-3-yl)-4(1-(2-
methoxyphenyl)-3-phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1022) 
IR (cm-1): 3552 (OH stretching), 3458, (N-H stretching), 3034 (Aromatic C-H 
stretching), 2901 (Aliphatic -CH3 stretching), 2849 (Aliphatic -CH2 stretching), 2342 
(C-N stretching), 1777(C=O stretching), 1561 (N-H bending), 1439,1382 (C-H 
bending),1261 (C-N bending), 1161 (OH bending), 758 (disubstituted), 
712(monosub.)  MS: m/z = 555.19; Anal. Calcd. for C33H25N5O4
 
: C, 71.34; H, 4.54; 
N, 12.61; O,11.52 Found: C, 71.23; H, 4.41;  N, 12.57; O,11.41. 
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3-Amino-6-(4-hydroxy-5,8-dimethyl-2-oxo-2H-chromen-3-yl)-4-(1-(3-nitrophenyl)-
3-phenyl-1H-pyrazol-4-yl)pyridine-2-carbonitrile. (STAB-1023)  
IR (cm-1): 3612 (OH stretching), 3455,3447 (N-H stretching), 3062,3014 (Aromatic 
C-H stretching), 2974, (Aliphatic -CH3 stretching), 2849 (Aliphatic -CH2 stretching ), 
2334 (C-N stretching), 1769(C=O stretching), 1569 (N-H bending), 1561 (C-NO2 
stretching), 1449,1384 (C-H bending), 1264 (C-N bending), 1164 (OH bending),  769 
(disubstituted), 719(monosubstituted), MS: m/z = 570.55; Anal. Calcd. for 
C32H22N6O5
 
: C,67.36; H, 3.89; N, 14.73; O,14.02 Found: C, 67.23; H, 3.81;  N, 
14.67; O,14.01. 
3-Amino-4-(1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-4-yl)-6-(4-hydroxy-5,8-
dimethyl-2-oxo-2H-chromen-3-yl)pyridine-2-carbonitrile. (STAB-1024) 
IR (cm-1): 3562 (OH stretching), 3456,3427 (N-H stretching), 3092,3084 (Aromatic 
C-H stetching), 2901 (Aliphatic -CH3 stretching), 2899 (Aliphatic -CH2 stretching), 
2342 (C-N stretching), 1787(C=O stretching), 1563 (N-H bending),  1449,1342 (C-H 
bending), 1264 (C-N bending), 1164 (OH bending), 768 (disubstituted), 
707(monosubstituted),  MS: m/z = 543(M+), 545(M+2); Anal. Calcd. for 
C32H22FN5O3
 
: C, 70.71; H, 4.08; N, 12.88; O,8.83 Found: C, 70.65; H, 4.02; 
N,12.79; O,8.72. 
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5.11   RESULTS AND DISCUSSION 
 
24 cyanopyridine derivatives were prepared in 60 to 70 percentage yield by 
conventional method and 70 to 80 percentage yield were obtained by microwave 
method. Thus the later is found to be superior method. 
  
5.12   CONCLUSION 
  
A comparative study of conventional and microwave assisted methods reveals 
that the time taken by the microwave method is approximately 5-10 minutes in 
compare to conventional method which takes minimum 5-6 hrs. The yield of the 
products also increases 10-15% by the microwave method. 
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5.13  REPRESENTATIVE  SPECTRAS 
5.13.1 IR Spectrum of STAB-1001 
 
 
5.13.2 Mass Spectrum of STAB-1001 
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5.13.3 1
 
H NMR Spectrum of STAB-1001 
 
5.13.4 Expanded 1
 
H NMR Spectrum of STAB-1001 
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5.13.5 IR Spectrum of STAB-1002 
 
 
5.13.6 Mass Spectrum of STAB-1002 
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5.13.7 1
 
H NMR Spectrum of STAB-1002 
 
5.13.8 Expanded 1
 
H NMR Spectrum of STAB-1002 
O O
OH
N NH2
CN
N N CH3
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6.1   INRODUCTION  
 
Coumarin system is an important heterocyclic skeleton which lead to number 
of synthetic drugs like dicoumarol, warfarin, acenocoumarin etc. Recently researchers 
introduced coumarin derivatives as inhibitors of lipoxygenase and cyclooxygenase in 
the arachidonic acid cascade1-3 of serine protease4-8 and of tyrosine kinase.9 Many 
coumarin derivatives have also been found to inhibit peroxidation9 and to possess 
vasorelaxant,9 anticoagulant,10 anti-inflammatory and antioxidant activities.11-14 
Coumarins have been evaluated in vitro, for their inhibitory activity towards bovine α-
chymotrypsin, human leukocyte elastase15-17 and thrombin, plasmin and tissue 
ploaminogen activators. 4-hydroxy coumarin and its derivatives are also reported to 
possess significant antibacterial,18 coronary dialatory,19 hypothermal20-23 and 
antiviral,24 antimicrobial,25-26 antitubercular,27 MDR reversal28 and cytotoxic 
activities29
 
 too. 
On the other hand, are the examples of the serendipitous discovery of new 
drugs based on an almost random screening of chemicals synthesized in the laboratory 
is striking. Since 1960, when chlordiazepoxide (Librium) entered in the market, 
efforts to discover new biologically active compounds with limited side effects in 
benzodiazepines are going on which are reflected by the important number of 
publication focused in this subject.
 
30-34 
Benzodiazepines have attracted attention as an important class of heterocyclic 
compounds in the field of drugs and pharmaceuticals. These compounds are widely 
used as anticonvulsant, antianxiety, analgesic, sedative, anti-depressive, hypnotic 
agents35 as well as anti-inflammatory agents.36 Other than their biological importance, 
benzodiazepine derivatives are also commercially used as dyes for acrylic fibres.37 
Moreover, 1,5-benzodiazepines derivatives are valuable synthons that can be used in 
preparation of other fused ring compounds such as triazolo, oxadiazolo, oxazino or 
furano-benzodiazepines.38 Research in this area is still very active and is directed 
towards the synthesis of compounds with enhanced pharmacological activity. 
Generally, these compounds are synthesized by the condensation of o-
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phenylenediamines with α, β-unsaturated carbonyl compounds,39 β-haloketones, or 
ketones.
 
40 
 Among all types of benzodiazepines (1,2-,1,3-, 1,4-, 1,5-, 2,3-, & 2,4- ) only 
1,4- and 1,5-benodiazepines have found wide applications in medicines, during one of 
the most important classes of the therapeutic agents with wide spread biological 
activities41 including hypnotics, sedatives, anxiolytics and antianxiety etc. Effects 
range from their well-documented anticonvulsive or tranquilizing properties, through 
pesticidal42 or antitumor43 action and to their more recently described peptidomimetic 
activity.
 
44 
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6.2 SYNTHETIC METHODS 
 
 The most widely used method for the synthesis of 3H-1,5-benzodiazepines is 
condensation of 1,2-diaminobenzene and 1,3-diketones or their enols, in presence of 
acid catalyst to yield violet 2,5-dialkyl-1,5-benzodiazepinium chlorides as primary 
product. Upon neutralization with sodium hydroxide will give yellow coloured 
diazepine tautomer ( a, b).
 
45 
N
H
N
CH3
CH3
N
H
N
CH3
CH3
(a) (b)
 
 
 Augustin et al.46 has synthesized 2-aryl substituted 2,5-dihydro-1H-1,5-
benzodiazepine (d) in 25-94% yield by condensation of (Z/E)-1-aryl-4-arylmethylene 
pyrrolidine-2,3,5-triones(c) with O-phenylene diamine. 
 
 
Risitano et al.47
 
 have discovered versatile method from chromone derivative 
as starting material. Thus, 3-cyano chromone (e), when reacts with O-phenylene 
diamine afforded 1H-1,5-benzodiazepine (f). 
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O
O
CN NH2
NH2
N
H
NH2N
(e)
O
HO
(f)
 
 
Cohen et al.48
 
 used crotonic acid or methacrylic acid (g) as a new starting 
material for preparation of substituted 1,5-benzodiazepine-2-ones (h) when it reacts 
with substituted 1,2-phenylene diamine. 
 
 
Insuasty et al.49
 
 had suggested that 1,2-diamino-4-methylbenzene reacts in the 
presence of sulphuric acid with 4-substituted acetophenones yielding 2,4-diaryl-2,3-
dihydro-2,8-dimetyl 1H-1,5-benzodiazepines(i) and as minor components 2,4-diaryl-
2,3-dihydro-2,7-dimethyl-1H-1,5-benzodiazepines(j). 
N
H
NH3C CH3
R
R
N
H
N
CH3
R
R
H3C
(i) (j)
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He-Xi et al. 50
 
 synthesized 2,4-diphenyl-1,5-benzodiazepine (k) via reaction of 
4-benzoyl-5-phenyl-1,3-oxathiol-2-ones (l) with 1,2-aminobenzene (Orthophenylene 
diamine). 
O
S
O
Ar
Ar
O
NH2
NH2
CH3CN N
H
N
(k) (l)
 
 
O-Nitro acetoacetanilide are reduced by iron in alcoholic hydrochloric acid to 
give 2-acetonyl benzimidazole(m). Catalytic hydrogenation of these anilides in 
presence of Raney Nickel yields the diazepinone derivative(n).
 
51 
N
H
N COCH3
R
Raney
Nickel N
H
H
N
O
CH3
R
(m) (n)
 
 
Hamdi et al.52
 
 has established a new method of synthesis of 1,5-
benzodiazepine-2-one (p) from 4-hydroxy coumarin(o) and substituted 1,2-
phenylenediamines by heating in xylene or acetic acid-ethanol. 
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Eduardo et al.53-54
 
 Cortes and his group have focused their efforts on search 
for superior central nervous system agent. They have studied heterocyclic varients of 
the 1,5-benzodiazepine system specially derivatives like (q), (r), (s), (t), (u). 
N
N
N CH3
R1
R2
N
N
NH
R1
R2
N
N
N
O
H3CO
O
OCH3
R2
(q) (r) (s)
N
N
O
OCH3
N CH3
R1
R2
(t)
N
N
N
NO
R
CH3
R1
(u)
 
Bougrin et al.55
 
 has carried out a reaction of O-β-arylenediamines with β-
ketoesters in xylene under microwave irradiation to prepare substituted 1,5-
benzodiazepines(v). Here, the specific effects of microwave are evidenced as no 
reaction occurs by classical heating in the same reaction. 
N
H
H
N
O
R
(v)
 
 
Reaction of 4-Chloro-1,2-diaminobenzene with 3,3-dimercapro-1-phenyl-2-
propen-1-one afforded a mixture of 7-chloro and 8-chloro-1,3-dihydro-4-phenyl-2H-
1,5-benzodiaze-2-thione. On separation of these two products, 7-chloro compound is 
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treated with NaH and N,N-diethyl amino ethyl chloride which on further chemical 
reaction gives 7-Chloro-2-(2-diethylaminoethylthio)-4-phenyl-3H-1,5-
benzodiazepine.
 
56 
 
2,3-Dihydro-4-(p-substituted phenyl)-7-[(o, m and p-substituted) phenoxy]-
1H-1,5-benzodiazepine-2-thiones has been  synthesized by condensing the 3,3-
dimercapto-1-(Para substituted phenyl)-2-propen-1-one with 3,4-diaminophenyl-R-
phenyl ethers.
 
57 
R2
O
HS SH
NH2
NH2O
R1
O N
H
H
N
S
R2
R1
 
 
The strategy, the design and the constraints for a lead discovery library are 
radically different than for a hit optimization library. Examples of both types of 
libraries and solid-phase chemistry to prepare 1,5-benzodiazepine-2-one and its 
derivatives were presented.
 
58 
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H
N
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N
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N O HN R3
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O
 
 
Various heterocycles including 1,5-diazepines were prepared from 3-
acetoacetyl-4-hydroxy coumarin and 1,2-phenylene diamine/3,4-diamino 
benzophenone using reported method.59-60 They also studied antimicrobial61, 
antifungal,62 anti-HIV63-64
 In many compounds,
 and antitubercular activity of these compounds. 
65,66 MIC were observed >6.25 µg/ml bearing >70% 
inhibition against mycobacterium tuberculosis (H37 Rv 
 
strain), when compared of 
Rifampicin (99% inhibition). 
O O
OH O O
CH3
R 3,4-diamino benzophenone
O-phenylene diamine
O
OH
O
N N
CH3
O
R
O O
OH N N
CH3R
 
 
Gopalakrishna et al.67
 
 reported the three component Mannich reaction of 1,5-
benzodiazepine  catalyzed by a tetranitrile-silver complex. 
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6.3   BIOLOGICAL PROFILE   
 
More recent analogues of the Benzodiazepines have attracted interest as anti 
HIV compounds, such as the clinically used nevirapine and as anticancer compounds, 
such as the pyrrolo fused antitumor antibiotic DC-18, analogues of which are in 
clinical development as anticancer agents.
N N
NH
N
O
CH3
Nevirapine
N
N
O
H
DC-18
68 
 
  
Buckle et al.69 prepared 1H-benzo-1,5-diazepine-2,4-(3H,5H)- diones(compound-a) 
from 4,2-R2(NH2)C6H3 NH2(R2= H, Cl, F, COOH) by refluxing with malonic acid in 
4N HCl for half an hour followed by nitration with fuming HNO3
 
 which is 
antiallergic substance useful in the treatment of rhinitis, hay fever and certain type of 
asthma. 
N
H
H
N
O
O
NO2
R
R1
R= NO2
R1= H,F,NO2,COOH
(Compound-a)
 
 
The a-β-unsaturated ketones of 3-arylsydnones were treated with 1,2-
phenylenediamine to obtain the 3-Aryl-4-[2’-aryl-2’,4’,6’,7’-tetrahydro-(1’H)-1’,5’-
benzodiazepine-4’-yl] sydnones in high yield. All the new compounds synthesized 
were screened for antibacterial and antifungal activities.
 
70 
Rubin et al.71 al have synthesized 4-phenyl-2-trichloromethyl-3H-1,5-
benzodiazepine hydrogen sulphate and examined its pharmacological effects in mice, 
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keeping diazepam as reference. The data suggest that this recently synthesized 
compound possesses anxiolytic activity and produces motor in co-ordination similar 
to those observed with diazepam.  
 
4-Alkyl/aryl-2-fluoroaryl-1H-1,5-benzodiazepines exhibits excellent gastric 
acid secretion pylorus ligation, passaive cutaneous and parasitological activities in 
rats and monkeys.
 
72 
O
R
Ar OH H2N
H2N
i) EtOH
ii) HClO4 N
H
H
N
Ar
R
R=CH3, C2H5,n-C3H7,C6H5
Ar= p-C6H5
 
 
 
 
6.4 AIM OF CURRENT WORK 
 
The current work is aimed as preparing some new hybrid derivatives of 
benzodiazepines clubbed with coumarin skeleton to arrive at small library of “drug 
like” substances. Since benzodiazepine is a priviledge structure, the possibility of 
diversed pharmacological activities are expected from compounds synthesized in this 
chapter. 
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6.5   REACTION SCHEMES 
 
6.5.1 PREPARATION OF PYRAZOLE ALDEHYDES : 
 
 It was prepared according to method described in Chapter-1 
 
 
6.5.2 PREPARATION OF 3-ACETYL 4-HYDROXY COUMARINS : 
 
It was prepared according to method described in Chapter-4 
 
 
6.5.3 PREPARATION OF 3-[(1E)-N-(2- AMINOPHENYL) 
ETHANIAMIDOYL]-4-HYDROXYL-2H-CHROMENE-2-ONE : 
 
O
OH
O
O
CH3
H2N
H2N
O
OH
O
N
CH3
H2N
R Ra
 
Reagents / Reaction Condition (a) :,Ethanol / Reflux, 8-10 hrs. 
 
6.5.4 PREPARATION OF 4-HYDROXY-3-[2-(4-N,N-DIMETHYLPHENYL)-
2,3-DIHYDRO-1,5-BENZODIAZEPIN-4-YL]-2H-CHEOMEN-2-ONE : 
 
O
OH
O
N
CH3
H2N
R
N
N
OHC R1
b O
OH
O
R
N NH
N
N
R1
 
Reagents / Reaction Condition (a) :,Ethanol + DMF, TFA / Reflux, 4-6 hrs. 
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6.6  PLAUSIBLE REACTION MECHANISM 
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6.7   EXPERIMENTAL 
 
6.7.1 MATERIALS AND METHODS 
 
 Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G plates of 
0.5 mm thickness and spots were located by iodine and UV. IR spectra were recorded 
in Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were 
recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe 
technique. 1H NMR was determined in CDCl3
 
/DMSO solution on a Bruker Ac 400 
MHz spectrometer. Elemental analysis of the all the synthesized compounds was 
carried out on Elemental Vario EL III Carlo Erba 1108 model and the results are in 
agreements with the structures assigned. 
6.7.2 PREPARATION OF PYRAZOLE ALDEHYDE : 
 
 It was prepared according to method described in Chapter-1 
 
 
6.7.3 PREPARATION OF 3-ACETYL 4-HYDROXY COUMARIN : 
 
It was prepared according to method described in Chapter-4 
 
 
6.7.4 PREPARATION OF 3-[(1E)-N-(2-AMINOPHENYL) 
ETHANIMIDOYL]-4-HYDROXYL-2H-CHROMEN-2-ONE : 
 
 
Similarly other compounds are also prepared. 
3-Acetyl-4-hydroxy coumarin (0.01mole) and O-phenylene diamine 
(0.01mole) was dissolved in 30ml ethanol and refluxed the content for 8-10 hrs. Solid 
separated out is to be filtered and washed with chilled methanol, recrystallize it from 
mixture of methanol–DMF. 
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6.7.5 PREPARATION OF 4-HYDROXY-3-[2-(4-N,N-DIMETHYLPHENYL)-
2,3-DIHYDRO-1,5-BENZODIAZEPIN-4-YL]-2H-CHROMEN-2-ONE : 
 
  3-[(1E)-N-(2-Aminophenyl) ethanimidoyl]-4-hydroxy-2H-chromen-2-
one (0.01mole) and substituted pyrazole aldehydes (0.01mole) was dissolved in a 
mixture of ethanol-dimethyl formamide and refluxed in an oil-bath at 115-120OC with 
catalytic amount of triflouroacetic acid for 4-5 hrs. During the reaction the progress 
and the completion of reaction were checked by silica gel-G F254
Similarly other compounds are also prepared. 
 thin layer 
chromatography using ethyl acetate: hexane (3:2) as a mobile phase. Pour the content 
into crushed ice. The solid separated out was filtered, washed, dried and recrystallized 
it from methanol.  
The physical constant of newly synthesized compounds are given in the Table No.6 
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6.8   PHYSICAL DATA  
  
Physical data of 3((E)-2,3-dihydro-2-(3-(substituted)phenyl)-1-phenyl-
1H-pyrazol-4-yl)-1H-benzo [b][1,4]dizepin-4-yl)-4-hydroxy-8-methyl-
2H-chromen-2-one.   
 
TABLE - 6 
Code Substitution MF MW MP Rf 
Value R R1 
TAP-01 H H C33H24N4O 524 3 180-182 0.46 
TAP-02 4-CH H 3 C34H26N4O 538 3 204-206 0.52 
TAP-03 4-NO H 2 C33H23N5O 569 5 226-228 0.44 
TAP-04 2-OH H C33H24N4O 540 4 208-210 0.48 
TAP-05 2-OCH H 3 C34H26N4O 554 4 196-198 0.50 
TAP-06 4-Cl H C33H23ClN4O 559 3 188-190 0.40 
TAP-07 3-NO H 2 C33H23N5O 569 5 210-212 0.44 
TAP-08 4-F H C33H23FN4O 542 3 178-180 0.48 
TAP-09 H 8-CH C3 34H26N4O 538 3 186-188 0.42 
TAP-10 4-CH 8-CH3 C3 35H28N4O 552 3 168-170 0.46 
TAP-11 4-Cl 8-CH C3 34H25ClN4O 573 3 194-196 0.42 
TAP-12 4-NO 8-CH2 C3 34H25N5O 583 5 206-208 0.54 
TAP-13 2-OH 8-CH C3 34H26N4O 554 4 178-180 0.50 
TAP-14 2-OCH 8-CH3 C3 35H28N4O 568 4 166-168 0.48 
TAP-15 3-NO 8-CH2 C3 34H25N5O 583 5 218-220 0.40 
TAP-16 4-F 8-CH C3 34H25FN4O 556 3 208-210 0.46 
TAP-17 H 5,8-di CH C3 35H28N4O 552 3 178-180 0.44 
TAP-18 4-CH 5,8-di CH3 C3 36H30N4O 566 3 212-214 0.48 
TAP-19 4-Cl 5,8-di CH C3 35H27ClN4O 586 3 202-204 0.40 
TAP-20 4-NO 5,8-di CH2 C3 35H27N5O 597 5 182-184 0.42 
TAP-21 2-OH 5,8-di CH C3 35H28N4O 568 4 176-178 0.45 
TAP-22 2-OCH 5,8-di CH3 C3 36H30N4O 582 4 218-220 0.49 
TAP-23 3-NO 5,8-di CH2 C3 35H27N5O 597 5 192-194 0.52 
TAP-24 4-F 5,8-di CH C3 35H27FN4O 570 3 188-190 0.48 
 
Rf value was determined using solvent system = Ethyl Acetate : Hexane (3 : 2) 
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6.9   SPECTRAL DISCUSSION 
 
6.9.1   IR SPECTRA 
 
IR spectra of the synthesized compounds were recorded on Shimadzu FT-IR 
8400 model using KBr pallet method. Various functional groups present were 
identified by characteristic frequency obtained for them.  
The characteristic bands of Hydroxyl groups were obtained for streching at 
3400-3650 cm-1 and those for bending were obtained at 1050-1250 cm-1.The 
stretching vibrations N-H group showed in the region of 3200 to 3500 cm-1 with a 
deformation due to in plane bending at 1650-1580 cm-1. It gives aromatic C-H 
stretching frequencies between 3000-3200 cm-1 and bending vibration near 1300-1500 
cm-1 respectively. C-H stretching frequencies for methyl and methylene group were 
obtained near 2950 cm-1 to 2850 cm-1.  Characteristic frequency of C-N stretching 
showed near 2100-2200 cm-1 and bending vibration near 1300-1400 cm-1
 
.  
 
6.9.2  MASS SPECTRA 
 
Mass spectra of the synthesized compounds were recorded on Shimadzu GC-
MS QP-2010 model using direct injection probe technique. The molecular ion peak 
was found in agreement with molecular weight of the respective compound. 
Characteristic M+2 
 
ion peaks with one-third intensity of molecular ion peak were 
observed in case of compounds having chlorine atom. Fragmentation pattern can be 
observed to be particular for these compounds and the characteristic peaks obtained 
for each compound. 
6.9.3   1H NMR SPECTRA 
 
1H NMR spectra of the synthesized compounds were recorded on Bruker 
Avance II 400 spectrometer by making a solution of samples in CDCl3 solvent 
using tetramethylsilane (TMS) as the internal standard unless otherwise mentioned. 
Numbers of protons and carbons identified from NMR spectrum and their chemical 
shift (δ ppm) were in the agreement of the structure of the molecule. J values were 
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calculated to identify o, m and p coupling and it gives approximately 8.0 Hz which 
indicates the presence of cis isomers of compounds. In some cases, aromatic protons 
were obtained as multiplet. 1
 
H spectral interpretation can be discussed as under. 
1
 
H NMR of 3-((E)-2,3-dihydro-2-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)-1H-
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-2H-chromen-2-one (TAP-02) 
O O
OH N NH
N
N
H3C
5
1
2
3
4
6
12
13 14 15
16
17
18
19
20
21
22
23
7
8
9 10
11
 
 
1. Proton no. 21 of total 3H gave a singlet at 2.39 δ ppm. 
2. Proton no. 6 of total 2H gave a doublet 3.1 δ ppm - 3.2 δ ppm. 
3. Proton no.12 of 1H gave a singlet at 4.5 δ ppm. 
4. Proton no. 7 of diazepine ring became deshielded and gave a characteristic 
doublet at 5.55 δ ppm. 
5. Proton no. 16 of 1H gave a doublet 6.90 δ ppm - 6.93 δ ppm. 
6. Proton no.11 of 1H gave a triplet at 7.07 δppm- 7.11 δppm. .  
7. Proton no. 20 and 22 
8. Proton no. 3,4,8,9 and 10 gave a multiplate at 7.23 - 7.30 δppm. 
gave a doublet at 7.21 δppm - 7.23 δppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling. 
9. Proton no. 15 and 17 of 2H gave a triplet at 7.40 δ ppm - 7.45 δppm. 
10. Proton no. 5 of 1H gave a triplet at 7.56 - 7.60 δ ppm.
11. Proton no.19 and 23 gave a doublet at 7.66 δ ppm and J value of this proton is 
8.0 Hz. It suggest ortho coupling. 
  
12. Proton no. 14 and 18 gave a doublet at 7.72 δ ppm -7.75 δ ppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling.  
13. Proton no. 13 of pyrazol ring gave a doublet at 8.00 δ ppm. 
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14. Proton no. 2 of 1H gave a doublet at 8.06 δ ppm - 8.09 δ ppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling. 
15. Proton no. 1 of 1H gave a singlet at 15.7 δ ppm. 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
structure for compound no. TAP-02 has been confirmed. The spectrum is given on 
page no. 238. 
 
1
 
H NMR of 3-((E)-2,3-dihydro-2-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-
yl)-1H-benzo[b][1,4]dizepin-4-yl)-4-hydroxy-2H-chromen-2-one (TAP-05) 
O O
OH N NH
N
N
OCH3
1
2
3
4
5
6
10
7
8
9
11
14 15
16
17
18
12
13
1920
21
23
22
 
 
1. Proton no. 6 of 2H gave a quartet at 2.85 δ ppm – 3.00 δ ppm. 
2. Proton no. 19 of total 3H gave a singlet at 3.83 δ ppm. 
3. Proton no. 12 of total H gave a singlet at 4.49 - 4.52 δ ppm. 
4. Proton no. 7 of 1H became deshielded and gave a characteristic doublet at 
5.23 δ ppm - 5.26 δ ppm. 
5. Proton no. 16 of 1H gave a doublet at 6.56 δ ppm 
6. Proton no. 5 and 11 of 2H gave a doublet at 6.97 δppm - 7.02 δppm.  
- 6.58 δ ppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling. 
7. Proton no. 3 and 4 
8. Proton no. 20, 21, 22 and 23 of 4H gave a multiplate at 7.17 δ ppm -7.26 δ 
ppm. 
of 2H gave a multiplate at 7.06 δppm - 7.15 δppm. 
9. Proton no. 8,9 and 10 of 3H gave a multiplate at 7.36 δppm - 7.41 δppm. 
10. Proton no. 15 and 17 2H gave a triplet at 7.49 δ ppm - 7.53 δ ppm. 
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11. Proton no. 14 and 18 of 2H gave a doublet at 7.64 – 7.66 δ ppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling. 
12. Proton no. 13 of 1H gave a singlet at 7.83 δ ppm. 
13. Proton no. 2 of 1H gave a doublet at 8.03 δ ppm – 8.05 δ ppm and J value of 
this proton is 8.0 Hz. It suggest ortho coupling.  
14. Proton no. 1 of 1H gave a singlet at 15.59 δ ppm.  
 
Thus, by observing and assigning the signals in the NMR spectrum and by the 
calculation of the J values for   above proton, we can clearly suggest that the proposed 
structure for compound no. TAP-05 has been confirmed. The spectrum is given on 
page no.240. 
 
 
6.9.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on Vario 
EL Carlo Erba 1108 which showed calculated and found percentage values of 
Carbon, Hydrogen and Nitrogen in support of the structure of synthesized 
compounds.  
 
The spectral and elemental analysis data are for all individual compounds 
synthesized in this chapter are mentioned below. 
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6.10 ANALYTICAL DATA  
 
3-((E)-2,3-dihydro-2-(1,3-diphenyl-1H-pyrazol-4-yl)-1H-benzo[b][1,4]diazepin-4-
yl)-4-hydroxy-2H-chromen-2-one. (TAP-01)  
Yield : 68% IR (cm-1):  3606 (OH stretching), 3425(N-H stretching), 3090, 3061 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2823 (Aliphatic -CH2 
stretching), 1776 (C=O stretching), 1606,1562 (N-H bending), 1454,1429,1374 (C-H 
bending), 1221 (OH bending), 766 (Disubstituted), 692,702 (monosubstituted), MS: 
m/z = 524.18; Anal. Calcd. for C33H24N4O3
 
  C, 75.56; H, 4.61; N,10.68; O, 9.15; 
Found: C, 75.46; H, 4.56; N, 10.68; O, 9.09. 
3-((E)-2,3-dihydro-2-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)-1H-benzo[b][1,4 
diazepin-4-yl)-4-hydroxy-2H-chromen-2-one. (TAP-02)  
Yield : 76% IR (cm-1): 3576, 3556 (OH stretching), 3525(N-H stretching), 3190, 3161 
(Aromatic C-H stretching), 2978 (Aliphatic -CH3 stretching), 2833 (Aliphatic -CH2 
stretching), 1766 (C=O stretching), 1676,1606,1562 (N-H bending), 
1492,1464,1419,1354 (C-H bending), 1211 (OH bending), 756 (Disubstituted), 
681,701 (monosubstituted), 1H NMR (DMSO-d6) δ ppm: 2.39 (s, 3H), 3.1-3.2 (d, 
2H), 4.5 (s, 1H), 5.55 (d, 1H), 6.90-6.93 (d, 1H),  7.07-7.11 (t, 1H), 7.21-7.23 (d, 2H, 
J=8.0 Hz ) , 7.23-7.30 (m, 5H), 7.40-7.45 (t, 2H), 7.56-7.60 (t, 1H), 7.66 (d, 2H, J=8.0 
Hz), 7.72-7.75(d, 2H, J=8.0 Hz), 8.00(d, 1H), 8.06-8.09 (d, 2H, J=8.0 Hz), 15.70 (s, 
1H),  MS= m/z = 538.20; Anal. Calcd. for C34H26N4O3
 
: C, 75.82; H, 4.87; N, 10.40; 
O, 8.91;  Found: C, 75.81; H, 4.80; N, 10.38; O,8.81.  
3-((E)-2,3-dihydro-2-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-2H-chromen-2-one. (TAP-03)  
Yield : 88%  IR (cm-1):  3616 (OH stretching), 3435(N-H stretching), 3043, 3021 
(Aromatic C-H stretching), 2978 (Aliphatic -CH3 stretching), 2820 (Aliphatic -CH2 
stretching), 1756 (C=O stretching), 1616,1582 (N-H bending), 1545 (C-NO2), 
1444,1419,1364 (C-H bending) , 1211 (OH bending), 756 (Disubstituted), 691,709 
(monosub.), MS: m/z = 569.57; Anal. Calcd. for C33H23N5O5
 
: C, 69.59; H, 4.07; N, 
12.30; O, 14.05, Found: C, 69.49; H, 4.04; N, 12.21; O,14.01. 
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3-((E)-2,3-dihydro-2-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-2H-chromen-2-one. (TAP-04)  
Yield : 72%  IR (cm-1):  3601,3523(OH stretching), 3383,3221 (N-H stretching), 
3115, 3051,3014 (Aromatic C-H stretching), 2945 (Aliphatic -CH3 stretching), 2879 
(Aliphatic -CH2 stretching), 1786 (C=O stretching), 1674,1604,1566 (N-H bending), 
1483,1462,1415,1346 (C-H bending), 1242,1205 (-OH bending), 1159,1126,1085 (C-
N bending), 761,750 (Disubstituted), 682,709 (monosubstituted), MS: m/z = 540.57; 
Anal. Calcd. for C33H24N4O4
 
: C, 73.32; H, 4.48;  N, 10.36; O,11.84, Found: C, 
73.24; H, 4.45; N, 10.30; O,11.79. 
3((E)-2,3-dihydro-2-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-
benzo[b][1,4]dizepin-4-yl)-4-hydroxy-2H-chromen-2-one. (TAP-05)  
Yield : 69%  IR (cm-1):  3668 (OH stretching), 3468 (N-H stretching), 3271, 3097, 
3012 (Aromatic C-H stretching), 2978 (Aliphatic -CH3 stretching), 2901 (Aliphatic -
CH2 stretching), 1766 (C=O stretching), 1697,1604, (N-H bending), 1467,1423,1340 
(C-H bending), 1290,1236 (-OH bending), 1201,1120,1022 (C-N bending), 765 ( 
Disubstituted), 688,708 (monosubstituted), 1H NMR (DMSO-d6) δ ppm: 2.85 - 3.00 
(q, 2H), 3.83 (s, 3H ), 4.49 - 4.52 (s, 1H ), 5.23 - 5.26 (d, 1H ), 6.56 - 6.58 (d, 1H,  
J=8.0 Hz), 6.97 - 7.02 (d, 2H ),7.06 - 7.15 (m, 2H), 7.17 - 7.26 (m, 4H), 7.36 - 
7.41(m, 3H), 7.49 - 7.53 (t, 2H), 7.64 - 7.66 (d, 2H, J=8.0 Hz), 7.83 (s, 1H), 8.03 - 
8.05 (d, 1H ), 15.59 (s, 1H), MS: m/z = 554.59; Anal. Calcd. for C34H26N4O4
 
: C, 
73.63; H, 4.73; N, 10.10; O,11.54 Found: C, 73.43; H, 4.59;  N, 10.03; O,11.43. 
3-((E)-2-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,3-dihydro-1H-
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-2H-chromen-2-one.(TAP-06)  
Yield : 78% IR (cm-1):  3568 (OH stretching), 3448 (N-H stretching), 3071, 3037 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2891(Aliphatic -CH2 
stretching), 1746 (C=O stretching), 1687,1624, (N-H bending), 1453,1440 (C-H 
bending), 1236,1286 (-OH bending), 1201,1120 (C-N bending), 755 (Disubstituted), 
688,702 (monosubstituted), MS: m/z = 559(M+), 562(M+2); Anal. Calcd. for 
C33H23ClN4O3
 
: C, 70.90; H, 4.15; Cl, 6.34; N, 10.02; O, 8.59 Found: C, 70.81; H, 
4.07; Cl,6.30;  N, 10.05; O, 8.46. 
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3-((E)-2,3-dihydro-2-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-2H-chromen-2-one. (TAP-07)  
Yield : 75% IR(cm-1): 3623(OH stretching), 3323 (N-H stretching), 3115, 3041 
(Aromatic C-H stretching), 2935 (Aliphatic -CH3 stretching), 2869 (Aliphatic -CH2 
stretching), 1776 (C=O stretching), 1675,1634 (N-H bending), 1560 (C-NO2 
stretching), 1482,1425,1326 (C-H bending), 1232,1215 (-OH bending), 
1169,1136,1075 (C-N bending) 771,760 (Disubstituted), 672,719 (monosub.) MS: m/z 
= 569.57; Anal. Calcd. for C33H23N5O5
 
: C, 69.59; H, 4.07; N, 12.30; O,14.05 Found: 
C, 69.54; H, 4.06;  N, 12.21; O, 14.02. 
3-((E)-2-(3-(4-flourophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,3-dihylro-1H-
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-2H-chromen-2-one. (TAP-08)  
Yield : 86% IR (cm-1): 3523(OH stretching), 3343 (N-H stretching), 3015, 3011 
(Aromatic C-H stretching), 2945 (Aliphatic -CH3 stretching), 2879 (Aliphatic -CH2 
stretching), 1786 (C=O stretching), 1685,1644 (N-H bending), 1472,1435 (C-H 
bending), 1282,1245 (-OH bending), 1210,1136, (C-N bending), 761,750 
(Disubstituted), 692,709 (monosubstituted), MS: m/z = 542, 544(M+2); Anal. Calcd. 
for C33H23FN4O3
 
: C, 73.05; H, 4.27; F, 3.50; N, 10.33; O, 8.85 Found: C, 73.00; H, 
4.21;  F, 3.42; N, 10.23; O, 8.75. 
3-((E)-2,3-dihydro-2-(1,3-diphenyl-1H-pyrazol-4-yl)-1H-benzo[b][1,4]diazepin-4-
yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-09)  
Yield : 78%  IR (cm-1):  3616 (OH stretching), 3445(N-H stretching), 3110, 3051 
(Aromatic C-H stretching), 2978 (Aliphatic -CH3 stretching), 2833 (Aliphatic -CH2 
stretching), 1786 (C=O stretching), 1696,1602 (N-H bending), 1464,1439,1364 (C-H 
bending), 1291,1236 (OH bending), 1211,1146, (C-N bending), 765 (Disubstituted), 
692,719 (monosubstituted), MS: m/z = 538.60; Anal. Calcd. for C34H26N4O3
 
: 
C,75.82; H, 4.87 ; N, 10.40; O, 8.91 Found: C, 72.83; H, 4.81;O, 8.89 . 
3-((E)-2,3-dihydro-2-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)-1H-benzo[b][1,4] 
diazepin-4-yl)-4-hydroxy-8-mehyl-2H-chromen-2-one. (TAP-10)  
Yield : 69%  IR (cm-1): 3609 (OH stretching), 3435(N-H stretching), 3190, 3051 
(Aromatic C-H stretching), 2978 (Aliphatic -CH3 stretching) , 2843 (Aliphatic -CH2 
stretching), 1777 (C=O stretching), 1616,1572 (N-H bending), 1439,1384 (C-H 
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bending), 1211 (OH bending), 1212,1146, (C-N bending), 756 (Disubstituted), 
681,701 (monosubstituted)  MS: m/z: 552.62; Anal. Calcd. for C35H28N4O3
 
: C, 
76.07; H, 5.11; N, 10.14; O, 8.69 Found: C, 76.03; H, 5.01;  N, 10.07; O,8.60. 
3-((E)-2-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,3-dihydro-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-11) 
Yield: 82% IR (cm-1):  3599 (OH stretching), 3445(N-H stretching), 3090, 3052 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2853 (Aliphatic -CH2 
stretching), 1767 (C=O stretching), 1606,1562 (N-H bending), 1449,1374 (C-H 
bending), 1221 (OH bending), 1201,1126, (C-N bending), 776 (Disubstituted), 
689,703 (monosubstituted), MS: m/z = 573, 575(M+2); Anal. Calcd. for 
C34H25ClN4O3
 
: C, 71.26; H, 4.40; Cl, 6.19; N, 9.78; O, 8.38  Found: C, 71.23; H, 
4.31;  Cl, 6.77; O,8.31. 
3-((E)-2,3-dihydro-2-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-12) 
Yield : 76%  IR (cm-1):  3589 (OH stretching), 3435(N-H stretching), 3190, 3062 
(Aromatic C-H stretching), 2998 (Aliphatic -CH3 stretching), 2863 (Aliphatic -CH2 
stretching), 1787 (C=O stretching) 1616,1542 (N-H bending), 1560 (C-NO2 
stretching), 1469,1382 (C-H bending) , 1221 (OH bending), 1212,1146, (C-N 
bending) , 766 ( Disubstituted), 692,701 (monosubstituted), MS: m/z = 583.59; Anal. 
Calcd. for C34H25N5O5
 
: C, 69.97; H, 4.32; N, 12.00; O,13.71 Found: C, 69.83; H, 
4.31;  N, 11.77; O,13.69. 
3-((E)-2,3-dihydro-2-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-13) 
Yield : 83%  IR (cm-1):  3609 (OH stretching), 3445(N-H stretching), 3090, 3072 
(Aromatic C-H stretching), 2998 (-CH3 stretching), 2873 (Aliphatic -CH2 stretching), 
1777 (C=O stretching), 1626,1532 (N-H bending), 1489,1372 (C-H bending), 
1320,1281 (OH bending), 1219,1116, (C-N bending)  766(Disubstituted), 692,719 
(monosubstituted),  MS: m/z = 554.59; Anal. Calcd. for C24H18FN5
 
: C, 73.63; H, 
4.73; N, 10.10; O,11.54 Found: C, 73.53; H, 4.61;  N, 9.77; O,11.41. 
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3((E)-2,3-dihydro-2-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]dizepin-4-yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-14) 
Yield : 68%  IR (cm-1):  3609 (OH stretching), 3445(N-H stretching), 3090, 3072 
(Aromatic C-H stretching), 2998 (Aliphatic -CH3 stretching), 2873 (Aliphatic -CH2 
stretching), 1777 (C=O stretching), 1626,1532 (N-H bending), 1489,1372 (C-H 
bending), 1320,1281 (OH bending), 1219,1116 (C-N bending), 766 ( Disubstituted), 
692,719 (monosubstituted),  MS: m/z = 568.62; Anal. Calcd. for C35H28N4O4
 
: C, 
73.93; H, 4.96; N, 9.85; O, 11.25 Found: C, 73.83; H, 4.81;  N, 9.67; O,11.15. 
3-((E)-2,3-dihydro-2-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-15) 
Yield : 86%  IR (cm-1):  3619 (OH stretching), 3415(N-H stretching), 3091, 3071 
(Aromatic C-H stretching), 2978 (Aliphatic -CH3 stretching), 2872 (Aliphatic -CH2 
stretching), 1787 (C=O stretching), 1616,1531 (N-H bending), 1561 (C-NO2 
stretching), 1488,1371 (C-H bending), 1321,1271 (OH bending), 1209,1106, (C-N 
bending), 776 (Disubstituted), 691,709 (monosubstituted),  MS: m/z = 583.59; Anal. 
Calcd. for C34H25N5O5
 
: C, 69.97; H, 4.32; N, 12.00; O, 13.71 Found: C, 69.91; H, 
4.31;  N, 10.77; O,13.69. 
3-((E)-2-(3-(4-flourophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,3-dihylro-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-8-methyl-2H-chromen-2-one. (TAP-16) 
Yield : 77%  IR (cm-1):  3589 (OH stretching), 3455(N-H stretching), 3098, 3082 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2883 (Aliphatic -CH2 
stretching), 1778 (C=O stretching), 1636,1522 (N-H bending), 1479,1382 (C-H 
bending), 1321,1282 (OH bending), 1209,1110 (C-N bending), 767 (Disubstituted), 
691,709 (monosubstituted), MS: m/z = 556, 558(M+2); Anal. Calcd. for 
C34H25FN4O3
 
: C, 73.37; H, 4.53; F, 3.41; N, 10.07; O,8.62 Found: C, 73.31; H, 4.51;  
F, 3.37; O,10.01. 
3-((E)-2,3-dihydro-2-(1,3-diphenyl-1H-pyrazol-4-yl)-1H-benzo[b][1,4]diazepin-4-
yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-17)  
Yield : 89%  IR (cm-1):  3601 (OH stretching), 3435(N-H stretching), 3080, 3062 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2883 (Aliphatic -CH2 
stretching), 1776 (C=O stretching), 1636,1542 (N-H bending), 1479,1382 (C-H 
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bending), 1321,1271 (OH bending), 1219,1117 (C-N bending), 767 ( Disubstituted), 
691,709 (monosubstituted), MS: m/z = 552.62; Anal. Calcd. for C35H28N4O3
 
: C, 
76.07; H, 5.11; N, 10.14; O, 8.69 Found: C, 76.05; H, 5.01;  N,10.07; O,8.58. 
3-((E)-2,3-dihydro-2-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)-1H-benzo[b][1,4] 
diazepin -4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-18) 
Yield : 82%  IR (cm-1):  3619 (OH stretching), 3455(N-H stretching), 3091, 3082 
(Aromatic C-H stretching), 2997 (Aliphatic -CH3 stretching), 2871 (Aliphatic -CH2 
stretching), 1767 (C=O stretching), 1616,1542 (N-H bending), 1499,1371 (C-H 
bending), 1310,1271 (OH bending), 1218,1106, (C-N bending), 776 (Disubstituted), 
682,709 (monosubstituted), MS: m/z = 566.65; Anal. Calcd. for C36H30N4O3
 
: 
C,76.31; H, 5.34; N, 9.89; O, 8.47 Found: C, 76.23; H, 5.31;  N, 9.77; O,8.44. 
3-((E)-2-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,3-dihydro-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-19) 
Yield : 84%  IR (cm-1):  3639 (OH stretching), 3455(N-H stretching), 3099, 3071 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2883 (Aliphatic -CH2 
stretching), 1778 (C=O stretching), 1616,1542 (N-H bending), 1499,1382 (C-H 
bending), 1321,1271 (OH bending), 1229,1106 (C-N bending), 776 ( Disubstituted), 
682,729 (monosubstituted), MS: m/z = 587, 589(M+2) ; Anal. Calcd. for 
C35H27ClN4O3
 
: C, 71.61; H, 4.64; Cl, 6.04; N, 9.54; O,8.18  Found: C, 71.53; H, 
4.51;  Cl, 6.01; N,9.51; O,8.17. 
3-((E)-2,3-dihydro-2-(3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-20) 
Yield : 69%  IR (cm-1):  3602 (OH stretching), 3435(N-H stretching), 3190, 3072 
(Aromatic C-H stretching), 2988 (Aliphatic -CH3 stretching), 2863 (Aliphatic -CH2 
stretching), 1776 (C=O stretching), 1636,1531 (N-H bending), 1570 (C-NO2 
stretching),  1479,1378 (C-H bending), 1320 (OH bending), 1209 (C-N bending), 769 
(Disubstituted), 719 (monosubstituted), MS: m/z = 597.62; Anal. Calcd. for 
C35H27N5O5
 
: C, 70.34; H, 4.55; N, 11.72; O,13.39  Found: C, 70.33; H, 4.51;  N, 
11.67; O,13.26. 
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3-((E)-2,3-dihydro-2-(3-(2-hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-21) 
Yield : 87%  IR (cm-1):  3612 (OH stretching), 3455(N-H stretching), 3191, 3032 
(Aromatic C-H stretching), 2998 (Aliphatic -CH3 stretching), 2861 (Aliphatic -CH2 
stretching), 1786 (C=O stretching), 1646,1541 (N-H bending), 1479,1378 (C-H 
bending), 1321(OH bending), 1219 (C-N bending), 759 (Disubstituted), 709 
(monosubstituted), MS: m/z = 568.62; Anal. Calcd. for C35H28N4O4
 
: C,73.93; H, 
4.96; N, 9.85; O, 11.25 Found: C, 73.83; H,9.81;  N, 9.77; O,11.24. 
3((E)-2,3-dihydro-2-(3-(2-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-1H-benzo 
[b][1,4]dizepin-4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-22) 
Yield : 82%  IR (cm-1):  3612 (OH stretching), 3455(N-H stretching), 3110, 3012 
(Aromatic C-H stretching), 2981 (Aliphatic -CH3 stretching), 2861 (Aliphatic -CH2 
stretching), 1778 (C=O stretching), 1632,1533 (N-H bending), 1478,1379 (C-H 
bending), 1320 (OH bending), 1208 (C-N bending), 768 (Disubstituted), 718 
(monosubstituted), MS: m/z = 582.65; Anal. Calcd. for C36H30N4O4
 
: C, 74.21; H, 
5.19; N, 9.62; O,10.98 Found: C, 74.13; H, 5.11;  N, 9.57; O,10.91. 
3-((E)-2,3-dihydro-2-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)-1H- 
benzo[b][1,4]diazepin-4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-23) 
Yield : 86%  IR (cm-1):  3582 (OH stretching), 3445(N-H stretching), 3120, 3071 
(Aromatic C-H stretching), 2998 (Aliphatic -CH3 stretching), 2863 (Aliphatic -CH2 
stretching), 1776 (C=O stretching), 1636,1531 (N-H bending), 1570 (C-NO2 
stretching), 1479,1378 (C-H bending), 1320 (OH bending), 1209 (C-N bending), 769 
(Disubstituted), 719 (monosubstituted), MS: m/z = 597.62; Anal. Calcd. for 
C35H27N5O5
 
: C, 70.34; H, 4.55; N, 11.72; O,13.39 Found: C, 70.23; H, 4.51;  N, 
11.67; O,13.31. 
3-((E)-2-(3-(4-flourophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,3-dihylro-1H-benzo 
[b][1,4]diazepin-4-yl)-4-hydroxy-5,8-dimethyl-2H-chromen-2-one. (TAP-24) 
Yield : 89%  IR (cm-1):  3612 (OH stretching), 3445(N-H stretching), 3191, 3082 
(Aromatic C-H stretching), 2998 (Aliphatic -CH3 stretching), 2861 (Aliphatic -CH2 
stretching), 1786 (C=O stretching), 1626,1521 (N-H bending), 1478,1388 (C-H 
bending), 1321 (OH bending), 1201 (C-N bending), 768 (Disubstituted),718 
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(monosubstituted), MS: m/z = 570, 572(M+2); Anal. Calcd. for C35H27FN4O3
 
: C, 
73.67; H, 4.77; F, 3.33; N, 9.82; O,8.41 Found: C, 73.65; H, 4.59;  F, 3.27; N,9.79; 
O,8.32. 
6.11   RESULTS AND DISCUSSION 
 
In  the current chapter, condensation of coumarinyl chalcones with pyrazole 
aldehydes led to several new benzodiazepines coumarins possessing pyrazole hybrid 
structures. 24 new molecules are prepared and charecterized. The yield of these 
compounds are approximetaly 70-80 percentage. 
 
6.12   CONCLUSION 
 
 The synthetic methodology adopted led to considerable inprovement in the 
reaction hours. The reaction completion time reduced from 8-10 hours to 4 to 5 hours. 
It was observed that the nitro bearing moiety will take longer reaction time. 
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6.13   REPRESENTATIVE SPECTRAS 
 
6.13.1 IR Spectrum of TAP-02 
 
  
6.13.2 MASS Spectrum of TAP-02 
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6.13.3 1
 
H NMR Spectrum of TAP-02 
 
 
6.13.4 Expanded 1
 
H NMR Spectrum of TAP-02 
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6.13.5 IR Spectrum of TAP-05 
 
 
 
6.13.6 Mass Spectrum of TAP-05 
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6.13.7 1
 
H NMR Spectrum of TAP-05 
 
 
6.13.8 Expanded 1
 
H NMR Spectrum of TAP-05 
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7.1 INTRODUCTION 
 
 An anti-microbial is a substance that kills or inhibits the growth of 
microorganisms such as bacteria, fungi, or protozoans. Antimicrobial drugs either kill 
microbes (microbicidal) or prevent the growth of microbes (microbistatic). 
Disinfectants are antimicrobial substances used on non-living objects. 
 
 Antibiotic resistance is a serious concern worldwide as it would result in 
strains against which currently available antibacterial agents will be ineffective. In 
general, bacterial pathogens may be classified as either gram-positive or gram-
negative pathogens. Antibiotics compounds with effective activity against both gram-
positive and gram-negative pathogens are generally regarded as having a broad 
spectrum of activity. The synthesized compounds were preliminary screened gram-
positive and gram-negative pathogens. 
 
 Gram-positive pathogens, for example staphylococci, Enterococci, 
Streptococci and Micobacteria bacteria are particular because of the development of 
resistant strains which is difficult to eradicate from the hospital environment once 
established. Example of such strains are methicilline resistance Staphylococcus 
(MRSA), methicillin resistance coagulase negative. Staphylococci (MRCNS), 
penicillin resistance Streptococcus pnumaniae and multiplied resistance Enteocouccus 
faecium, community acquired pathogens (CAP) and so on. 
 
                              In 1928, a German scientist C.E. Chrenberg first used the term 
“Bacterium” to denote small microscopic organism with a relatively simple and 
primitive form of the cellular organization known as “Prokaryotic”.  
BACTERIA:- 
                              danish physician, Gram in peculiarity, Bacteria are generally 
unicellular E.G. Cocci, Bacilli, Etc… Filamentous, Eg.Actinomycetes, some being 
sheathed having certain cells specialized for reproduction. The microorganisms are 
capable of producing diseases in host are known as ‘Pathogenic’. Most of the 
microorganisms present on the skin and mucous membrane are non pathogenic and 
are often referred to as “Commensals” or if they live on food residues as in intestine, 
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they may be called “Saprophytes”. Generally, the pathogenic Cocci and Bacilli are 
gram positive and the pathogenic coco bacilli are gram negative. 
                            
Fro evaluation of antibacterial activity in our case, we have used 
staphylococcus aureus and streptococcus pyogenes from gram positive group of 
bacteria and escherichia coli and pseudomonas aeruginosa from gram negative Group 
of bacteria. 
 
STAPHYLOCOCCUS AUREUS
 
 : - 
Genus: Staphylococcus [Microccaceae] 
Staphylococci are differentiated from micrococcus, a genus of the same family 
by its ability to utilize glucose, mannitol and pyruvate anaerobically. Cells of 
staphylococci are usually to be found on the skin or mucous membranes of the animal 
body, especially of the nose and mouth where they occur in large numbers even under 
normal conditions. 
 
Species: Staphylococcus Aureus 
The individual cells of S.Aureus are 0.8 To 0.9 micro in diameter. They are 
ovoid or spherical, non motile, non capsulated, non sporing stain with ordinary aniline 
dyes and gram positive, typically arranged in groups of irregular clusters like 
branches of groups found in pus, singly or in pairs. The optimum temperature for the 
growth us 370
 
 C, optimum PH is 7.4 to 7.6. They produce golden yellow pigment, 
which develops best at room temperature. They cause pyoregenic of pus forming 
[Suppurative] conditions, mastitis of women and cows, boils, carbuncles infantile 
impetigo, internal abscess and food poisoning. 
ESCHERICHIA COLI
 
 : - 
Genus: Escherichia [Enterobacteriaceae] 
  This genus comprises escherichia and several variants and are of particular 
interest to the sanitarian since they occur commonly in the formal intestinal tract of 
man and animals. Their presence in foods or in drinking water may indicates faecal 
pollution. E.Coli is the most distinctively recognized feacal species. 
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Species: Escherichia coli 
E.Coli is the most important type in this species, which contains a number of 
other types.escherichia in 1885 discovered in from the faces of the newborn and 
showed the organisms in the intesting within three days after birth. It is a commensals 
of the human intesting and found in the intestinal tract of men and animals and is also 
found in the sewage water, land, soil contaminated by feacal matters. The gram 
negative rods are 2 to 4 micro by 0.4 micro in size, commonly seen in coccobacillary 
form and rarely in filamentous form. They are facultative anaerobes and grow in all 
laboratory media. Colonies are circular, raised, and smooth and emit a faecal odour. 
E.Coli are generally non pathogenic and are incriminated as pathogens because in 
certain instances some strains have been found to produce septicemia, inflammations 
of liver and gall bladder, appendix, meningitis, pneumonia and other infections and 
this species is a recognized pathogen in the veterinary field. 
 
 
STREPTOCOCCUS PYOGENES:- 
Genus: Streptococcus    
The term Streptococcus was first introduced by Bilroth [1874] and the term 
Streptococcus Pyogenes was used by Rosenbach [1884]. These are spherical or ovoid 
cells; divide in one axis and form chains; nonmotile and nonsporing. The growth is 
absence of native proteins in the medium; they produce characteristic haemolytic 
changes in media containing blood; produce acid only by fermentation of 
carbohydrates; often fail t liquefy gelatin; some strains produce exotoxin and 
extracellular products; a few of them are anaerobic. 
 
Species: Streptococcus Pyogenes 
Streptococcus pyogenes is pathogenic to human and found in sore throat, 
follicular tonsillitis, septicemia, acute or malignant ulcerative endocarditis etc. These 
are spherical Cocci 0.5 to 0.75 micro in diameter, arranged in moderately long chains 
of round Cocci and easily differentiated from Enterococci that from short chains of 2 
to 4 spheres. Streptococcus Pyogenes is recently isolated from throat or other lesions; 
they show either mucoid or matt colonies. On keeping in the laboratory, they undergo 
varation to a glossy type. Streptococci are susceptible to destructive agents, and to 
penicillin and sulphomamides. 
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PSEUDOMONAS AERUGINOSA:- 
Genus: Pseudomonas   
Genus Pseudomonas is characterized by gram negative motile rods, 
nonsporing aerobes, oxidase positive, bluish green or yellowish pigment diffusing into 
the medium. Out of 140 species, only one is pathogenic to human. 
 
Species: Pseudomonas aeruginosa 
Ps.aeruginosa occurs as a commensal in the intestine of human and animal’s 
but, when the defensive mechanism of the body is poor. It acts as a minor pathogen 
producing Suppurative wound, otitis media, peritonitis, cystitis, bronchopneumonia 
and empyema. In children it causes diarrhea and septicemia. The pus produced by 
p.aeruginosa is greenish blue. These are gram negative, actively motile, non sporing 
organisms 1.5-3 micro by 0.5 micro with rounded ends and bipolar flagella. They 
occur singly or in pair, of short chains. They grow well in ordinary media under 
aerobic conditions, producing diffusible pigment. 
 
 
 
METHODS USED FOR PRIMARY AND SECONDARY SCREENING: 
Each synthesized drug was diluted obtaining 2000 microgram /ml 
concentration, as a stock solution. 
Primary screen:    In primary screening 1000 micro/ml, 500 micro/ml, and 250 
micro/ml concentrations of the synthesized drugs were taken. The active synthesized 
drugs found in this primary screening were further tested in a second set of dilution 
against all microorganisms. 
Secondary screen:  The drugs found active in primary screening were similarly 
diluted to obtain 200 micro/ml 100 micro/ml, 50 micro/ml, 25 micro/ml, 12.5 
micro/ml, 6.250 micro/ml, and concentrations.  
Reading Result:-                            
The highest dilution showing at least 99 % inhibition zone is taken as MIC. 
The result of this is much affected by the size of the inoculum. The test mixture 
should contain 108 
 
organism/ml.                           
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7.2 MINIMUM INHIBITION CONCENTRATION (MIC) 
 
 In microbiology, MIC is the lowest concentration of an antimicrobial that will 
inhibit the visible growth of a microorganism after overnight incubation. Minimum 
inhibitory concentration are important in diagnostic laboratories to confirm resistance 
of microorganisms to an antimicrobial agent and also to monitor the activity of new 
antimicrobial agents. An MIC is generally regarded as the most basic laboratory 
measurement of the activity of an antimicrobial agent against an organism.  
 MIC can be determined by agar or broth dilution dilution methods usually 
following the guidelines of a reference body such as the CLSI, BSAC or EUCAST. 
There are several commercial methods available, incliuding the well established Etest 
strips and the recently launched Oxiod MIC Evaluator method. 
 The Etest system comprises a predefined and continuous concentration 
gradient of different antimicrobial agents, which when applied to inoculated agar 
plates and incubated, create ellipses of microbial inhibition. The MIC is determined 
where the ellipse of inhibition intersects the strip and is easily read off the MIC 
reading scale on the strip. 
 Clinically, the minimum inhibitory concentrations are used not only to 
determine the amount of antibiotic that the patient will receive but also the type of 
antibiotic used, which in turn lowers the opportunity for microbial resistance to 
specific antimicrobial agents. 
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TABLE- 7.1  MIC VALUE(µg/ml) OF NEWLY SYNTHESIZED COMPOUNDS 
 
CHAPTER -1 
 
 
COMPOUND 
CODE 
 
STRUCTURE 
MIC VALUE (µg/ml) 
S.TYPHI 
MTCC-98 
VI.CHOLERAE 
MTCC-3906 
S.PYOGENUS 
MTCC-442 
C.ALBICANS 
MTCC-227 
 
 
STAB-01 
 
 
 
500 
 
 
500 
 
 
250 
 
 
500 
 
 
STAB-02 
 
 
 
500 
 
 
500 
 
 
500 
 
 
500 
 
 
STAB-03 
 
 
 
250 
 
 
250 
 
 
250 
 
 
250 
 
 
STAB-04 
 
 
 
250 
 
 
200 
 
 
200 
 
 
500 
 
 
STAB-05 
 
 
 
100 
 
 
200 
 
 
250 
 
 
1000 
 
 
STAB-06 
 
 
 
100 
 
 
100 
 
 
200 
 
 
1000 
 
 
STAB-07 
 
 
 
250 
 
 
250 
 
 
500 
 
 
250 
 
 
STAB-08 
 
 
 
500 
 
 
500 
 
 
500 
 
 
250 
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TABLE- 7.2  MIC VALUE(µg/ml) OF NEWLY SYNTHESIZED COMPOUNDS 
 
CHAPTER -5 
 
 
COMPOUND 
CODE 
 
STRUCTURE 
MIC VALUE(µg/ml) 
S.TYPHI 
MTCC-98 
VI.CHOLERAE 
MTCC-3906 
S.PYOGENUS 
MTCC-442 
C.ALBICANS 
MTCC-227 
 
 
STAB-1001 
 
 
 
100 
 
 
100 
 
 
250 
 
 
1000 
 
 
STAB-1002 
 
 
 
250 
 
 
250 
 
 
1000 
 
 
1000 
 
 
STAB-1003 
 
 
 
250 
 
 
250 
 
 
250 
 
 
250 
 
 
STAB-1004 
 
 
 
200 
 
 
200 
 
 
250 
 
 
1000 
 
 
STAB-1005 
 
 
 
200 
 
 
200 
 
 
500 
 
 
500 
 
 
STAB-1007 
 
 
 
250 
 
 
250 
 
 
500 
 
 
250 
 
 
STAB-1009 
 
 
 
500 
 
 
250 
 
 
250 
 
 
500 
 
 
STAB-1010 
 
 
 
500 
 
 
200 
 
 
250 
 
 
250 
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STAB-1012 
 
 
 
100 
 
 
250 
 
 
500 
 
 
500 
 
 
STAB-1015 
 
 
 
200 
 
 
200 
 
 
200 
 
 
100 
 
 
STAB-1016 
 
 
 
200 
 
 
250 
 
 
500 
 
 
500 
 
 
STAB-1017 
 
 
 
250 
 
 
250 
 
 
200 
 
 
1000 
 
 
STAB-1018 
 
 
 
250 
 
 
250 
 
 
250 
 
 
1000 
 
 
STAB-1020 
 
 
 
500 
 
 
250 
 
 
250 
 
 
500 
 
 
STAB-1021 
 
 
 
500 
 
 
200 
 
 
500 
 
 
500 
 
 
STAB-1023 
 
 
 
200 
 
 
250 
 
 
250 
 
 
500 
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TABLE- 7.3  MIC VALUE(µg/ml) OF NEWLY SYNTHESIZED COMPOUNDS 
 
CHAPTER -6 
 
 
COMPOUND 
CODE 
 
STRUCTURE 
MIC VALUE(µg/ml) 
S.TYPHI 
MTCC-98 
VI.CHOLERAE 
MTCC-3906 
S.PYOGENUS 
MTCC-442 
C.ALBICANS 
MTCC-227 
 
 
TAP-01 
 
 
 
500 
 
 
200 
 
 
250 
 
 
500 
 
 
TAP-02 
 
 
 
250 
 
 
250 
 
 
500 
 
 
250 
 
 
TAP-03 
 
 
 
250 
 
 
500 
 
 
500 
 
 
250 
 
 
TAP-04 
 
 
 
500 
 
 
200 
 
 
200 
 
 
1000 
 
 
TAP-05 
 
 
 
200 
 
 
200 
 
 
200 
 
 
1000 
 
 
TAP-09 
 
 
 
250 
 
 
100 
 
 
250 
 
 
250 
 
 
TAP-10 
 
 
 
200 
 
 
250 
 
 
500 
 
 
250 
 
 
TAP-11 
 
 
 
250 
 
 
250 
 
 
500 
 
 
500 
 
 
TAP-13 
 
 
 
200 
 
 
250 
 
 
1000 
 
 
1000 
Chapter – 7                                                                  Biological evaluation of newly..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  255 
 
 
 
TAP-14 
 
 
 
500 
 
 
200 
 
 
250 
 
 
1000 
 
 
 
TAP-16 
 
 
 
500 
 
 
200 
 
 
500 
 
 
1000 
 
 
TAP-17 
 
 
 
250 
 
 
500 
 
 
250 
 
 
>1000 
 
 
TAP-18 
 
 
 
250 
 
 
200 
 
 
200 
 
 
500 
 
 
TAP-19 
 
 
 
100 
 
 
200 
 
 
500 
 
 
500 
 
 
TAP-20 
 
 
 
200 
 
 
250 
 
 
250 
 
 
200 
 
 
TAP-21 
 
 
 
200 
 
 
250 
 
 
500 
 
 
200 
 
 
TAP-23 
 
 
 
62.5 
 
 
250 
 
 
250 
 
 
1000 
 
 
TAP-24 
 
 
 
100 
 
 
250 
 
 
200 
 
 
1000 
 
 
 
 
 
 
 
 
 
Chapter – 7                                                                  Biological evaluation of newly..... 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005  256 
 
TABLE 7.4  STANDATDS DRUGS 
 
MINIMUM  INHIBITION CONCENTRATION(µg/ml) : 
 
DRUG 
 
S.TYPHI VI.CHOLERAE S.PYOGENUS 
MTCC-98 MTCC-3906 MTCC-442 
AMPICILLIN 100 100 100 
CHLORAMPHENICOL 50 50 50 
 
 
MINIMUM FUNGICIDAL CONCENTRATION : 
 
DRUG C.ALBICANS 
MTCC-227 
NYSTATIN 100 
GRESEOFULVIN 500 
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7.3 RESULT AND DISCUSSION 
 
Antimicrobial activity is shown by STAB-05, STAB-06, TAP-09, TAP-19, 
TAP-23, TAP-24, STAB-1001, STAB-1012, STAB-1015 and these compounds are 
moderately active. The rests of the compounds are poorly active.  
 
TABLE 7.5 
  
Sr. No. Code Structure 
1 STAB-05 
 
2 STAB-06 
 
3 TAP-09 
 
4 TAP-19 
 
5 TAP-23 
 
6 TAP-24 
 
7 STAB-1001 
 
8 STAB-1012 
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9 STAB-1015 
 
 
 
 
 
 
7.4 CONCLUSION 
 
 As mentioned in Table No. 7.5, among the synthesized compounds, two 
compounds from dihydropyridines, four from diazepines and three from Cyano 
pyridine analogues have shown good activity. Coumarin bearing DHPs, Diazepines 
and Cyano pyridine are good scaffold for anti microbial activity. On the basis of the 
above interesting results, new synthetic programmes can be planned to develop more 
active compounds. 
Summary 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                             
 
 SUMMARY 
 
 The work represented in the thesis entitled “Studies on Bioactive 
Heterocycles and other moieties” is divided into seven chapters which can be 
summarized as under. 
 
Chapter-1 The synthesis of pyrazole aldehydes and dihydropyridines remains of 
great interest owing to the wide applications in pharmaceutical for their analgesic, 
antipyretic, antibacterial, multidrug resistance and anti inflammatory properties. 
Synthesis and yield optimization of 1,4-dihydropyridines was carried out in this 
chapter by modified simple and fast conventional method. Eight (8) compounds were 
synthesized and studied for Antimicrobial activity. To confirm the structure of 1,4-
dihydropyridine, single crystal was developed and data were collected.  
Chapter-2 deals with the introduction and preparation of dihydropyridines. 
Dihydropyridines were prepared by reacting the benzoylactone with different 
substituted pyrazol aldehyde. The compounds synthesized in this chapter possess the 
DHP nucleus and are basically pyrazole core structure at C-4 position. In this chapter, 
16 compounds enlisted which are newly synthesized bioactive compounds for various 
biological activities. 
Chapter-3 covers the preparation of 16 Unsymmetric dihydropyridines by three 
component reaction. Under normal conditions the DHPs were prepared by refluxing 
the aldehydes, 3-aminocrotononitrile and methyl acetoacetate/ethyl acetoacetate more 
than 10 hours, but by newer protocols, it takes only one hour. Thus, a simple, easy 
and fast method for preparation of dihydropyridine is developed. 
Chapter-4 encompasses the rapid microwave assisted synthesis of different 
chalcones. Charting out the important of coumarin and chalcone nucleus, the chapter 
starts with the introduction to the chalcone systems and the previous synthetic routes 
thereof. Different Pyrazole aldehydes and 3-acetyl 4-hydroxy coumarin  were taken 
using microwave irradiation as the nonconventional source of energy and a green 
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synthetic approach. Again the inclusion of two bioactive motifs like coumarin and 
pyrazole aldehyde nucleus into a single skeleton to arrive at “drug like” structure.  
Chapter-5 deals with the preparation of 24 different Cyanopyridines by conventional 
as well as microwave irradiation method and comparative study thereof. The yield of 
the compound synthesized in this chapter by microwave method is more than the 
conventional method. The study reveals that the time taken by the microwave method 
is approximately 5-10 minutes only in compare to conventional method which it takes 
5-6 hours.  
Chapter-6 covers the condensation reaction of coumarinyl chalcones with pyrazole 
aldehyde led to several new benzodiazepines clubbed coumarins possessing pyrazole 
hybrid structure. 24 new molecules are prepared and characterized in this chapter. The 
yield of these compounds is approximately 70-80 percentage. The compounds 
synthesized in this chapter are screened for antimicrobial activity.   
Chapter-7 narrates the biological activity study of the synthesized compounds which 
have been screened for Antimicrobial activity against four strains namely S.TYPHI, 
VI.CHOLERAE, S.PYOGENUS as well as C.SLBICANS. The protocol by which the 
activity study has been carried out is also discussed in brief in the chapter. Some 
preliminary results were found and only few compounds are moderately active either 
against all strains or against any single strains. The standard antimicrobial drugs like 
Ampicillin, Chloramphenicol, Nystatin as well as Greseofluvin were used as reference 
standards for the screening. Moderate to weak antimicrobial compounds as the drugs 
have a significantly lower MIC value. The details of specific active compounds are 
given in Table No. 7.5. 
 The synthesized compounds are also under screening for Anticancer, Anti-
tubercular as well as multi drug resistance reversal (mdr) activity study, the results of 
which are awaited. 
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Funded Department of Chemistry, Saurashtra University, Rajkot dated March, 
3-4, 2009. 
 
 DST-FIST, UGC (SAP) supported and GUJCOST Sponsored “National 
Workshop on Management and Use of Chemistry Database and Patent 
Literature” organized by GUJCOST & Dept. of Chemistry of Saurashtra 
University, Rajkot, (Gujarat), dated February, 27-29, 2008. 
 
 PAPER/POSTER PRESENTED AT THE INTERNATIONAL 
CONFERENCE
 
: 
 “Invitro cytotoxic evaluation of indoline based anticancer compounds 
against MCF (breast cancer) celllines” 
Shailesh Thakrar, Manu Jaggi, Anu singh Anamik Shah* 
Poster presented at 13th ISCB International Conference was organized on 
“Interplay of Chemical and Biological Sciences: Impact on Health and 
Environment” at Delhi University, Delhi on 26th February - 1st
 “Synthesis of Hybrid Structures : Thiazole linked coumarin derivatives” 
 March 2009  
Shailesh Thakrar and Arun Mishra* 
Poster presented at 14th
 “Synthesis and Anticoagulant activity of dimeric 4-hydroxycoumarins having 
indole and chromone as central linkers” 
 ISCB International conference on chemical biology for 
discovery: perspectives and challenges, CDRI, Lucknow, 15-18 Jan., 2010. 
Shrey Parekh and Shailesh Thakrar, Anamik Shah* 
Poster presented at 14th ISCB International conference on chemical biology for 
discovery: perspectives and challenges, CDRI, Lucknow, 15-18 Jan., 2010. 
